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Abstract*
Km values were measured for zero-trans entry of 2-deoxy-D-glucose and 
p-D-fructose into Xenopus oocytes heterologously expressing GLUT2. GLUT2 
transports 2-deoxy-D-glucose with a Km of 11 mM and D-fructose with a Km of 
67 mM. Ki values for D-glucose, m altose, D-fructose and  cytochalasin B 
inh ib ition  of 2-deoxy-D-glucose tran sp o rt by GLUT2 w ere m easured. 
Inhibition of 2-deoxy-D-glucose transport by D-glucose, maltose and D-fructose 
was competitive, with Ki values of 6.5 mM, 125 mM and 200 mM, respectively. 
Inhibition by cytochalasin B was non-competitive, w ith a K\ of 6.9 |iM. In 
addition, Ki values were measured for D-glucose, maltose, and cytochalasin B 
inhibition of D-fructose transport by GLUT2. D-glucose and m altose were 
com petitive  inh ib ito rs d isp lay ing  Kj values of 15.3 mM and 116 mM, 
respectively. Inhibition by cytochalasin B was non-com petitive, with a Ki 
value of 6.1 pM.
The inhibitory effects of L-sorbose and 2,5-anhydro-D-mannitol, P-D- 
fructopyranose and p-D-fructofuranose analogues, respectively, on 2-deoxy-D- 
glucose transport into Xenopus oocytes by heterologously expressed GLUT2, 
were investigated. L-sorbose and 2,5-anhydro-D-mannitol both competitively 
inhibited 2-deoxy-D-glucose transport with Ki values of 170 mM and 26 mM, 
respectively, suggesting that p-D-fructose is likely to interact with GLUT2 in 
the furanose ring form.
The structural basis of sugar binding to GLUT2 has been investigated 
using a range of hexoses, halogeno- and deoxy-D-glucose analogues to inhibit 
the transport of 2-deoxy-D-glucose by GLUT2 expressed heterologously in 
Xenopus oocytes. Results indicate that hydrogen bonding is im portant at the 
C-l, C-3, and to a lesser extent at the C-4 and C-6 hydroxyls of D-glucose, and 
that hydrophobic interactions at the C-6 position m ay also prove important.
The results obtained for GLUT2 have been compared with those published for 
GLUT1 and GLUT4, and with GLUT3 in oocytes, and the binding patterns of 
the transporters were found to be broadly sim ilar but this varied subtle^ 
between isoforms. A model has been produced to show the interactions of D- 
glucose and D-fructose with the exofacial binding site of GLUT2.
Site-directed m utagenesis and recom binant polymerase chain reaction 
(PCR) technology have been used to construct a series of nineteen m utant 
GLUT3 cDNAs. These contain single codon changes such that each cDNA 
encodes a protein with a single transm em brane helix 8 residue substituted 
w ith alanine. These transporter cDNAs have been used as a template for in 
vitro synthesis of mRNA which has been injected into Xenopus oocytes. Each 
of these m utants has been found to transport 2-deoxy-D-glucose at levels 
betw een 40-200% of that m easured with w ild-type GLUT3, but expression 
levels have not yet been determined.
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CHAPTER 1. 
Introduction.
1.1 General Background.
The utilisation of glucose as an energy source by mam m alian cells has 
been a subject of great interest for many years. One im portant aspect of 
glucose metabolism relates to the transport of glucose across the cellular 
plasma membrane. There are three m ethods by which this event can occur 
(reviewed in Carruthers, 1990). The first is simple, bidirectional diffusion 
which, due to the polar nature of the glucose molecule, is predicted to be 
much too slow to meet the energy requirements of cells. Therefore, a protein- 
m ediated m ethod of uptake was thought to be responsible for the bulk of 
sugar uptake. The second m ethod of uptake is rapid, bidirectional, protein- 
mediated facilitated diffusion; and the third is rapid, active protein-mediated 
transport. Facilitated transport does not require a coupled energy-providing 
reaction such as ATP hydrolysis, or cotransport of an ion. A lthough 
facilitated transport is bidirectional, net transport always occurs down the 
sugar's concentration gradient, i.e. from high to low concentration.
Both types of protein-m ediated transport have been observed in 
m am m alian cells, bu t although alm ost all cells exhibit sugar uptake by 
facilitated diffusion, only those of the absorptive epithelia of the gut and 
reabsorptive epithelia of the kidney possess the ability to actively transport 
glucose, which is coupled to the cotransport of sodium. Active transporters 
are not required elsewhere since blood glucose levels are kept roughly 
constant at the relatively high concentration of 5-10 mM, thus enabling 
passive uptake by cells as glucose can be transported down its concentration 
gradient.
The observations of saturation of sugar transport by erythrocytes at 
high sugar concentrations (Widdas, 1952) and competition between different 
sugars (reviewed in LeFevre, 1961) for transport, suggested that transporters
follow  sim ple M ichaelis-M enten sa tu ra tion  kinetics and  behave like 
enzymes, with D-glucose as the substrate on one side of a membrane and the 
product on the other. The kinetics of D-glucose uptake were also found to 
vary su b tly  betw een tissues, predicting the existence of m ore than one 
facilitative transporter.
The existence of a protein moiety responsible for the uptake of glucose, 
was dem onstrated by Jung who showed that the transport capacity of the 
erythrocyte was retained by erythrocyte ghosts bu t not by erythrocyte lipids 
alone (Jung, 1971). This finding was reinforced by the observation that very 
low concentrations of two com pounds, cytochalasin B and phloretin, are 
capable of inhibiting transport very efficiently with Ki values of 140 nM and 
200 nM, respectively (Bloch, 1973; Zoccoli et al, 1978; LeFevre & Marshall, 
1959).
Although protein-mediated uptake of sugar had been detected in many 
tissue types, all the early kinetic studies w ere perform ed on hum an 
erythrocytes, since they could be obtained easily and in great quantity. They 
also p rov ided  a sim ple experim ental system  w hich could be easily 
m anipulated. The transporter protein content of hum an erythrocytes has 
since been determ ined to be 5% of the total m em brane protein (Allard & 
Lienhard, 1985). Studies were performed by several groups in the early 1970s, 
investigating the nature of the transporter's sugar binding site, which was 
predicted to utilise hydrogen bonding to reversibly bind glucose (Barnett et al., 
1973; Kahlenberg & Dolansky, 1972). These studies are reviewed in Chapter 4.
The functional purification of the erythrocyte transporter was achieved 
independently by two groups. The first group based their purification on the 
ability of reconstitu ted fractionated erythrocyte m em brane proteins to 
transport glucose (Kasahara & Hinkle, 1977). The second group used the 
specific binding of the transport inhibitor cytochalasin B as a basis for the
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purification procedure (Baldwin et al., 1979; Baldwin et al., 1981). Both studies 
revealed a heterogeneously glycosylated integral m em brane protein  which 
migrated on SDS-polyacrylamide gels as a broad band with an approxim ate 
molecular mass of 55 kDa, which was reduced to a mass of 46 kDa upon 
treatment with Endoglycosidase H. When this protein was reconstituted into 
phospholipid vesicles it behaved in an identical fashion kinetically to native 
protein (Wheeler & Hinkle, 1981). Additionally, when present in vesicles this 
protein binds cytochalasin B at a stoichiom etric ratio of 1: 1 (Baldwin & 
Lienhard, 1989). The purification of the erythrocyte transporter led to the 
production of antibody probes (Sogin & Hinkle, 1978) and its partial protein 
sequencing. This in turn led to cloning and sequencing of the transporter 
from hum an hepatoma G2 (HepG2) cells (Mueckler et al., 1985). This glucose 
transporter has been named GLUT1 (Fukumoto et al., 1989). Other members 
of the facilitative glucose transporter family have been nam ed GLUTs 2-7, in 
the chronological order of the isolation of cDNAs.
1.2 Tissue-specific D istribution of the Facilitative Glucose Transporter
Family.
1.2.1 General.
The unique requirem ents of different mammalian tissues for glucose, 
and the varying needs of each tissue for glucose at distinct stages of 
development, suggests the necessity for one or more regulatory mechanisms. 
A family of glucose transporters had been suspected to exist for m any years, 
reinforced by the observation that different tissues display unique kinetics for 
D-glucose uptake. This family comprises six members to date (GLUTs 1-7, of
which GLUT6 is a pseudo-gene sequence) which are structurally very similar 
and distinct from the mammalian active sodium -linked transporters of the 
intestinal and kidney absorptive epithelia.
1.2.2 GLUT1.
GLUT1 is the most extensively studied member of the family to date 
and is the only m ember of the family to be purified in a functional form 
(K asahara & H inkle, 1977). GLUT1 is o therw ise referred  to as the 
erythrocyte/brain  or HepG2 transporter since clones encoding it were first 
isolated from rat brain and HepG2 cDNA libraries using antibodies raised 
against purified GLUT1 (Birnbaum et al, 1986; Mueckler et al., 1985). These 
cDNAs were found to encode 492-residue proteins, which are more than 97% 
identical in sequence, and were predicted to span the m em brane bilayer 12 
times by hydropathy analysis (Mueckler et al., 1985). Since then GLUT1 has 
been cloned from mice (Kaestner et al., 1989), rabbits (Asano et al, 1988) and 
pigs (Weiler Guttler et al, 1989). All cDNAs encode a 492-residue protein 
with 97% sequence identity to hum an GLUT1.
The isolation of a hum an GLUT1 cDNA clone led to the production of 
oligonucleotides which enabled the screening of tissues for the presence of 
GLUT1 mRNA. This paralleled  studies perform ed w ith  anti-GLUTl 
antibodies looking at the relative protein levels in the various tissue types. 
Highest levels of GLUT1 protein in hum an adults were found in erythrocytes 
(Allard & Lienhard, 1985). It was also abundant in blood-tissue barriers 
(reviewed in Takata et al, 1990) such as the blood-brain barrier, the blood- 
nerve barrier, the placenta syncytiotrophoblast and various blood-eye barriers, 
although it was found in almost every tissue. Only very low levels were 
found in the liver. High concentrations were found in all foetal tissues,
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including heart, liver and brown fat which possess very little GLUT1 in adults 
(Asano et al., 1988; Santalucia et al., 1992). Cultured cell lines also have 
elevated levels of GLUT1 protein (reviewed in Gould & Holman, 1993).
Since GLUT1 is expressed at some level in most tissues it has been 
proposed to be a basal transporter, not responsible for the post-prandial 
insulin-stim ulated uptake of sugar by adipose tissue and skeletal muscle, 
although it is also expressed at lower levels in these tissues. The Km for zero- 
trans entry  of D-glucose into cells at 37°C by GLUT1 is 7 mM (Lowe & 
Walmsley, 1986). This allows GLUT1 to efficiently transport glucose in its 
physiological concentration range. H ow ever the reason for its high 
expression levels in erythrocytes, w here it constitutes 5% of the total 
membrane protein, is unclear (Allard & Lienhard, 1985).
The abundance of GLUT1 in blood-tissue barriers suggests that a 
prim ary role of this protein is the transepithelial and transendothelial 
transport of D-glucose.
GLUT1 is found universally at high levels in all foetal tissues (Asano et 
al., 1988), including adipose tissue and muscle, where no GLUT4 has been 
found. It established that mammalian foetal erythrocytes have a high capacity 
for transport and that this ability is lost soon after birth (Widdas, 1955). It has 
been suggested that this high capacity erythrocyte transporter facilitates the 
transfer of glucose across the placenta into the intracellular space of the foetal 
erythrocyte, and that this occurs to a lesser extent across the blood-tissue 
barriers in adult primates (Jacquez, 1984).
The reason for the existence of elevated levels of GLUT1 protein in 
transform ed cells and all cultured cell lines is unknown. However, it has 
been shown that m any mitogens stim ulate the transcription of the GLUT1 
gene (reviewed in Merrall et al., 1993), as does glucose starvation (reviewed in
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Gould & Holman, 1993). Cultured cells are continually subjected to these 
conditions.
1.2.3 GLUT2.
Since the quantities of GLUT1 detected in liver w ere very low, and 
because this tissue displays notably different kinetics for D-glucose uptake 
from GLUT1, it was likely that this tissue was host to a related transporter. 
Hepatocyte cDNA libraries were screened by low stringency hybridisation 
using GLUT1 cDNA as a probe. This led to the isolation of GLUT2 clones 
from hum an (Fukumoto et al., 1988), rat (Thorens et al., 1988) and mouse 
(Suzue et al, 1989) cDNA libraries. These encode proteins of 522, 523 and 524 
residues, respectively, and share 80% identity. H um an GLUT2 has 55% 
sequence identity  with hum an GLUT1, and both pro teins have virtually 
superim posable hydropathy  plots. M ost d iversity  occurs in the large 
extracellular loop and at the extreme C-terminus (Figure 1.1).
Screening of tissue types by imm unocytochemical techniques showed 
high GLUT2 protein levels in the p-cells of the Islets of Langerhans in the 
pancreas (Thorens et al., 1988; Orci et al., 1989), in the transepithelial cells of 
the intestine and the kidney (Thorens et al, 1990), as well as the hepatocytes of 
the liver itself. Here its expression was found to be restricted to the sinusoidal 
plasma membrane of hepatocytes, where it was expressed at high levels in the 
periportal area, with a steady decrease in numbers tow ard the perivenous area 
(Thorens et al, 1990; Hacker et al., 1991). GLUT2 protein has also been found 
expressed at very low levels in all brain regions (Brant et al., 1993).
In the liver, GLUT2 is required for the influx of postprandial glucose, 
and under fasting conditions, for the release of glucose produced from
glycogenolysis and gluconeogenesis into the b loodstream . The high 
concentration of GLUT2 in the plasma m embranes of hepatocytes, coupled 
with the transporter's high Km values for D-glucose entry and exit (reviewed 
in Elliot & Craik, 1982), allows for a rapid, non-saturable translocation of D- 
glucose in either direction in times of stress.
The presence of GLUT2 in the Islets of Langerhans is strictly limited to 
the C-cells, which release insulin- there is no expression in the a -  or y- cells 
(Thorens et al, 1988; Orci et al, 1989). This specific distribution of expression, 
coupled w ith the high Km value of GLUT2 led to the speculation that this 
isoform m ight allow glucokinase, which is the rate-lim iting step in liver 
glucose metabolism (Vischer et al, 1987), to act as a blood glucose level sensor 
(Thorens et al, 1988; Orci et al, 1989) over the range of blood sugar levels 
which stim ulate insulin secretion (5- 15 mM). Presum ably the high Km 
would ensure that the uptake of glucose into the P-cell would be linear over a 
large range of concentrations rather than saturating at low levels like GLUT1. 
This would allow the production of an intracellular metabolite of D-glucose 
to be a rate-limiting step in an unidentified pathw ay leading to the release of 
insulin. Simulations of the transport of D-glucose by cells possessing glucose 
transporters with a range of Km values and similar capacities for glucose 
transport suggest that those w ith high Km values are less efficient at 
producing rapid equilibration of D-glucose between interstitial and cytosolic 
water (Herbert & C arruthers, 1991). Therefore it is likely to be the high 
capacity (Vmax) of GLUT2-expressing p-cells for D-glucose that enables them to 
act as a glucose sensor, not the low affinity property (high Km) of GLUT2 . 
Results obtained from studies with two insulinom a cell lines, one of which 
expresses GLUT1 in addition to GLUT2, show that only the cell line which 
expressed GLUT2 alone secreted insulin in response to elevated glucose levels 
(Miyazaki et al, 1990). Both cell lines produced insulin mRNA, so this would
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suggest that the defect in the GLUTl-containing cell-line occurs due to the 
presence of that isoform, which may lead to non-linear influxes of sugar. 
However, there might also be some other undefined defect in the GLUT1- 
expressing cell line which leads to this phenotype.
GLUT2 is also found in the basolateral surfaces of the transepithelial 
cells of the intestine and of the proximal tubule of the kidney (Thorens et ah,
1990). In the intestine, it is proposed to work in conjunction with SGLT1, the 
active glucose transporter, which is present on the apical surface of the same 
cells. SGLT1 actively transports glucose against its concentration gradient 
from the lumen of the gut into the cell, utilising the energy obtained from the 
cotransport of sodium  ions. This leads to the build-up of high glucose 
concentrations in the cell which are released down the concentration gradient 
into the blood by GLUT2. A similar situation occurs in the proximal tubule of 
the kidney, where SGLT1 is responsible for the reabsorption of D-glucose, and 
GLUT2 functions to translocate it from the epithelial cells into the blood.
W herever it is expressed, GLUT2 seems to play an im portant role in 
glucose homeostasis.
1.2.4 GLUT3.
GLUT3 clones were isolated and cloned from a hum an foetal skeletal 
m uscle (Kayano et al., 1988) and m ouse (N agam atsu et al., 1992) cDNA 
libraries, encoding proteins w ith 496 and 493 residues, respectively. These 
share 83% identity and the hum an isoform has 64% identity  w ith hum an 
GLUT1. An avian homologue of GLUT3 has also been cloned (White et al,
1991).
N orthern analysis of hum an tissues showed that GLUT3 mRNA was 
expressed in almost every tissue type, but was found at particularly high
levels in neurones and brain, especially in the cerebrum (Kayano et al., 1988). 
Surprisingly, very little was found in skeletal muscle itself, so GLUT3 was 
ruled out as a candidate for insulin-stimulated glucose uptake by that tissue.
This ubiquitous distribution of human mRNA contrasted strongly with the 
same analysis of monkey, rat, rabbit and m ouse tissues (Nagam atsu et al., 
1992; Maher et al., 1992; Yano et al., 1991), which show ed that GLUT3 mRNA 
was confined to neural tissue and brain. Immunological studies show that 
GLUT3 protein is expressed in most areas of rat brain, and also in primary 
cultured rat cerebellar neurones and neuronal cell lines (Maher et al., 1992).
Studies screening hum an tissues using anti-GLUT3 antibodies showed 
that GLUT3 protein was present at high levels in neural tissue and brain, and 
at lower levels in placenta, liver, heart and kidney (Gould et al., 1992; 
Shepherd et al., 1992). None was found in skeletal muscle. GLUT3 expression 
is expressed in virtually all regions of the brain, bu t is expressed at different 
levels in different sections (Brant et al., 1993). The apparen t differences 
betw een hum an GLUT3 protein and mRNA levels in other hum an tissues 
may be due to neural contamination of tissues used for N orthern analysis, or 
to post-transcriptional regulation of the mRNA in non-neural tissues. The 
differences in tissue-specific mRNA and protein expression levels measured 
in hum ans and other species are not known.
The brain is dependent on glucose as an energy source since it is unable 
to derive energy from fatty acid hydrolysis. It is docum ented that the glucose 
concentrations of the extracellular fluid of the brain are lower than those 
found in the plasm a (Lund-Andersen, 1979). GLUT3 has been shown to 
exhibit relatively low Km values for 2-deoxy-D-glucose zero-trans entry (1.4 
mM) (Colville et al., 1993) and 3-O -m ethyl-D -glucose u n d e r equilibrium  
exchange conditions (10 mM) (Gould et al., 1991). This leads to the 
speculation that this glucose transporter is probably responsible for the more
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efficient uptake of glucose by the brain under hypoglycaem ic conditions, 
where its low Km value allows it to transport glucose more efficiently. GLUT3 
is probably not responsible for transport under hyperglycaemic conditions, 
since GLUT1, which is co-expressed in brain, can transport glucose more 
efficiently at higher concentrations.
1.2.5 GLUT4.
GLUT4 cDNA was finally obtained in 1989, where its isolation was 
reported sim ultaneously by five separate groups. It was cloned from human 
(Fukumoto et al., 1989; James et al., 1989), rat (Birnbaum, 1989; Charron et al,
1989), and m ouse (Kaestner et al., 1989) cDNA libraries. These encode 
proteins of 509, 509 and 510 residues, respectively, and share about 95% 
sequence identity . The hum an GLUT1 and GLUT4 isoform s are 65% 
identical. A gain, h yd ropathy  analysis of the p rim ary  sequence is 
superim posable w ith those of the other members of the family. The major 
differences in sequence occur at the N-terminus, where GLUT4 is 12 residues 
longer, in the central loop and the C-terminus.
Subsequent im m unolabelling studies w ith various tissue sam ples 
showed that GLUT4 is predom inantly present in brown and white adipose 
tissue, skeletal m uscle and heart, those tissues which exhibit insulin- 
stim ulated uptake of glucose (James et al, 1988; James et al, 1989), although it 
has been discovered at low levels in the cerebellum, hypothalam us, and the 
pituitary (Brant et al, 1993).
M easurem ent of the rate of glucose transport into rat adipose cells has 
shown that transport is increased 20- to 30-fold above basal levels in response 
to insulin (Taylor & Holm an, 1981; May & Mikulecky, 1982; W hitesell & 
Gliemann, 1979; Simpson & Cushman, 1986; Holman et al, 1990). Rat muscle
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transport is increased 7-fold on exposure to insulin (Ploug et al., 1987). The 
effect of insulin on human adipocytes and skeletal muscle are only 2- to 4-fold 
(Pederson & Glieman, 1981) and 2-fold (Dohm et al., 1988) stim ulations of 
transport, respectively.
These effects were found to be caused prim arily by an increase of the 
Vmax of these tissues for glucose (Taylor & Holman 1981; May & Mikulecky, 
1982; W hitesell & Gliemann, 1979; Simpson & C ushm an, 1986). This has 
been found to be caused by a rapid translocation of GLUT4 transporters from 
an intracellular location to the plasma membrane after insulin exposure both 
in fat (Cushman & W ardzala, 1980; Suzuli & Kono, 1980) and skeletal muscle 
(Klip et al., 1987; H irshm an et ah, 1990; Klip et al., 1992). It has been shown 
that these transporters cycle continuously in the absence of insulin but at any 
point in time m ost are present in an endosom al-like com partm ent. Upon 
stimulation, the exocytosis of transporter is stim ulated and it appears in large 
quantities on the cell surface (reviewed in Holman et al., 1994).
When expressed in Xenopus oocytes, GLUT4 has been found to display 
equilibrium  exchange Km values for 3-O-methyl-D-glucose of 1.8 mM (Keller 
et al., 1989). and 4.3 mM (Nishimura et al., 1993) com pared to a value of 26.2 
mM obtained with GLUT1 (Nishimura et al., 1993). Turnover numbers were 
calculated to be sim ilar for both transporte r isoform s (20,000 m in-l) 
(N ishim ura et al., 1993), which is comparable to the figure of 10,000 m in 'l 
previously observed with GLUT1 (Gould & Lienhard, 1989). This would 
indicate that at low substrate concentrations, GLUT4 w ould be responsible for 
the m ajority of glucose uptake in hum an tissues, and tha t insulin- 
stimulation increases the quantity of GLUT4 to > increase the up take  at 
higher concentrations (Nishimura et ah, 1993).
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1.2.6 GLUT5.
GLUT5 cDNA was isolated from hum an small intestine (Kayano et al.,
1990). It encodes a 501 residue transporter which has 40% identity w ith 
hum an GLUT1. GLUT5 mRNA and protein has been found at highest levels 
in the small intestine, bu t low levels have been found in kidney, skeletal 
muscle, brain and adipose tissue (Davidson et al., 1992; Shepherd et al., 1992). 
Its distribution in the intestine is lim ited to the apical brush border of the 
transepithelial cells, where it is co-expressed with SGLT1, the active, sodium- 
linked transporter. The function of GLUT5 in this location is probably the 
absorption of dietary fructose from the lumen. This conclusion is based on 
the finding that GLUT5, when expressed in Xenopus oocytes, transports D- 
fructose with a Km value of 6 mM (Burant & Bell, 1992) but has very poor 
affinity for D-glucose.
The presence of low levels of GLUT5 in other tissues m ight enable 
these to transport D-fructose, but it is not know n w hether other fructose 
transporters also exist.
1.2.7 GLUT6.
A GLUT6 cDNA clone was isolated at the same time as GLUT5 (Kayano 
et al, 1990). The cDNA sequence had 80% identity with hum an GLUT3, bu t 
also was found to contain multiple stop codons and frame shift m utations, so 
was unlikely to encode a functional transporter protein. It was suggested that 
the transcript was formed by the insertion of a reverse-transcribed copy of a 
ubiquitously expressed gene (Kayano et al., 1990).
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1.2.8 GLUT7.
GLUT7 cDNA was cloned from a rat cDNA library (W addell et al.,
1992). It encodes a 528 residue protein which has 68% identity w ith rat 
GLUT2. A major difference between the amino acid sequences of these two 
isoforms is the presence of a six amino acid endoplasm ic reticulum  targeting 
motif (K K X K X X) at the C-terminus of GLUT7. GLUT2 and GLUT7 cDNA 
sequences are completely identical at three locations and there is very little 
base-drift over large sequences of the cDNA. Although the sequences do not 
coincide with the intron-exon boundaries (Bell et al., 1990), it is possible that 
GLUTs 2 and 7 mRNA are generated by an unknow n splicing mechanism 
(Waddell et a/., 1992).
W estern blotting experiments have shown that GLUT7 is expressed in 
the microsomal fraction of rat hepatocytes (W addell et a l,  1991), and is also 
localised to the endoplasm ic reticulum  w hen expressed in COS-7 cells 
(Waddell et al., 1992).
The expression of a glucose transporter localised in the endoplasmic 
reticulum of hepatocytes is an im portant discovery. The liver is a key factor 
in the regulation of blood glucose levels. It is responsible for the uptake and 
release of glucose (m ediated by GLUT2) u n d er hyperglycaem ic and 
hypoglycaemic conditions respectively. However the term inal step in both 
glycogenolysis and gluconeogenesis, the dephosphorylation of glucose-6- 
phosphate by glucose-6-phosphatase, occurs in the lum en of the hepatocyte 
endoplasmic reticulum. To be released from the cell, glucose m ust traverse 
the endoplasm ic reticulum  m em brane to the cytosol from  which it is 
transported into the bloodstream by GLUT2. Until the discovery of GLUT7, it 
was not understood how this initial transport event occurred.
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1.3 Structure of the Mammalian Facilitative Glucose Transporter Family.
1.3.1 General Studies.
After the purification of GLUT1 (Kasahara & Hinkle, 1977) and the 
isolation of the cDNAs encoding the m em bers of the hum an  glucose 
transporter fam ily (section 1.2), it was possible to p red ic t a comm on 
m em brane-spanning topology for each of the transporter isoforms. Using 
hydropathy analysis of the primary sequence of GLUT1 (Mueckler et al, 1985) 
a pattern was obtained where twelve regions were long enough (21 residues) 
and  sufficien tly  hydrophobic  to form  hyd rophob ic  or am ph ipath ic  
m em brane-spanning a-helices (Figure 1.1). The N- and C-termini and the 
large loop between transmembrane helices 6 and 7 are predicted to lie on the 
cytoplasmic side of the membrane and the other loop, between helices 1 and 2, 
on the extracellular side. The other transporter sequences align together very 
closely and have very similar hydropathy plots. The sequences predicted to be 
transmembrane helices are most conserved between transporter isoforms and 
the extramembranous regions, especially the two large loops and the N- and 
C-term ini are least conserved. Five of the transm em brane helices are 
predicted to be amphipathic; helices 3, 5, 7, 8 and 11 (Mueckler et al., 1985), 
which could form a hydrophilic "pore" through the m em brane bilayer 
allowing the passage of D-glucose.
The structure is divided into two halves by the large intracellular loop 
between helices 6 and 7, although it is not know n w hether this division is 
significant in the tertiary  structure. The other cytoplasm ic loops are 
uniform ly short (eight residues long) and probably serve to restrict the 
m ovement of the transmembrane helices. The extracellular loops are not so
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conserved in size and sequence as those on the cytoplasmic side. This may 
allow the protein some flexibility of movement during transport.
Conserved sequence motifs in the glucose transporters include: GRR(K) 
betw een transm em brane helices 1 and 2, w hich is repeated  betw een 
transmembrane helices 7 and 8; EXXXXXXR between transm em brane helices 
4 and 5, and again between helices 10 and 11; and PESPR present in the 
cytoplasmic loop between helices 6 and 7, which is paralleled by the PETKG 
motif in the C-terminal cytoplasmic loop. The repetition of these sequences 
in the same position of the N- and C-terminal halves of the transporters 
suggest that the transporters m ay have evolved from an ancestral 6 
transmembrane helix membrane protein by a gene duplication event (Maiden 
et al., 1987; Baldwin & Henderson, 1989). This, and the constraints imposed by 
the short length of the cytoplasmic loops, suggest that the transporter tertiary 
structure may be composed of two groups of six helices in a bilobular structure 
(Hodgson et al., 1992) as observed with low. resolution electron microscopic 
images of E. coli lactose permease (Li & Tooth, 1987). Photolabelling studies 
and proteolytic digestion have suggested that the glucose binding sites are 
located in the C-terminal half of GLUT1 (section 1.7), so transport occurs in 
this region, but the N-terminal half of the protein might also play a role.
An alternative topology has been described where the transporters 
have 16 p-sheet transm em brane helices, form ing a large P-barrel structure 
(Fischbarg et al, 1993). This is, however, not generally accepted.
1.3.2 Topology studies.
This section summarises studies aimed at delineating the topology of 
GLUT1. Tryptic digestion of GLUT1 (Cairns et al., 1987) yields two peptides 
corresponding to GLUT1 residues 213-269 and residues 457-492 only when
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trypsin is present on the cytoplasmic side of erythrocyte m embranes. These 
fragments are predicted to form part of the cytoplasmically disposed large 
intracellular loop and C-terminal sequence respectively. Specific antibodies 
raised against peptides representing these sequences have also been found to 
bind only to the cytoplasmic side of the erythrocyte mem brane (Davies et al, 
1987; Davies et al, 1990; Haspel et al, 1988). This evidence would suggest that 
these regions are, as predicted, intracellularly disposed.
The loop connecting putative transm em brane helices 1 and 2, which is 
predicted to be extracellular, contains the only site of N-linked glycosylation 
in the prim ary sequence, asparagine-45 (Asn45) (Cairns et al, 1987). Since the 
protein is heavily glycosylated, this residue m ust lie in an extracellular 
location. Indeed it has been dem onstrated that the substitution of Asn45 by 
Asp, Trp or Gin abolished N-linked glycosylation of GLUT1 (Asano et al,
1991).
Cysteine-429 (Cys429), which is predicted to lie in the extracellular loop 
just before helix 12, is possibly the site of labelling with the reagent bis- 
(m aleim idom ethyl)-ether-L-[35S]cysteine (May et al, 1990). The imperm eant 
thiol-group-reactive agent p-chloro-m ercuribenzenesulphonate (pCMBS) has 
also been demonstrated to bind to this residue (Wellner et al, 1992).
Chemical m odification of GLUT1 in intact erythrocytes w ith  the 
impermeant, amino-group-specific biotinylating reagent sulphosuccinimidyl- 
6-(biotinamido)-hexano-oate (NHS-LC-biotin), leads to the m odification of a 
single exofacial lysine residue (Preston & Baldwin, 1993). Tryptic digestion of 
the protein revealed this residue to be Lys300, which is predicted to lie in the 
exofacial loop connecting transmembrane helices 7 and 8.
A recent study  (Hresko et a l, 1994) investigated  the effects of 
in troducing  cDNA sequence encoding the GLUT4 glycosylation site 
individually into each of the various regions of GLUT1 sequence which are
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predicted to encode hydrophilic soluble loops, and injecting the in vitro- 
synthesised mRNA into Xenopus oocytes. Each GLUT1 cDNA had also been 
altered by substituting Asn45 with Thr so that the encoded protein would not 
be glycosylated at its native region. These w orkers then assayed the 
glycosylation levels of each m utant by the change of mobility on SDS-PAGE 
after glycosidase digestion. Only proteins which presented the stretch of 
GLUT4 sequence to the lum en of the endoplasm ic reticulum  and Golgi 
apparatus (and hence be exofacially disposed) w ould  be glycosylated. 
Insertions into each predicted exofacial loop always produced proteins which 
were glycosylated, and insertions into endofacial loops in each case yielded 
non-glycosylated proteins, thus confirming the predicted 12 transm em brane 
helices model (Mueckler et al., 1985).
Hence, the bulk of evidence supports the m odel of GLUT1 which 
predicts that the orientation is such that it forms 12 transm em brane helices 
w ith the N- and C- termini and large loop located on the cytoplasmic side of 
the membrane, and the smaller loop on the extracellular side (Mueckler et al.,
1985). Other transporter isoforms are predicted to have identical topologies.
H owever, a recent study (Fischbarg et al., 1993) has produced an 
alternative topological model. Polyclonal antibodies raised against a synthetic 
peptide corresponding to the highly conserved fifth endofacial loop of GLUT1 
(He386 to Ala405) have been shown to increase 2-deoxy-D-glucose transport by 
GLUT1-, GLUT2- and GLUT4-expressing Xenopus oocytes w hen applied to 
extracellular m edium  (Fischbarg et al., 1993). This result was interpreted by 
these authors to imply that this loop is actually exofacially orientated, and a 
new  m odel of GLUT1 topology was predicted consisting of 16 P -sh ee t 
transm em brane helices w ith cytoplasmic hydrophilic N- and C-term inal 
dom ains. This m odel is based on Chou and Fassman secondary structure 
analyses which predict that GLUT1 exclusively contains p-sheet structure
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(Carruthers, 1990). However, it is not evident how antibody binding to a 
supposedly exofacial sequence could increase the rate of transport. Although 
their results are difficult to explain, the conclusions of Fischbarg et al cannot 
be supported from their data.
1.3.3 Spectroscopic studies.
Infra-red (IR) spectroscopy is a valuable m ethod for investigation of 
protein secondary structure, with which the relative proportions of a-helical, 
p -strand  and random  coil conform ations can be determ ined  from the 
frequency of the amide I and amide II bands. Fourier-transforming infra-red 
m ethods (FTIR) allow the analysis of protein structure in d ilu te aqueous 
m edia, p roducing  spectra w hich can be deconvoluted  to analyse the 
overlapping amide absorptions caused by the various secondary structures 
present in the protein (Carruthers, 1990). FTIR studies of GLUT1 protein in 
lipid bilayers have shown that a-helical structure is predom inant, bu t there is 
also a proportion of p-sheet, p-turns and random  coil conform ation present 
(Alvarez et al, 1987). Extensive hydrolysis of the m em brane im bedded 
transporter with papain reduces the a-helical and random  coil conformation 
content of the transporter, relative to the p-strand content. H ow ever the 
rem aining protein contains a substantial am ount of both a-helical and p- 
strand structure. Tryptic digestion of the transporter leads to a decrease in a- 
helical and random  coil conform ation content of the m em brane-bound 
transporter (Cairns et al., 1987). Trypsin digestion is predicted to remove the 
large intracellular loop (residues 213-269) and the cytoplasmically disposed C- 
term inal sequence (residues 457-492). These results suggest that the 
m em brane-spanning regions contain both a-helical and P-strand structure, 
and that the large cytoplasmic domains contain a-helical structure.
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Polarised FTIR spectroscopy has detected the presence of a-helical and 
random  coil conformation in GLUT1 but no |3-sheet structure (Chin et al., 
1986). Circular dichroism (CD) spectroscopy perform ed by the same group 
detects 82% a- helix, 10% P-turns and 8% random  coil structure but no P-sheet 
structure (Chin et al, 1987). The polarised FTIR results suggest that the a - 
helices are preferentially orientated perpendicular to the plane of the lipid 
bilayer, with a tilt of < 38° from the membrane normal (Chin et al., 1986).
H ydrogen-deuterium  exchange studies of purified GLUT1 in lipid 
bilayers (Alvarez et al, 1987; Jung et al, 1986) dem onstrate that 80% of the 
polypeptide backbone of GLUT1 is readily accessible to solvent. The residual 
portion of the protein which is exchanges only slowly includes a -h e lica l 
structure which presum ably exists in a hydrophobic environm ent. This 
suggests the presence of a hydrophilic pore-like structure, possibly surrounded 
by amphipathic transmembrane helices.
All the above data are consistent with the 12 transm em brane a-helix  
structure and further suggest that D-glucose is transported across the lipid 
bilayer via a hydrophilic pore formed by bundles of helices which span the 
bilayer.
1.4 Homologous Transporter Proteins in other Organisms.
The advent of Molecular Biology has led to the cloning and sequencing 
of m any cDNAs and genes from diverse organism s. The am ino acid 
sequences of the proteins encoded by these sequences can be aligned together 
to look for regions of similarity and identity. Griffith et al. searched protein 
databases for sequences which possessed sim ilarity to: TetC protein (the 
tetracycline resistance protein of gram-negative bacteria); TetL (the tetracycline
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resistance protein of gram-positive bacteria); AraE (a sugar transporter of E. 
coli)', GLUT2; and CitA (the citrate transporter of gram  negative bacteria) 
(Griffith et al., 1992). Using various algorithm s to analyse those transport 
p roteins which were selected, these w orkers found that m any of these 
possessed sequences which were conserved in various others. Griffith et al 
proposed that sequence information alone suggested that these transporters 
function  by a com m on m echanism  of action, and  form  a related  
"superfamily" of transporter proteins, despite the observed differences in 
sugar specificity, direction of transport and mechanism of transport.
Both active and passive eukaryotic and prokaryotic transporters are 
included in this "sugar transporter superfamily". It contains the mammalian 
facilitative glucose transporters and both passive transporters and active, 
s u g a r /H + symporters from higher plants, green algae, protozoans, yeasts, 
cyanobacteria and eubacteria (reviewed Henderson et al., 1992; Griffith et al,
1992). Bacterial tetracycline and citrate transporters and fungal quinate 
transport proteins are also included in the "superfamily". It does not, 
how ever, contain the apparently  unrela ted  m am m alian sodium -linked 
glucose transporters or bacterial ATP- and PEP-utilising active transporters. 
All members of the family seem to yield similar hydropathy plots to those of 
the m am m alian glucose transporters in the regions of sequence similarity, 
and are predicted to form 12 transm em brane a-helices, bisected by a large 
loop between transm em brane helices 6 and 7, despite large differences in 
overall length.
Sequence analysis suggest that the proteins m ost closely related to 
GLUT1 are the E. coli H +/L-arabinose sym porter, AraE, and the E. coli H +/D - 
xylose sym porter, XylE, which are 23% and 27% identical, respectively, in 
sequence to human GLUT1. These proteins even bind the same ligands as the 
m ammalian facilitative glucose transporters (section 1.7).
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More distantly related to GLUTl, for example, are tetracycline/H + 
antiporters, the citrate transporter, and m altose and lactose transporters 
(Griffith et al., 1992). It is not known whether the lactose/H + transporter of E. 
coli (lac permease) is a member of the "superfamily". Although it bears little 
sequence sim ilarity  to GLUT1, it has been pred ic ted  to contain  12 
transm em brane helices (Biichel et al., 1980), and does contain m any identical 
or conserved residues in regions that are also conserved in the "sugar 
transporter superfamily".
1.5 The Dynamics of D-Glucose Transport.
The majority of kinetic, therm odynam ic and ligand binding studies 
have been carried out investigating GLUT1, due to its availability from 
hum an erythrocytes and its functional purification (Kasahara & Hinkle, 1977). 
Many properties m easured w ith GLUTl will undoubtedly apply to all the 
members of the glucose transporter family since they all share very similar 
structures, although sugar specificities, kinetic parameters, targeting patterns, 
ligand b inding , and both  acute and chronic horm onal regu lation  of 
expression is found to vary widely between different transporter isoforms.
1.5.1 Kinetic Parameters of GLUTl D-Glucose Transport
Transport of D-glucose by GLUTl has generally been m easured in 
erythrocytes using a variety of m ethods (reviewed in C arruthers, 1990), 
usually by the accumulation of radiolabelled sugar, henceforth referred to as 
"tracer". Other methods include chemical analysis of cellular sugar content, 
spectrophotometric m easurem ent of glucose induced changes in cell volume,
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and coupled secondary enzyme-linked assays. There are several categories of 
assay which can be employed to measure different parameters of the transport 
process. These are listed below. The terms cis and trans refer to the same side 
of the membrane from which transport is m easured and the opposite side, 
respectively.
1.5.1.1 Zero-trans entry.
The simplest study to perform involves measuring the uptake of trace 
am ounts of radioactively labelled D-glucose into cells which have been stored 
in a medium without glucose for a certain period of time, so that the cytosolic 
sugar concentration is as low as possible. The external sugar concentration is 
varied for each m easurement. The initial transport of glucose into the cell 
should  be linear since the cytosolic sugar concentration is zero. Only 
m easurem ents of initial rates are recorded, before reverse-flow  of sugar 
occurs. Therefore, w hat is being m easured is sugar binding affinity of the 
exofacial binding site (Km outside) and the maximum velocity of sugar entry 
under infinitely high substrate concentrations (Vmax entry).
1.5.1.2 Zero-trans exit.
In this case, cells are preincubated with varying concentrations of sugar 
plus tracer until equilibrium  is reached. Then the m edium  is rap id ly  
removed and replaced with one without sugar. Initial rates of sugar exit are 
m easured by testing the am ount of radioactivity in the external medium. 
This assay m easures the affinity of the endofacial sugar binding site (Km 
inside) and the Vmax for sugar exit.
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I.5.I.3. Infinite-ds entry.
As in section 1.5.1.2 above, the cells are preincubated in variable 
concentrations of sugar plus tracer until equilibration. The assay is begun by 
the addition of a saturating concentration of sugar plus tracer. This assay 
measures the Km of the internal binding site and the V max for entry.
1.5.1.4 Infin ite-ds exit.
This is the opposite of infinite-c/s entry. The cells are preincubated 
with saturating concentrations of sugar and tracer, then the exit of tracer into 
variable concentrations of sugar plus tracer is m easured. The Km of the 
exofacial binding site and the Vmax f°r exit are measured.
1.5.1.5 Infinite-traus entry.
In this assay the cells are incubated w ith saturating concentrations of 
sugar. Uptake of tracer from varied concentrations of sugar gives a m easure 
of the Km for the exofacial binding site and the V max for sugar exchange i.e. 
the maximum rate for a complete transporter cycle where two molecules of 
sugar are exchanged.
1.5.1.6 Infinite-fraws ex it
The initial concentration of sugar inside the cells is variable and the 
exit of tracer into a saturating concentration of sugar is m easured. This 
m easures the Km for the endofacial binding site and the V max for sugar 
exchange.
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1.5.1.7 Equilibrium Exchange.
This is the most common type of assay. Cells are preincubated with 
various concentrations of sugar and the uptake of tracer m easured from 
external media w ith the same concentration of sugar. Alternatively, the exit 
of tracer could be m easured, although both m ethods would give values of Km 
and Vmax for sugar exchange.
The results of m any sugar transport assays perform ed by different 
groups w ith erythrocytes under conditions outlined above at both 0°C and 
20°C have been reviewed recently (Carruthers, 1990). The kinetics of glucose 
transport by GLUTl are very tem perature dependent, generally displaying 
lower Km and V max values at lower tem peratures. All transport profiles show 
simple, hyperbolic Michaelis-Menten kinetics, bu t also display very different 
Km and V max values depending on the conditions used. For example, at 0°C, 
under zero -trans entry conditions the Km and V max values are approxim ately 
0.15-0.2 mM and 0.0035-0.0055 mM s-1, respectively; w hereas these values 
under zero -trans exit conditions are 1.6-3.4 mM and 0.071-0.150 m M s-1, 
respectively. Thus, the kinetic values for zero -trans exit are substantially  
greater (12-fold) than those for zero-trans entry. This asymmetry of transport 
is reduced somewhat at 20°C, to a 3-fold difference in kinetic values for entry 
and exit. One physiologically significant function of GLUTl utilising this 
observed asymmetry might be the preferential transport of D-glucose in one 
direction across blood-tissue barriers, such as the blood-brain barrier, under 
hypoglycaem ic conditions. Studies in oocytes suggest that the kinetic 
properties of GLUT2 and GLUT4 are sym m etrical (reviewed in Gould & 
Holman, 1993).
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The equilibrium  exchange Km and Vmax values are even larger than 
those m easured for zero-trans exit (8.7 mM and 0.73 mMs-1, respectively, at 
0°C). This observation is due to a phenom enon nam ed trans-acceleration, 
which describes the stimulation of sugar transport by the presence of sugar on 
the opposite (trans) side of the membrane.
1.5.2 Mechanistic Models for D-Glucose Transport.
1.5.2.1 The Single-Site Alternating Conformer Model.
The simplest model for the transport event is the single-site alternating 
conformer, or, as it is otherwise known, the simple asymmetric model (Figure 
1.2). This model was developed initially by W iddas (W iddas, 1952) as a 
symmetric carrier model and adjusted to account for the observed asymmetry 
of GLUTl-mediated glucose transport (Geek, 1971). This model also explains 
the phenomenon of trans-acceleration.
This model kinetically describes the re-orientation of the transporter 
between two conformations: one which exposes the D-glucose-binding site to 
the extracellular medium, T0; and one which exposes the D-glucose-binding 
site to the cytoplasm, T\. This re-orientation can occur in the presence or 
absence of D-glucose. The outward-facing and inw ard-facing transporters 
with D-glucose bound are labelled T0S and TjS, respectively (Figures 1.2 & 1.3). 
This re-orientation event might involve just the substrate-binding site, or a 
large proportion of the transporter structure (Hodgson et al., 1992). The 
dissociation constants of the substrates at the exofacial (Kso) and endofacial 
binding sites (Ksi) are not necessarily equal and the rate constants describing 
the movement of the loaded carrier (kj, k_i) are greater than those relating to
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the m ovem ent of the empty carrier (k^, k_2 ). The rates of association and 
dissociation of D-glucose from the transporter are also m uch greater than 
either re-orientation step, as shown by NMR m easurem ents (W ang et al.,
1986). During zero -trans transport, the initial unidirectional flux of D-glucose 
is rate-lim ited by the slow re-orientation of the unloaded carrier molecule. 
This does not occur under equilibrium  exchange conditions w hen the 
dissociation of a D-glucose molecule is followed by the rapid association of 
another. This accounts for the phenomenon of trans-acceleration.
1.5.2.2 M easurem ent of Rate Constants for Transport Events.
The rate constants for the re-orientation of the transporter in the 
presence and absence of D-glucose have been measured. Steady-state values 
have been evaluated by the m easurem ent of the zero -trans entry zero -trans 
exit and equilibrium  exchange transport of radiolabelled D-glucose by 
erythrocytes over a range of tem peratures (Lowe & Walmsley, 1986), utilising 
the tem perature dependence of transport. Pre-steady-state values for these 
steps have been measured with purified GLUTl, reconstituted in "leaky" lipid 
vesicles, in the presence and the absence of D-glucose (Appleman & Lienhard, 
1989) by m easuring the differences of intrinsic fluorescence at 336 nm  
displayed by the two transporter conform ations. This fluorescence is 
quenched in the presence of the external ligand 4,6-O-ethylidene-D-glucose or 
the in ternal ligand phenyl (3-D-glucoside. R apid  changes in the 
conform ational state at 10°C were induced by the addition of saturating 
concentrations of 4,6-O-ethylidene-D-glucose, which binds to the exofacial 
b inding site (T0) and traps the transporter in that conform ation, thus 
m easuring single half turnovers (k_2 in the presence of glucose or k_i in the 
absence of glucose), or phenyl p-D-glucoside, which binds the endofacial
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binding  site (Tj) and traps the transporter in that conform ation, thus 
m easuring single half turnovers (kj in the presence of glucose and k2 in its 
absence).
Values obtained for these rate constants are shown in the Figure 1.2 
legend. To summarise, the relative values of each rates constant are k 2 > k_2 > 
k i > k_j. The results support the existence of the alternating conform er 
model.
The dissociation constants for substrate at the exofacial and endofacial 
binding sites can also be calculated from knowledge of the rate constants and 
the observed transport kinetics. These values for the exofacial binding site 
were found to be Kso = -10 mM for all temperatures from 0°C to 37°C, but the 
dissociation for the endofacial binding site was found to vary from Ksj = 13 
mM, at 0°C, to Ksi = 23 mM, at 37°C (Lowe & Walmsley, 1986). Therefore at 
low tem peratures the affinity of both endofacial and exofacial binding sites for 
glucose are similar, which contrasts sharply with the m easured 10-fold lower 
affinity (Km) of the endofacial binding site at 0°C. This difference m ust be due 
to the differences in rate constants, which preferentially  orientate  the 
transporter to the inward-facing conformation, hence reducing the exit of 
glucose relative to its entry. Indeed only 7.5% of the loaded and 6% unloaded 
transporter molecules are predicted to be in an outward-facing conformation 
at 0°C. At 37°C, these values increase to 40% unloaded and 60% loaded 
transporters in an outward-facing conform ation (Walmsley & Lowe, 1987). 
The reason for this tem perature-dependence of d istribu tion  has been 
suggested to be caused by large positive entropy and endotherm ic enthalpy 
changes required for the attainm ent of an outw ard-facing conform ation, 
perhaps due to the salt-bridge induced stability  of the inw ard-facing 
conformation (Walmsley & Lowe, 1987).
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1.5.2.3 Multiple Site Models.
There are inconsistencies in the data obtained by kinetic studies with 
GLUT1, and predicted values derived from integrated rate equations using the 
simple one-site alternating conformation model, as described by Carruthers 
and others (Carruthers, 1990). They postulate that the alternating conformer 
m odel is an incorrect sim plification. C arru thers has proposed  several 
alternative models including the iso two-site model, and the allosteric two- 
site model. These two-site or fixed-site m odels assum e that each carrier 
molecule possesses two sim ultaneously existing glucose binding sites. Re­
orientation of the transporter can occur in the presence of two, one or no 
glucose molecules. The mechanism of transport is such that re-orientation of 
one binding site to the opposite side of the membrane is accompanied by the 
sim ultaneous and opposite re-orientation of the other site, such that both 
sites are always located on opposite sides of the membrane (Carruthers, 1991).
Evidence for the existence of a two-site model includes the observation 
that erythrocyte glucose transporters have been shown to bind the endofacial 
ligand cytochalasin B and then exofacial ligands, such as maltose, 4,6-0- 
ethylidene-D-glucose or phloretin, sim ultaneously (Helgerson & Carruthers,
1987). The effects of each inhibitor on the inhibition of transport (Ki) of D- 
glucose by the other inhibitor suggest that as well as existing simultaneously, 
the binding of one ligand exhibits negative co-operativity on the binding of 
the second ligand (Carruthers & Helgerson, 1991).
On the other hand, the bulk of the kinetic data does agree with the 
single-site model, if allowances for differences in m easuring techniques and 
the fact that sugars do not exhibit "ideal" behaviour, such that m easured 
values for kinetic parameters do not always agree with values obtained with 
integrated rate equations (Baldwin, 1993).
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Other evidence for the single-site m odel is derived from studies in 
w hich erythrocytes are incubated w ith the non-transported  reversible 
exofacial ligand maltose, which has the effect of pulling transporters into an 
outward-facing conformation (if the alternating model is correct) (Lowe & 
Walmsley, 1987). Rapid dilution of maltose and the simultaneous addition of 
D-glucose induces a change in the intrinsic fluorescence of the transporter, 
which corresponds to the formation of the inward-facing conformation, prior 
to the attainm ent of steady-state transport levels. This single-half turnover 
supports the existence of the single-site model, since no initial fluorescence 
change would be predicted in a two-site model, where the maltose could bind 
to one of two binding sites, and hence could not pull the transporters into in 
outward-facing conformation.
The results of different analyses support either of the two models. It is 
far more likely that neither of these models are correct, and that in reality the 
mechanism of transport incorporates elements of both models. However, for 
the sake of simplicity, all work done in this study assumes that the single-site 
model is correct.
1.6 Conformational Changes in GLUT1.
Although the mechanism of transport by GLUT1 is unknow n and the 
num ber of distinct glucose binding sites is still unresolved, it is certain that 
the transport of glucose involves a change in transporter conformation.
Sugars with large substituent C-4 groups (compared to D-glucose) such 
as maltose or 4,6-O-ethylidene-D-glucose or large C-6 groups such as 6 -0- 
propyl-D-glucose were found to inhibit erythrocyte D-glucose transport only 
when present outside the cell (Baker & W iddas, 1973; Barnett et al, 1975), and 
thus were proposed to bind the exofacial glucose binding site. Moreover, n-
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propyl-p-D-glucopyranoside only inhibited transport when present inside the 
cell, and thus was proposed to bind the endofacial binding site (Barnett et al., 
1975). This dem onstrates the asym m etry of GLUT1 and supports the 
alternating conformation model of transport.
1.6.1 Detection of GLUT1 Conformational Changes by Measurement of
Transporter Intrinsic Fluorescence.
There is a difference in the intrinsic fluorescence of outward-facing and 
inward-facing conformations of GLUT1 at 336 nm, as observed whilst using 
ligands which interact w ith either the exofacial binding site or the endofacial 
binding site (Appleman & Lienhard, 1989; section 1.5.1.2) The fluorescence 
observed with native exofacially-orientated transporters is 20% less than those 
in the inward-facing conformation. The fluorescence spectrum  corresponds 
to that emitted by tryptophan residues in polar and non-polar environments 
(Gorga & Lienhard, 1982). The fluorescence is quenched in the presence of D- 
glucose and ligands proposed to bind the exofacial and endofacial binding sites 
(Gorga & Lienhard, 1982; Chin et al., 1992), and this effect is strongest at 
wavelengths corresponding to that emitted by tryptophan residues in a polar 
environment. Thus it is possible that tryptophan residues are present in one 
or both of the glucose binding sites. Indeed, substitution of GLUT1 Trp388 or 
Trp412 leads to a decrease in transport activity and perturbation of cytochalasin 
B binding, which is proposed to bind to the endofacial binding site (Inukai et 
al., 1994). Of course, fluorescence quenching by ligands need not occur by 
direct interaction with a glucose binding site.
Moreover, GLUT1 intrinsic fluorescence is only partially quenched by
the addition of potassium  iodide, indicating that these tryptophan residues
are located both in the membrane bilayer and in a more accessible hydrophilic
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environm ent (Pawagi & Deber, 1990). In the presence of D-glucose, this 
quenching is reduced at longer w avelengths, and increased at shorter 
wavelengths (Pawagi & Deber, 1990; Chin et al, 1992). This suggests that the 
transport of D-glucose causes the m ovem ent of one or m ore tryptophan 
residues from a hydrophilic environm ent to a hydrophobic environm ent, 
presumably representing a transition state in the transport process.
1.6.2 Sensitivity of Different Transporter Conformations to Chemical
Inactivation.
l-fluoro-2,4-dinitrobenzene (FDNB) is an am ino group-m odifying 
reagent which has been found irreversibly inactivate glucose transport by 
erythrocyte GLUT1. Moreover the rate of this inactivation is increased in the 
presence of extracellular glucose but reduced in the presence of intracellular 
glucose (Edwards, 1973). S im ila rly the  presence of the intracellular n-propyl- 
p-D -glucopyranoside the inactivation is accelerated (Barnett et a l,  1975). 
However, protection from inactivation is afforded by extracellular ligands 
such as maltose, 4,6-O-ethylidene-D-glucose, phloretin (Krupka, 1971; Baker & 
W iddas, 1973) and 6-O-alkyl-D-galactoses (Barnett et al, 1975). Although it is 
not known precisely w here this reagent binds, it apparently  binds the 
transporter whilst in an inward-facing orientation, probably at the external 
surface. The protection afforded by intracellular glucose is likely due to the 
increase in steady-state levels of outward-facing transporter achieved by the 
increased rate of re-orientation toward an outward-facing conformation due 
to bound glucose (Figure 1.2).
The m odification of the exofacial residue Cys429 by im perm eant 
su lphydry l g roup-m odify ing  reagents [bis-(m aleim idom ethyl)-ether-L - 
[35S]cysteine, (May et al, 1990); pCMBS (Wellner et al, 1992)] also leads to
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transporter inactivation. It has been demonstrated that modification by these 
reagents has been increased in the presence of substances which interact with 
the exofacial binding site, such as maltose and phloretin. H ow ever, the 
presence of cytochalasin B leads to a reduction in the effectiveness of the 
reagents (Krupka, 1971; May, 1988; May, 1989). Cytochalasin B has been 
proposed to stabilise the transporter in an inward-facing conform ation by 
binding at or close to the endofacial glucose binding site (Deves & Krupka, 
1978). Cys429 probably lies in a location that is structurally distinct from the 
exofacial binding site, since the binding of substances known to interact with 
the exofacial binding site actually increase its modification. This increase of 
modification in the presence of exofacial ligands and the inhibitory effect of 
cytochalasin B on modification suggest that this residue lies in a position that 
is buried when the transporter adopts the inward-facing conformation.
1.6.3 Effects of GLUT1 Conformational State on Proteolytic Cleavage.
As described in section 1.3.2, trypsin cleaves m em brane-inserted GLUT1 
at three sites, yielding two fragments corresponding to fragments of the large 
cytoplasmic loop and the hydrophilic C-terminal sequence. Thermolysin is 
p redicted  to cleave off the transporter's large cytoplasmic loop. The rate of 
proteolytic cleavage is reduced in the presence of reversibly binding exofacial 
ligands such as maltose, 4,6-O-ethylidene-D-glucose and phloretin (Gibbs et 
al., 1988; King et al., 1991). In addition, the photoaffinity-labelling of the 
transporter by exofacial ligands such as the bis-m annose derivative ATB- 
BMPA (section 1.7), alm ost completely protects GLUT1 from therm olysin 
cleavage (Clark & Holman, 1990). These results suggest that the increase in 
the steady-state levels of outw ard-facing  transporters p ro tec t against 
proteolytic cleavage of the cytoplasmic loops by indirectly causing them to
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adopt an orientation that is less susceptible to proteolytic cleavage. Moreover, 
the presence of reversible endofacial ligands such as n -p ropy l-p -D - 
g lucopyranoside and m ethyl-a-D -glucopyranoside increase the rate  of 
thermolytic cleavage relative to native transporter. This is presumably due to 
the increase in the steady-state levels of inward-facing transporters which are 
orientated such that the cytoplasmic loops are in a position that is susceptible 
to proteolysis. The presence of intracellular D-glucose increases the rate of 
proteolysis (Gibbs et al, 1988; King et al, 1991). Since kinetic theory applied to 
the alternating conformation model predicts an increase in the num bers of 
outward-facing, proteolytic-resistant transporters in the presence of glucose 
(Lowe & Walmsley, 1986), this susceptibility to digestion m ust occur during 
the transport process.
Surprisingly, binding of cytochalasin B, which is predicted to stabilise 
the inward-facing conformation, had no effect on proteolysis (Gibbs et al, 
1988; King et al, 1991). Perhaps the increased steady-state levels of inward- 
facing transporters is balanced by partial steric hindrance by the bulky 
cytochalasin B molecule, or the lack of effect might be due to the formation of 
a second distinct inward-facing conformation which binds cytochalasin B.
However, cytochalasin B was found to successfully bind to GLUT1 
which had previously been completely digested w ith trypsin (Cairns et al, 
1984; Karim et al, 1987). Conversely, the binding of the exofacial ligand, ATB- 
BMPA, to this transporter is much reduced (Clark & Holman, 1990). Similar 
behaviour is exhibited by a GLUT1 m utant which lacks the C-terminal 37 
residues (Oka et al, 1990; section 5.2.1.5), but not with one which has only the 
C-terminal 12 residues removed (Lin et al, 1992). These data would suggest 
that removal of the GLUT1 C-terminal residues 455-480 causes the formation 
of a transport-deficien t m utant w hich is locked in the inw ard-facing 
conform ation.
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Taken together, these results suggest that the conformational changes 
which occur in the transporter are very dynamic, causing m ovem ent of at 
least some of the transmembrane helices and the cytoplasmic loops.
As described in section 5.2.1.3, m olecular m odelling and molecular 
dynamics techniques suggest that transm em brane helix 10 of GLUT1 may 
undergo large conformational changes which could account for the ability of 
the transporter to assum e two d istinct g lucose-binding conform ations 
(Hodgson et al., 1992). The same modelling predicts that Pro383, Pro385 and 
P ro 387 w ould probably act as the pivot necessary for this conformational 
change. Substitution of Pro385 with isoleucine (Tamori et al, 1994) produced a 
m utan t which was locked into the inw ard-facing conform ation, indeed 
suggesting that this region is im portant in the conformational change.
1.7 D-Glucose-Inhibitable Photoaffinity labelling.
The location of the D-glucose binding site, or sites, is unknown, but 
much work has been done with photoaffinity ligands, the binding of which 
inhibit, and are inhibited by D-glucose transport. Limited proteolysis of the 
transporter followed by radiolabelled ligand photoaffinity labelling should 
reveal the approximate position of the glucose binding site, given that the site 
of photoaffinity labelling does not merely sterically hinder glucose binding, 
whether directly or by affecting transporter conformation, and assuming that 
the site of photoaffinity binding and the site of reversible inhibition of glucose 
transport are the same.
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1.7.1 Photoaffinity Labels Proposed to Interact w ith the Endofacial D-Glucose
Binding Site.
One such ligand is the fungal metabolite cytochalasin B, which binds 
GLUT1 in a D-glucose-sensitive m anner at the ratio of one m olecule per 
polypeptide chain (Baldwin & Lienhard, 1989) with a Kd of 120 nM (Zoccoli et 
a l , 1978). It binds GLUT2 [Kd of ~1 pM (Axelrod & Pilch, 1983)] and GLUT7 
(Waddell et al, 1991) w ith relatively weak affinity, and does not appreciably 
bind GLUT5 (Burant et al, 1992).
C ytochalasin B binds GLUT1 at the in tracellu lar surface of the 
membrane (Deves & Krupka, 1978). Photolabelling with [3H] cytochalasin B 
after tryptic cleavage (Cairns et al, 1984; Deziel & Rothstein, 1984) yields a 
labelled fragment corresponding to residues 270-456, which comprises most of 
the C-terminal half of the protein. The site of photoaffinity labelling has been 
proposed to lie within residues 389-412, which comprises the loop connecting 
helices 10 and 11, and helix 11 itself (Holman & Rees, 1987). Recent studies 
suggest that Trp388 is included in this sequence too (Inukai et al, 1994). This 
sequence is believed to contain the endofacial glucose binding site. The D- 
glucose inhibitable binding of cytochalasin B and forskolin derivatives to 
GLUT1 (and other transporters) is proposed to occur to the endofacial binding 
site since the oxygen atoms of these molecules are superimposable with those 
of D-glucose, hence allowing these inhibitors to interact with the binding site 
via hydrogen bonding. The E. coli ga lactose /H +  symporter, GalP, and the 
a ra b in o se /H + symporter, AraE, both bind cytochalasin B but the xylose/H + 
symporter, Xyl E, does not (Henderson et al, 1992). It has recently been found 
that cytochalasin B and 4 ,6-O -ethylidene-D -glucose can b ind  GLUT1 
simultaneously (Carruthers & Helgerson, 1991), a finding which casts doubts 
on the accuracy of the alternating conformation model (section 1.5.2.3).
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Forskolin has been found to inhibit D-glucose transport by GLUT1. It is 
also found to bind to the intracellular surface of the m em brane and bind 
GLUT1 in a cytochalasin B and D-glucose inhibitable m anner (Sergeant & 
Kim, 1985). Therefore it binds close to the cytochalasin B binding site. 
Proteolytic digestion and labelling w ith the photoactivatable derivative 
[3H]IAPS-forskolin, followed by proteolytic and chemical cleavage have 
suggested that it binds within helix 10, that is, residues 369-389 (Wadzinski et 
al., 1990). This may also comprise part of the endofacial binding site, since 
forskolin binding is inhibitable by cytochalasin B. GalP of E. coli binds 
[3H]IAPS-forskolin and its sugar tran sp o rt is inh ib ited  by forskolin 
(Henderson et al., 1992). AraE and XylE do not bind forskolin.
1.7.2 Photoaffinity Labels Proposed to Interact w ith the Exofacial D-Glucose
Binding Site.
The requirem ent for a m em brane im perm eant affin ity  label to 
participate in the quantitation of cell surface glucose transporters led Holman 
and colleagues to develop a series of bis-hexoses (Midgley et al., 1985; Holman 
& Midgley, 1985) with the rational that these should bind the exofacial D- 
glucose binding site. The bis-m annose-derivative, l,3-bis-(D-m annos-4- 
yloxy)-2-propylam ine (BMPA), a hydroph ilic  im perm eable com pound 
consisting of two mannose moieties, bisected by an amino group which can be 
linked to a photoactivatable group, was found to be useful. A lthough 
derivatives of this were found to bind to GLUT1 w ith lower affinity than 
cytochalasin B or IAPS-forskolin, they bound with greater affinity than D- 
mannose itself.
The derivative 2-N-(4-azidosalicoyl)-l,3-bis(D-mannos-4-yloxy)propyl-
2-amine (ASA-BMPA), which possesses an azidosalicoyl photoactivatable
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group, was found to selectively label the extracellular surface of GLUT1 
(Holman et al., 1986). This compound was found to bind to GLUT1 the region 
between residues 347-388, probably at the extracellular end of helix 9, which 
was proposed to be the exofacial glucose binding site (Holman & Rees, 1987).
How ever, ASA-BMPA was found not to selectively label plasm a 
membrane glucose transporters when they were in low abundance. Therefore 
a new photoaffinity probe, 2-N-[4-azi-2,2,2-trifluoroethyl)benzoyl]-l,3-bis(D- 
m annos-4-yloxy)-2-propylam ine (ATB-BMPA), w as developed  (Clark & 
H olm an, 1990). This com pound, w hich incorporates an azitrifluoro- 
ethylbenzoyl reactive group was found to exhibit better selectivity than its 
predecessor, allowing its use even with membrane fractions. The site of ATB- 
BMPA labelling has been localised to residues 301-330, w ithin transmembrane 
helix 8 (Davies et al., 1991).
Thus, the site of the exofacial binding site is propose to include helices 8 
and 9, whereas the endofacial binding site is proposed to include helices 10 
and 11. Therefore there seems to be some structural separation between the 
endofacial and exofacial binding sites. The results of several m utagenesis 
studies have supported the proposed position of the endofacial binding site, 
and suggested that helix 7 is also included as part of the exofacial binding site 
(section 5.2).
1.8 Oligomerisation of GLUT1.
It has been  show n th a t the  ap p lica tio n  of s ize-exclusion  
chrom atography  and sucrose g rad ien t u ltracen trifuga tion  to cholate- 
solubilised GLUT1, and reconstitu tion of the resu lting  com plexes into 
proteoliposom es, leads to the form ation of transporter complexes which 
display D-glucose inhibitable-cytochalasin B binding (Herbert & Carruthers,
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1991). The sizes of these particles indicate that GLUT1 can exist as a tetramer 
or a dim er under different reducing conditions. Further hydrodynam ic 
studies, chemical cross-linking and use of conformational-specific antibodies 
suggest that the tetram er binds 1 mole of cytochalasinB/Z moles GLUT1, 
presenting at least two binding sites to D-glucose; and the dimer binds 1 mole 
of cytochalasin B/m ole GLUT1, presenting a single population of binding sites 
to D-glucose (Herbert & Carruthers, 1992).
Furthermore, Carruthers has suggested that the tetram er is the native 
erythrocyte transporter, which is form ed of two dim ers, stabilised by 
intramolecular disulphide bonds (Herbert & Carruthers, 1992). He suggests 
that the tetrameric transporter isoform is 2-8-fold catalytically more efficient 
than dimeric forms, and that discrepancies in previous kinetic studies with 
GLUT1 arise from the fact that these have been perform ed on both 
erythrocytes (tetrameric form) and detergent-treated reconstituted transporters 
(dimeric form).
Carruthers proposes a model to explain this difference in efficiency 
between different forms. In the dimeric form, each subunit is independent of 
the actions of the other, and thus displays no allosteric interactions, each 
behaving in such a m anner as explained by the single-site alternating 
conformation model. On the other hand, the tetram er is composed of two 
dimers which are bound to each other in such a way that they adopt a pseudo- 
D2 symmetry, and the active region of each subunit is conformationally 
constrained by the isomerisation of the neighbour such that the binding sites 
are arranged in an antiparallel manner. Thus each "dimer" in the tetrameric 
structure presents one exofacial and one endofacial binding site, and the 
tetramer displays characteristics of a multi-site, allosteric transporter which is 
consistent with the two-site fixed site model. Carruthers speculates that the 
tetramer is intrinsically more efficient since the conformation change induced
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by transport of glucose by one subunit causes the re-orientation of the 
neighbouring unloaded subunit, overcoming the large energy barrier required 
for this step (Lowe & Walmsley, 1986) in dimers and monomers. Presumably 
this rate-lim iting re-orientation step w ould not occur under equilibrium  
exchange conditions (Carruthers, 1991), so that the steady-state kinetics 
observed for both tetramers and dimers would be identical.
In a fu rther study, two chimeric transporters w ere individually  
expressed in Chinese hamster ovary (CHO) cells (Pessino et al., 1991). These 
were m utants of GLUT1 which had the C-term inal 29 residues or the C- 
terminal 294 residues substituted with those of GLUT4. Both m utants were 
found to quantitatively co-immunoprecipitate native GLUT1 from CHO cells 
using  an anti-GLUT4 C -term inal pep tide  an tibody , as detected  by 
im m unoblotting the precipitates w ith an anti-GLUTl C-term inal peptide 
antibody. No co-immunoprecipitation of native GLUT4 with native GLUT1 
was observed from 3T3-L1 adipocytes using the same antibody. These results 
dem onstra te  that GLUT1 form s at least hom odim ers in vivo, but not 
heUrodimers w ith GLUT4, and  that the sequence responsible  for the 
interaction of dimer subunits is present in the first 199 residues of GLUT1.
Studies perform ed with GLUT2 and GLUT3 expressed heterologously 
in Xenopus oocytes show that the kinetics of these two transporters are 
distinguishable (Burant & Bell, 1992; Colville et al, 1993; see also Chapter 3). It 
has been show n that co-expression of these two transporters in oocytes 
displays a kinetic profile that can be separated  into tw o com ponents 
attribu tab le  to each of the ind iv idual transporters, indicating that no 
hete rod im ers are form ed (B urant & Bell, 1992). C o-expression of 
heterologous GLUT3 and a transport-defective GLUT3 transporter in oocytes, 
displayed kinetics associated with wild-type GLUT3, even when a 3-fold excess 
of m utant GLUT3 mRNA was injected, suggesting that GLUT3 also behaves
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as a monomer in oocytes (Burant & Bell, 1992). It is impossible to tell whether 
it is the intrinsic nature of the GLUT3 transporter to form m onom ers, or 
whether this is due to the conditions in oocytes that accounts for thesfcdata. It 
is interesting to note that dimers could still be formed and have subunits that 
are independent of each other, as suggested by C arruthers (H erbert & 
Carruthers, 1992). Additionally, factors such as tem perature m ight influence 
oligom erisation. The suitability of the oocyte system  for oligom erisation 
studies could be tested by the co-expression of GLUT1 and the constructs 
described by Pessino et al.
1.9 Aims of this Study.
The objectives of this work are to characterise kinetic param eters of 
sugar transport by GLUT2 and GLUT3 in Xenopus oocytes, w ith particular 
attention to interactions at the exofacial binding sites. This should help gain 
some insight into their respective in vivo functions. In addition, basic kinetic 
values for zero -trans en try  should  provide standard  kinetic values as 
baselines for com parison w ith transporters which have substitu tions of 
specific residues that are believed to be involved in their exofacial binding 
sites. Since it is not currently  know n how  GLUT2 binds D-fructose, 
investigation of which ring form of this sugar that is transported by GLUT2 is 
necessary. Further aims include an investigation of the effects of substituting 
various hydroxyl groups of D-glucose on the ability the sugar to bind to the 
exofacial binding sites of GLUT2 and GLUT3, and thus investigate the 
interactions at that sugar group.
Some of the work in this study has been perform ed by Dr. Carol 
Colville, and is noted w here it is included. This is for the purposes of 
comparison only.
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Lastly, an investigation  of the im portance of the residues of 
transmembrane helix 8 is necessary. In GLUT1 this helix is proposed to be the 
site of binding of the external ligand ATB-BMPA, and possibly comprises part 
of the exofacial D-glucose binding site. It is likely to have a similar function 
in GLUT3, since the this transporter isoform has a high identity, a similar 
substra te  specificity, and no t dissim ilar kinetic p roperties to GLUT1. 
Therefore an objective of this study is to system atically alter each of the 
residues of GLUT3 helix 8 to alanine and m easure any perturbation of sugar 
transport or exofacial ligand binding caused by the m utations, and to assess 
which residues are involved in D-glucose binding a n d /o r  transport.
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Figure 1.1
Model for the O rientation of Mammalian Facilitative Glucose Transporters in 
the M embrane.
This model is based mainly on studies performed with hum an GLUT1, 
and so this model corresponds to that transporter. However, it is predicted 
from hydropathy  analysis of the prim ary sequence of other m am m alian 
transporters (Mueckler et al., 1985) and numerous other studies that they will 
adopt an identical conformation. The 12 transmembrane a-helices are shown 
as boxes, num bered  from  1-12. The site m arked  "CHO" betw een 
transm em brane helices 1 and 2 represents the potential site of N -lin k ed  
glycosylation in the large exofacial loop. The amino- and carboxy-termini 
(N H 2 and  COOH, respectively) are cytoplasmically disposed. Invariant 
residues are show n by their single-letter abbreviations, and filled circles 
represent invariant polar residues which are predicted to reside in the lipid 
bilayer. Residues which have been implicated to be important for transporter 
function by m utagenesis studies are shown as red circles (section 5.2). This 
diagram was taken from Bell et al., 1993).
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This show s a K ing-A ltm an rep resen ta tion  of the A lternating- 
C onform ation M odel of D-glucose transport. T0 and Tj represent the 
unloaded transporter in outward-facing and inward-facing conformations, 
respectively. T0S and TiS represent the transporter with bound substrate (D- 
glucose), in outw ard-facing and inward-facing conformations, respectively. 
Kso an± Kgi represent the dissociation constants for substrate (D-glucose), at 
the exofacial and endofacial binding sites, respectively. Rate constants for the 
re-orientation transporter are denoted as lq, k_i, lq  and k_2 . Re-orientation of 
unloaded transporter from outward-facing conformation to inw ard-facing 
conformation is represented by lq. Re-orientation of unloaded transporter 
from  inw ard-facing  conform ation to outw ard-facing  conform ation is 
represented by kq. Re-orientation of loaded transporter from outward-facing 
conform ation to inw ard-facing conform ation is represented by k 2 - Re­
orientation of loaded transporter from inw ard-facing conform ation to 
outward-facing conformation is represented by k_2 - Values of these constants 
for GLUT1 at 0°C are shown below (Lowe & Walmsley, 1986).
Rate Constant Value at 0°C (s-1)
12.1 ±  0.98
k-i 0.726 ± 0.498
k2 1113 ±498
k-2 90.3 ± 3.47
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Figure 1.2-
King-Altman Representation of the Alternating-Conform ation M odel 
for Sugar Transport by GLUT1.
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Figure 1.3
This is a schem atic  d iag ram  rep re sen tin g  the A lte rn a tin g  
Conformation Model depicting the conformational changes occurring during 
D-glucose transport. T0 and Tj represent the unloaded transporte r in 
outward-facing and inward-facing conformations, respectively. T0S and TiS 
represent the transporter with bound substrate (D-glucose), in outward-facing 
and inward-facing conformations, respectively. Note that this diagram  does 
not in any way attem pt to represent the actual transporter conformations.
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Figure 1.3-
Schematic Diagram Showing the Conform ational Changes Occurring during 
D-Glucose Transport as Predicted by the A lternating Conformation Model.
►
k
i i
y r
►
48
CHAPTER 2. 
Materials and M ethods.
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2.1 Materials.
A dult fem ale Xenopus laevis w ere obtained from  either Blades 
Biologicals, Edenbridge, Kent, UK, or directly from South Africa, (African 
Xenopus Facility, PO Box 118, Noordhoek, Republic of South Africa). ’’Frog 
Brittle" was also obtained from Blades Biologicals.
Recrystalised 4 ,6 -0 -ethylidine-D-glucose was a gift of Prof. G. E. 
Lienhard (Dartmouth Medical School, Hanover, NH, USA).
3-O-propyl-D-glucose, 1-deoxy-D-glucose, 6-deoxy-D-glucose, 6 -0 - 
propyl-D-galactose, 6-fluoro-D-galactose, 6-0-methyl-D-galactose and 3-fluoro- 
D-glucose were the gift of Dr. G. D. Holman (University of Bath, UK).
All other sugars and analogues were the gift of Prof. M ohammed 
Akhtar (University of Southampton, UK).
Tricaine M ethane Sulphonate, MS222 was supplied by Thompson & 
Joseph Ltd., Norwich, UK.
Chromic sterile catgut® was supplied by Ethicon Ltd., London, UK.
2-deoxy-D-glucose, 3-O-methyl-D-glucose, 3-deoxy-D-glucose, 3-fluoro-
3-deoxy-D-glucose, maltose, D-galactose, p-D-fructose, P-lactose, D-cellobiose, 
L -arabinose, D -m annose, D-xylose, ph lo re tin , kanam ycin, am picillin, 
tetracycline, dithiothreitol, collagenase, cytochalasin B, and 2,5-anhydro-D- 
mannitol were supplied by Sigma Chemical Company, Poole, Dorset, UK.
D-allose, D-fucose, and  L-sorbose w ere supp lied  by Pfanstiehl 
Laboratories Inc., W aukegan, IL, USA.
A m m onium  form ate, calcium  chloride-6-hydrate, and chloroform  
(Analytical Reagent) were supplied by BDH, Poole, UK.
Bacto®-tryptone, Bacto®-agar and Bacto®-yeast extract were supplied by 
Difco, East Molesey, Surrey, UK.
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Tris was supplied by Boehringer Mannheim Gmbh., Lewes, East Sussex,
UK.
Agarose (electrophoresis grade), DNA ligase and 5x ligase buffer were 
supplied by Gibco BRL, Paisley, UK.
Lambda ladder (BsfE II digested) and ribonuclease A were supplied by 
New England Biolabs, Hitchen, Herts, UK.
Sequencing grade urea, Tris, EDTA, de-ionised formamide, TEMED and 
Mixed Bed Resin were obtained from International Biotechnologies Inc. Ltd. 
(IBI), Cambridge, UK.
N ational D iagnostics Sequagel-6™ 6% sequencing gel solution and 
Sequagel™ Com plete Buffer Reagent were obtained from BS&S, Edinburgh, 
UK.
Ultima-flo AF scintillant was obtained from Canberra Packard Ltd., 
Pangbourne, Berks., UK.
Taq DyeDeoxy™ Term inator Cycle Sequencing kits and sequencing- 
g rade  p h e n o l/c h lo ro fo rm /H 2 0  (68:18:14) was obtained from A pplied 
Biosystems Inc. (ABI), W arrington, Cheshire, UK.
Plasmid Midi and Maxi Preparation Kits were supplied by QIAGEN,
UK.
Elutip-D  DNA purification colum ns (Schleicher & Schuell) w ere 
obtained from Anderman Ltd, London, UK.
Perm acel™  tape was obtained from Genetic Research Instrum ents, 
Dunmow, Essex, UK.
Alconox™ detergent was supplied by Aldrich Chemical Company Ltd., 
Gillingham, Dorset, UK.
'Native' Pfu DNA polymerase and 'Native' Pfu polym erase lOx buffer 
were obtained from Stratagene, Cambridge, UK.
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All restriction enzym es and corresponding lOx buffers, Taq D N A  
polym erase w ith supplied  lOx buffer and MgCl2 , calf intestinal alkaline 
phosphatase and lOx buffer, polynucleotide kinase and polynucleotide kinase 
lOx buffer, rNTPs, dNTPs, nuclease-free H 2 O, 5x transcrip tion buffer, 
dithiothreitol (DTT), RNasin, RNA ladder (360-9,490 bases) and SP6 RNA 
polymerase were supplied by Promega, Southampton, UK.
[2,6-3H]2-deoxy-D-glucose, [U-14C]D-fructose and [U-3H]D-galactose were 
supplied by DuPont NEN, Stevenage, Herts, UK.
"S culp tor™  in vitro m utagenesis system - RPN 1526" kits and 
[32P]dATP (5000 C i/m m ole; 10 m C i/m l) w ere supplied  by Am ersham  
International pic., Aylesbury, Bucks, UK.
Dialysis tubing (Visking size 1-8/32") w as supplied  by Medicell 
International Ltd, London, UK.
Sterile Acrodisc® 0.2 pm filters were supplied by Gelman Sciences Ltd., 
N ortham pton, UK.
DE-81 filter paper was supplied by W hatman Scientific Ltd., Maidstone, 
Kent, UK.
Sodium diguanosine triphosphate, GpppG (5* Cap) was supplied by 
Pharmacia, Milton Keynes, UK.
All oligonucleotides (Tables 5.1 and 5.2) were synthesised by Dr. V. 
Math, Department of Biochemistry, University of Glasgow.
Unless indicated otherwise, all rem aining chemicals were supplied by 
Fisons, Loughbourgh, UK.
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2.2 In Vitro Synthesis of mRNA from Plasmid cDNA.
All work with mRNA was conducted with sterile equipm ent whilst 
wearing gloves since ribonucleases which can degrade mRNA can be found 
on the skin and elsewhere, and as they are very stable enzymes, care was 
taken to avoid potential degradation of the mRNA. All reagents were thawed 
on ice. A nucleotide stock (2.5 mM rATP, 2.5 mM rCTP, 2.5 mM rUTP and 0.5 
mM rGTP) was diluted from stock 100 mM ribonucleotides. The following 
reagents were added to a sterile microfuge tube in the order shown, at room 
tem perature:-
75 pi ribonuclease-free H 2O
40 pi 5x transcription buffer
20 pi 100 mM dithiothreitol (DTT)
5 pi RNasin (a synthetic inhibitor of ribonuclease)
40 pi nucleotide mix (see above)
10 pi GpppG (5' Cap) (25 u n its /100 pi).
10 pi linearised plasmid cDNA (~ 1 pg/m l; see section 2.5.2).
2.5 pi SP6 polymerase (25 units)
This gave a total volume of 200 pi. The tube was placed in a 37°C water 
bath for 1 hour, after which a further 0.5 pi of SP6 polymerase was added, 
mixed and incubated at 37°C for 30 min. At this point the reaction was 
centrifuged in a microfuge to collect the condensate and then 1 volum e of 
phenol/chloroform  [1:1 (v/v)] added. This was vortexed for 1 m in and 
centrifuged in a microfuge for a further 1 min. The upper aqueous phase, 
which contained both mRNA and cDNA, was carefully collected into a clean 
tube. 100 pi of chloroform /isoam y 1-alcohol (24:1) was added to the solution,
before vortexing, centrifuging, and again collecting the aqueous phase. This
procedure was repeated, before finally adding 0.3 volumes of 5 M potassium
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acetate and 2.5 volumes of ice-cold absolute ethanol to precipitate the nucleic 
acid. The reaction was mixed and placed at -20°C for approximately 1 hour, 
then centrifuged in a microfuge for 30 min. The pellet was washed w ith 0.5 
ml 70% ethanol and centrifuged as above. All traces of ethanol were removed 
from the pellet by drying under vacuum. The pellet was resuspended in 20 pi 
of ribonuclease-free H 2 O. lp l of this was mixed with 3 pi of 5x DNA gel 
loading buffer (see Table 2.1) and loaded into a 1% agarose gel overlaid with lx  
TAE running buffer (see Table 2.1). 5 pi of 100 p g /m l BstE II-cut lam bda 
ladder DNA was loaded into an adjacent well and the current adjusted to 50 
mA so that negatively charged nucleic acids m igrated tow ard the positive 
electrode. Electrophoresis was carried out until the dye-front was half to two 
thirds across the gel, then 20 pi of 10 m g/m l ethidium  bromide added per litre 
of running buffer. The bands were visualised by viewing the gel under ultra­
violet light, and the size of any mRNA band checked by its relative migration 
to the lambda ladder. A typical photograph of mRNA on a 1% agarose gel can 
be seen in Figure 2.1.
2.3 Using Xenopus Oocytes.
2.3.1 H andling Xenopus.
A dult female Xenopus laevis (average length 15 cm) were kept in 
aquaria at a constant tem perature of 16-18°C on a 12 hour day /n ig h t cycle. 
The anim als w ere housed 2-4 per tank, in d istilled  w ater in a quiet 
environment. They were fed once weekly with raw  chopped sheep heart and 
the aquaria cleaned the following day. Alternatively they were fed Blades 
Biologicals "Frog Brittle". Each animal was kept for at least one m onth before
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operating to allow acclimatisation to its new environm ent. Oocytes were 
generally satisfactory after this initial period, however during the sum m er 
poor oocytes were occasionally encountered, coincident w ith seasonal 
variability of the female cycle in these animals.
2.3.2 Anaesthesia.
The anaesthetic was prepared by dissolving 0.75 g Tricaine Methane 
Sulphonate (MS222) in 500 ml distilled water. 25 ml of 0.5 M sodium  
bicarbonate was added to ensure that the pH  of the anaesthetic approached 
neutrality  and  hence was acceptable for the animal. The anim al to be 
operated on was placed in the tank with the anaesthetic and supervised to 
ensure that it did not drown. Typically, animals were unconscious after 5-10 
min. The animal was placed on its back and observed. If it did not move, it 
was judged to be unconscious.
2.3.3 Surgery.
Home Office Project and Individual Animal Handling Licenses were 
required for work on Xenopus. The animal was placed on its back and, using 
a sharp scalpel, a centimetre-long incision was m ade in the dermis and then 
another one directly underneath in the abdominal wall. A small clump of 
oocytes was rem oved using fine w atchm aker’s forceps and small scissors. 
These were placed into a petri-dish containing Barths buffer (Table 2.1). 
Oocytes were determ ined to be healthy if they fulfilled several im portant 
criteria. Oocytes had to be approximately 1 mm in diameter; required well- 
defined animal and vegetable poles, with a sharp distinction at the boundary; 
required no discoloured patches; and had to exhibit a certain robustness when
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m anipulated. These were defined as stage V and VI oocytes. If the oocytes 
were judged to be healthy, enough were removed from the toad as required 
for injection and non-injected controls. The animal was then sewn up using 
chromic sterile catgut, with a single stitch in the abdominal wall and two 
stitches in the dermis. The animal was then placed on its front in a recovery 
tank  contain ing  2-3 mm of d istilled  w ater un til it fully  regained  
consciousness, when it was returned to its own holding tank. A m inimum 
period of no less than three m onths was allowed to pass before operating on 
the same animal.
2.3.4 Oocyte Isolation and Injection.
Oocytes w ere rem oved from  adu lt fem ale Xenopus laevis a n d  
ind iv idually  dissected. This involved rem oving the oocytes from the 
connective tissue and blood vessels which provide the oocytes with nutrients 
and remove toxic wastes. Oocytes were placed into a petri-dish, immersed in 
Barths buffer (see Table 2.1), to maintain the environm ent as close to in vivo 
conditions as possible. Using a binocular microscope and fine watchmakers 
forceps, stage V and VI oocytes were rem oved from their stalks and then 
transferred to a container with fresh Barths buffer. Damaged oocytes were 
im m ediately discarded to m inim ise the exposure of healthy oocytes to 
proteases. Generally, 2-3 times as many oocytes were isolated than actually 
required since a percentage of the population would be expected to die before 
they were assayed. Oocytes were selected as required for injection with 40 nl 
of in vitro transcribed mRNA encoding GLUT2, GLUT3 or a m utan t 
transporter, or to act as non-injected "control" oocytes.
The injection apparatus consisted of a 10 pi micro-injector (Drummond 
Scientific Co.); six inch long capillary tubes; a m icro-manipulator (Narishige,
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Japan); a needle-puller (World Precision Instruments); a binocular microscope 
with separate light source; a petri-dish with a SpectraMesh grid (Fischer); and 
paraffin oil. Gloves were worn at all times to prevent contamination of the 
mRNA by ribonuclease present on fingertips. A capillary tube was placed in 
the needle-puller and by a combination of heating and pulling produced 
needles with a bore size of about 2 |im. The tip of one was broken off near the 
end with fine forceps and, using a syringe and 25 gauge needle, filled with 
paraffin oil. This was attached to the m icropipette (set at about 3 pi) and 
secured in the m icro-manipulator. GLUT mRNA was placed into a 1.5 ml 
microfuge tube and pulsed for 30 sec in a microfuge to remove any debris or 
insoluble material. About 7 pi of mRNA was taken from the supernatant and 
placed onto a sterile microfuge tube lid. The micropipette was lowered so that 
the end of the needle was submerged in the droplet, and the mRNA taken up 
slowly into the needle. Oocytes were placed on a grid in a petri-dish with 
Barths buffer and orientated so that the pale vegetable pole was upperm ost. 
They were injected w ith a precise volume of mRNA (10-50 nl) and then 
removed to a separate container. The oocytes were incubated in Barths buffer 
for 48-72 hours prior to assay, transferring to fresh buffer every 12 hours. 
Non-injected oocytes were treated in an identical fashion. After this period, 
oocytes were assayed for the ability to transport 2-deoxy-D-glucose.
2.4 Sugar Transport in Xenopus oocytes.
Groups of 6 oocytes were incubated in 0.45 ml Barths buffer (Table 2.1) 
at room tem perature in 13.5 ml centrifuge tubes. Transport (zero-trans entry) 
was initiated by the addition of 50 pi of [2,6-3H]2-deoxy-D-glucose, [U-14C]D- 
fructose or [U-3H]D-galactose to give a specified final sugar concentration with 
an activity of ~1 pC i/m l. After a designated time, usually 15 or 30 min, the
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transport of sugar into the oocytes was quenched by rapid aspiration of the 
media and three washes with 5 ml ice-cold 150 mM phosphate buffered saline, 
pH  7.4, (lxPBS, Table 2.1) containing 0.1 mM phloretin (a potent transport 
inhibitor). The oocytes were dispensed individually into scintillation vials 
using a pipetteman and a tip which had the end cut off, and then 0.5 ml of 1% 
sodium  dodecyl sulphate (SDS) added. The vials were left for an 1 hour at 
room tem perature then vortexed to solubilise the oocytes, before the addition 
of 4 ml scintillation fluid and subsequent m easurement of radioactive uptake 
by a scintillation counter. For each group of GLUT-injected oocytes assayed at 
a particular sugar concentration, a group of non-injected oocytes were assayed 
under identical conditions. This control gave a value for radioactive sugar 
transport by native oocyte glucose transporters plus background radiation 
levels. Hence, the rate of uptake in GLUT-injected oocytes less the rate of 
transport in control (non-injected) oocytes gave a value corresponding to 
specific transport by heterologous transporters. Transport with a variety of 
sugar concentrations was m easured for each assay so that Lineweaver-Burk 
plots could be constructed, and Km and Ki values determ ined. For assays 
involving the inhibition of radioactive sugar uptake by another sugar or the 
fungal metabolite cytochalasin B, the inhibitor was added to the oocytes in 
0.45 ml Barths buffer at least 15 min prior to addition of labelled sugar.
2.5 General Techniques for the Manipulation of DNA.
2.5.1 Plasmid Construction.
The hum an glucose transporter constructs used for the preparation of 
mRNA have been described previously (Kayano et al., 1990). Human GLUTs
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2 and 3 and m utant GLUT3 were in pSP64T (Krieg & M elton, 1984) and 
nam ed pHTL217 and pSPGT3, respectively. These constructs contain the 
protein coding region of the cDNA (and various am ounts of 5'- and 3'- 
untranslated regions) flanked by 89 bp of 5'- and 141 bp of 3'-untranslated 
sequence from the Xenopus (3-globin gene (Kayano et al., 1990) (Figure 2.2). 
The plasm id contains a SP6 RNA polymerase prom oter at the 5’ end of the 
transporter sequence and a sequence encoding ampicillin resistance.
GLUT3 cDNA was also present in M13mpl8GT3, cloned as a BamH 
l/Xba  I fragment into the m ultiple cloning site of M 13mpl8 (Figure 2.3). This 
bacteriophage vector has no RNA polymerase prom oters, and hence was not 
used as a template for the synthesis of mRNA.
2.5.2 Linearisation of Plasmid cDNA.
pHTL217 or pSPGT3, or a derivative thereof, was specifically restricted 
once at the 3' end of the cDNA, downstream of the coding sequence. This had 
the effect of linearising the plasm id, so that the efficiency of subsequent 
mRNA synthesis reactions were increased by ensuring that the SP6 RNA 
polymerase used did not continue synthesis of mRNA after transcription of 
the transporter. The choice of restriction enzyme depended on the particular 
plasmid and transporter. GLUT3 and its point m utants were linearised using 
Xba I, and GLUT2 by Sal I. 10 pg of plasm id cDNA was digested in a total 
volume of 20 pi overnight at 37°C (section 2.5.4). 1 pi of this reaction was 
loaded onto a 1% agarose gel and electrophoresed to confirm linearisation 
(section 2.5.3). From this point onw ards, all work was done using sterile 
microfuge tubes whilst wearing gloves. 70 pi of ribonuclease-free H 2 O was 
a d d ed  to the tube, the so lu tio n  ex trac ted  w ith  1 vo lum e of 
phenol/chloroform  (1:1), then twice with chloroform /isoam yl-alcohol (24:1).
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The cDNA was precipitated by the addition of 0.3 volumes of 5 M potassium  
acetate and 2.5 volumes of absolute ethanol, and incubation at -20°C for at 
least 1 hour. The tube was centrifuged in a microfuge for 30 min at 4°C, the 
pellet resuspended in 0.5 ml 70% ethanol, centrifuged again in a microfuge for 
30 min, and the pellet finally resuspended in 10 |il of ribonuclease-free H 2 O. 
This was ready to be used in a mRNA synthesis reaction (section 2.2).
2.5.3 Agarose Gel Electrophoresis of cDNA.
Various gel volumes, combs and agarose concentrations were used. 
The gel volume was governed by the num ber of samples, the volume of the 
samples and to a lesser extent the required degree of separation of the cDNA 
bands. The choice of comb depended only on the volum e of the samples. 
The concentration of agarose used varied depending on the molecular weight 
of the cDNA band to be visualised- high agarose concentrations aided the 
separation of low molecular weight bands, and lower agarose concentrations 
give better separation  w ith h igher m olecular w eight bands. Typical 
concentrations used were 1.0% and 1.5% (w /v).
Example:- for a 100 ml 1.0% Agarose Gel.
An appropriate gel base was selected and the ends secured with tape to 
prevent gel leakage. 1.0 g of agarose was weighed out and distilled water 
added to a total volume of 100 ml. This was heated in a microwave oven 
until the solution just boiled and left to cool until hand hot. 2 ml of 50xTAE 
buffer (Table 2.1) was added to the gel solution and mixed. The contents were 
poured onto the gel base, the comb inserted and the gel left to set for about 10 
min. The tape was then removed and the entire ge l/ gel base placed into the
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electrophoresis tank so that the wells were nearest to the negative electrode. 
About 1 litre of lxTAE buffer (40 mM Tris-acetate, 1 mM EDTA, pH  8.0) was 
added to the chamber so that the entire gel was submerged, and then the comb 
was removed . To each sample, 1 /4  volume of 5x DNA gel-loading buffer 
(Table 2.1) was added and mixed. The samples were loaded into the wells by 
pipetting directly above them- the glycerol in the sample buffer ensured that 
the samples were more dense than the buffer and therefore the samples sank 
into the wells. 10 pi of loading buffer containing 25 p g /m l BstE II-cut lambda 
ladder cDNA was loaded into an adjacent well. The electrodes were 
connected so that the negative electrode was closest to the sample wells. The 
samples were electrophoresed at 50-100 mA using an LKB 2197 power supply 
until the dye front had migrated two thirds of the way along the gel towards 
the positive electrode, then 50 pi of 10 m g/m l ethidium  brom ide was added 
per litre of running buffer, and left at room tem perature for 30- 45 min. The 
DNA was visualised by ultra-violet light using an Ultraviolet Products Inc. 
transillum inator, and the size of any cDNA band checked by its relative 
m igration to the lam bda ladder. The gel was then photographed using a 
Mitsubishi video copy processor.
2.5.4 Restriction Digestion of cDNA.
Restriction digestion of cDNA was perform ed by the addition of 
restriction enzym es to cDNA in the appropriate  buffer, optim ising salt 
concentration and pH  for individual enzymes. Generally, from 0.5-10 pg of 
cDNA was digested per reaction. The total reaction volume was 10 pi per 1 pg 
cDNA and the quantity of enzyme added equal to 1 unit per 1 pg cDNA. The 
reaction was carried out by the addition of 1 volum e of lOx buffer to 9 
volumes diluted cDNA solution, before the addition of enzyme. This was
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incubated for 1 hour at 37°C (or otherw ise depending  on the particular 
enzyme). For digestions with m ore than one enzym e, the reaction was 
carried out as usual with the first enzyme (the one which utilises lower salt 
concentrations), and then salt added to the reaction to optim ise conditions for 
the second digestion which was subsequently carried out. A lternatively, if 
both enzymes utilised approximately the same optim um  reaction conditions, 
both digests could be carried out sim ultaneously. The reactions were then 
added to 1 /4  volume of 5x DNA gel loading buffer and the solution loaded 
onto an appropriate agarose gel. This was electrophoresed, stained w ith 
ethidium  brom ide and cDNA bands visualised as described above (section 
2.5.3). Any bands of interest were excised from the gel w ith a scalpel and 
purified as described (sections 2.7.4; 2.7.5; 2.7.6).
2.5.5 Dephosphorylation of Double-Stranded cDNA using Calf Intestinal
Phosphatase.
Plasmid cDNA was digested with the appropriate restriction enzyme 
for 60 min and then treated with RNase A for 15 min at 37°C (section 2. 5. 10). 
The mix was then made up to a volume of 100 pi w ith dephosphorylation 
buffer (1 mM ZnCl2 , 1 n\M MgCl2 , 10 mM Tris-HCl pH  8.8) and 1 unit of Calf 
Intestinal Phosphatase (CIP) was added. After incubation at 37°C for 60 min, 
plasmid cDNA was isolated from the enzyme reagents by phenol extraction 
and precipitation (section 2.5.2), and cDNA was resuspended in 20 pi of H2O.
2.5.6 Ligation of Double-Stranded cDNA.
cDNA fragm ents were ligated to plasm id cDNA by the following 
procedure. In order to increase the efficiency of ligation, the reaction was
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perform ed with a high GLUT cDNA: plasmid cDNA m olar ratio, (10:1). 100 
ng of plasmid cDNA which had been CIP-treated was added to GLUT cDNA at 
a molar ratio of 1:10 and the mix incubated at 60°C for 5 min. After pulsing 
the sam ples briefly in a microfuge, an aliquot of 5x concentrated ligation 
buffer and 3 units of T4 DNA ligase were added, and  the sam ples then 
incubated overnight at 16°C. Competent bacteria were then transform ed with 
5- 10 pi of the ligation reaction as described (section 2.5.9).
2.5.7 Preparation of Competent Cells.
Lyophilised E. coli XLl-Blue MRF cells were resuspended in 3 ml of LB 
m edium  (Table 2.2) with 10 p g /m l tetracycline and grown overnight at 37°C. 
These were then streaked onto a LB plate containing 10 p g /m l tetracycline 
and again incubated overnight at 37°C. This culture was then streaked onto 
glucose/m inim al m edium  plates (Table 2.2) and left for about 48 hours at 
37°C. This procedure selected for bacteria possessing the "F pilus", via which 
M13 bacteriophage enter the cell upon infection. This plate was used as a 
m aster p late  for m aking both  com petent cells and  "law n cells" for 
transform ation protocols involving M13 (2.5.8). A single E. coli X L l-B lue 
MRF' colony was picked from a glucose/m inim al m edium  plate using a 
sterile pipette tip and dropped into 3 ml LB m edium  containing 10 p g /m l 
tetracycline. This was grown overnight in a shaking 37°C incubator. Two 40 
ml cultures of LB m edium  (10 p g /m l tetracycline) in sterile flasks were 
inoculated w ith  400 pi of overn ight cu ltu re  and grow n at 37°C for 
approximately 2 hours until the A600 reached a value of 0.3. One flask was 
stored at 4°C as lawn cells. The contents of the other were transferred to a 
chilled 50 ml centrifuge tube and centrifuged at 4°C for 5 m in at 2500x gaV in a 
prechilled rotor. The supernatant was gently poured  off and the pellet
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resuspended in 20 ml of cold sterile 100 mM CaCl2 and incubated on ice for 40 
min. The cells were centrifuged again and resuspended in 4 ml of 100 mM 
CaCl2 . Cells were left at 4°C for at least one hour before the addition of cDNA, 
how ever the cells reached m axim um  transform ing efficiency after several 
hours, only decreasing after 24 hours.
W hen preparing competent cells for use w ith plasm id cDNA (section 
2.5.9), the procedure was identical except that it was not necessary to include 
the grow th on a glucose/m inim al m edium  plate since the F pilus was not 
required for simple transformation. Plasmid transform ations do not require 
"lawn cells".
2.5.8 Transform ation of Com petent E. coli. w ith M13mpl8GT3.
M13mp8 rfDNA (100 n g /p l)  w as inc luded  in the A m ersham  
Sculptor™  site-directed mutagenesis kit. This was used as a positive control 
for transform ation. 1 ng of rfDNA (double stranded  replicating form) 
produced 200-300 plaques if the cells were competent. Each control and 
transformation reaction was carried out in duplicate.
For each transform ation reaction a 15 ml polypropylene Falcon tube 
was placed on ice and 300 pi of competent E. coli XLl-Blue MRF' cells added 
(section 2.5.7). 100 pi of M13 rfDNA was added to the competent cells. This 
was mixed by stirring while adding the rfDNA and then left on ice for 40 min. 
The cells were heat shocked in a 42°C waterbath for 45 sec, returned to ice for 5 
min, then allowed to reach room temperature. 200 pi of noncompetent E. coli 
XLl-Blue MRF' lawn cells and 3 ml of molten LB top agar (Table 2. 2) at 45°C 
were subsequently added to each tube. The contents of the tube were mixed 
vigorously and im m ediately  poured  onto a LB plate w ith  10 p g /m l 
tetracycline, gently rolling the plate to ensure that the top agar covered its
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entire surface. This was left to set for 10 min and then the plates were 
inverted and incubated overnight at 37°C. Plaques were isolated, and single­
stranded or double-stranded cDNA was isolated as described (sections 2.5.11 
and 2.5.13).
2.5.9 Transform ation of Com petent E. coli w ith Plasm id cDNA.
This process was similar to that of section 2.5.8. 100 ng of purified 
pSPGT3 plasm id cDNA was used as a positive control for transformation. 
Sterile H 2O was used as a negative control.
For each transform ation reaction a 15 ml polypropylene Falcon tube 
was placed on ice and 200 pi of competent E. coli XLl-Blue MRF' cells added. 
10 pi of cDNA was added to the competent cells. This was mixed by gently 
rolling the tube while adding the cDNA, then left on ice for 40 min. The cells 
were heat shocked in a 42°C waterbath for 45 sec, returned to ice for 5 min, 
and finally allowed to reach room tem perature. 0.8 ml or 0.98 ml of LB 
m edium  was added to 200 pi and 20 pi sam ples, respectively, of each 
transformation reaction and incubated in a shaking 37°C incubator for 1 hour 
to "pre-grow" the cells. Ampicillin was used consistently for selection of cells 
transformed with pHTL217 and pSPGT3 plasmid cDNA. This pre-growth step 
allows the cells to establish plasmid encoded ampicillin resistance, after which 
the cells were harvested by centrifugation in a Beckman CPR benchtop 
centrifuge for 5 min at 4000 rpm  at 4°C. The supernatant was removed, except 
for the last 100 pi, in which the cells were resuspended by gentle pipetting. 
The cells were spread onto LB agar plates with 10 p g /m l tetracycline and 50 
p g /m l ampicillin and grown overnight at 37°C. Colonies were selected and 
used to prepare double-stranded cDNA (section 2.5.10).
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2.5.10 Preparation of Small Amounts of Plasmid cDNA.
Colonies of interest were picked w ith sterile tips and dropped into 
universals, each containing 3 ml of 2xYT m edium  containing 10 p g /m l 
tetracycline and 50pg/m l ampicillin. These were grown overnight at 37°C in 
a shaking incubator. 1.5 ml of culture was removed, placed in a microfuge
j
tube and centrifuged for 15 min in a m icrofuge to pellet the cells. The 
supernatant was discarded and the pellet resuspended in 100 pi of glucose 
buffer (50 mM glucose, 25 mM Tris, pH  7-8 and 12.5 mM EDTA) with 
extensive vortexing. This was incubated on ice for 5 min, then 200 pi of 1% 
SDS in 0.2 M NaOH was added and the tube gently inverted 5 times. The tube 
was incubated on ice for 10- 20 min, or until viscous. 300 pi of 3 M K +/5 M Ac 
was added, the tube inverted gently 5 times, and incubated on ice for another 
5 m in before centrifuging in a microfuge for 5 min. The supernatant was 
removed to a fresh tube, 5 pi of 1 m g /m l RNase A was added and incubated at 
37°C for 15 min. One phenol extraction, two phenol/chloroform  (1:1 v /v ) 
extractions, and two chloroform / isoamylalcohol (24:1 v /v )  washes of the 
supernatants were perform ed, retaining each time the upper aqueous phase. 
After the final wash, 0.3 volumes of 3 M sodium  acetate and 2.5 volumes of 
100% ethanol were added to precipitate the cDNA. This was incubated at 
-20°C for at least an hour before pelleting the cDNA by centrifugation for 30 
min in a microfuge. The ethanol was removed, the pellet washed with 70% 
ethanol and centrifuged for a further 30 min, before drying under vacuum. 
The pellet was resuspended in 20 pi of sterile water. 1 pi of this was added to 
1 ml of sterile w ater and the absorbance m easured at 260 nm. The 
concentration was determined from the calculation below.
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Calculation to Determine the Plasmid cDNA Concentration and Purity.
absorbance value of 1.0 at 260 nm = 50 p g /m l of dsDNA. 
absorbance value of "y" at 260 nm = "y" x 50 p g /m l of dsDNA.
absorbance at 260 nm =" Z " 
absorbance at 280 nm
cDNA has a lower protein concentration and has a higher purity when 
the value of " Z " is nearer to 2.0.
2.5.11 Preparation of Small Am ounts of Bacteriophage M13 "Replicative 
Form" cDNA.
An appropriate plaque was picked from a recent plate (no more than 1 
week old). The tip was dropped into a sterile universal w ith 1 ml of LB 
m edium  containing 10 p g /m l tetracycline, and left for 1 hour to allow the 
agar plug to diffuse into the medium. 700 pi of the m edium  was removed 
and stored as a primary stock of bacteriophage particles. A further 2 ml of LB- 
broth containing 10 p g /m l tetracycline and 100 pi of an overnight culture of 
XLl-Blue MRF' E. coli were added. The cells were incubated at 37°C for 5 
hours with shaking. 1.5 ml was then removed, placed into a microfuge tube 
and centrifuged for 15 min to pellet the cells. The double-stranded rfDNA is 
inside the cells (i.e. in the pellet), so the supernatant was discarded. The 
rem ainder of the protocol is identical to that used for preparation of plasmid 
cDNA from E. coli (section 2.5.10).
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2.5.12 QIAGEN Plasmid Midi/Maxi Preparation Kits.
These kits use various buffer reagents and columns to bind and purify 
cDNA from 100 ml or 300 ml cultures of plasmid-containing bacteria.
Com ponents:-
(supplied with kits)
Buffer PI lOOpg/ml RNase A, 50 mM
(Resuspension buffer) Tris/H Cl, 10 mM EDTA, pH  8.0
stored at 4°C.
Buffer P2 200 mM NaOH, 1% SDS.
(Lysis buffer)
Buffer P3 3 M KAc, pH  5.5, stored at 4 °C.
(Neutralisation buffer)
Buffer OBT 
(Equilibration buffer)
750 mM NaCl, 50 mM MOPS, 15% 
ethanol, pH  7.0, 0.15% Triton-X- 
100.
Buffer OC 
(Wash buffer)
1.0 M NaCl, 50 mM MOPS, 15% 
ethanol, pH  7.0.
Buffer OF 
(Elution buffer)
1.25 M NaCl, 50 mM Tris/H Cl, 15% 
ethanol, pH  8.5.
TE buffer 10 mM Tris/H Cl, 1 mM EDTA,
pH 8.0.
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STE buffer 100 mM NaCl, 10 mM Tris/H Cl, 
1 mM EDTA, pH  8.0.
QIAGEN-tip 100 columns These contain a patented anion-
exchange resin, which is a 
modification of m acroporous 
silicagel
2.5.12.a M13mpl8GT3 M idi Preparation Procedure:-
An overnight culture of XLl-Blue MRF' E. coli was grow n in LB
m edium  containing 10 p g /m l tetracycline. 1 ml of this culture was mixed
with 200 pi of the appropriate stock of Ml 3 bacteriophage particles (pfu =1012
particles/m l), and incubated at room tem perature for 5 min. This m ixture
was then added to 100 ml of LB m edium  containing 10 p g /m l tetracycline,
prew arm ed to 37°C, and incubated for 6 hours at 37°C with shaking. The cells
were harvested by splitting the culture into two 50 ml centrifuge tubes and
centrifuging at 4000x gav for 5 min at 4°C. The supernatant, which contains
the bacteriophage particles, was removed and stored at 4°C. The pellets were
resuspended and combined in 15 ml of STE buffer to remove residual phage
and spun down at 4000x gav for 5 min at 4°C. The supernatant was discarded
and the pellet resuspended in 4 ml of buffer PI. 4 ml of buffer P2 was added,
mixed gently, and incubated at room tem perature for 5 min. Then 4 ml of
buffer P3 was added, mixed quickly but gently, and incubated on ice for 15
min. The contents of the tube were placed into 50 ml Beckman centrifuge
tubes and centrifuged in a JA-20 rotor at 30,000x gav for 30 min at 4°C. The
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supernatant was quickly removed and passed through 2 layers of m uslin to 
remove any particles. If necessary, the centrifugation step and filtering were 
repeated. A QIAGEN-tip 100 was equilibrated with 4 ml of buffer QBT and 
the supernatant passed through the column. The tip was w ashed twice with 
10 ml of buffer QC. The cDNA was eluted w ith 5 ml of buffer QF, then 
precipitated with 0.7 volumes of isopropanol. This was centrifuged at 15,000x 
g a v  t o  30 min at 4°C. The supernatant was rem oved taking care not to 
d isturb the pellet. 5 ml of cold 70% ethanol was added to the pellet and 
centrifuged as before. Lastly, the ethanol was rem oved and the pellet air- 
dried for 5 min, before dissolving in 100 |il of sterile H 2 O. 4 pi of this was 
added to 1 pi of DNA gel-loading buffer and electrophoresed in a 1% agarose 
gel to check the recovery of cDNA (section 2.5.3).
2.5.12. b Plasmid Maxi Preparation Procedure.
An overnight culture of XLl-Blue MRF' E. coli containing the plasm id 
of interest was grown in 3 ml LB m edium  containing 10 p g /m l tetracycline 
and 50pg/m l ampicillin. 1 ml of this culture was added to 300 ml of LB 
m edium  containing 10 p g /m l tetracycline and  5 0 p g /m l am picillin , 
prew arm ed to 37°C, and incubated overnight at 37°C with shaking. The cells 
were harvested by splitting the culture into two 250 ml centrifuge tubes and 
centrifuging at 4000x gav for 5 min at 4°C. The supernatant was discarded and 
the pellet resuspended in 10 ml of buffer PI. 10 ml of buffer P2 was added, 
mixed gently, and incubated at room tem perature for 5 min. Then 10 ml of 
buffer P3 was added, mixed quickly bu t gently, and incubated on ice for 20 
min. The contents of the tube were placed into 50 ml Beckman centrifuge 
tubes and centrifuged in a JA-20 rotor at 30,000x gav for 30 m in at 4°C. The 
supernatant was quickly removed and passed through 2 layers of muslin to
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remove any particles. If necessary, the centrifugation step and filtering were 
repeated. A QIAGEN-tip 300 was equilibrated with 10 ml of buffer QBT and 
the supernatant passed through the column. The tip was washed twice with 
30 ml of buffer QC. The cDNA was eluted and collected with 10 ml of buffer 
QF, then precipitated w ith 0.7 volumes of isopropanol. This was centrifuged 
at 15,000x gav for 30 min at 4°C. The supernatant was removed taking care not 
to disturb the pellet. 5 ml of cold 70% ethanol was added to the pellet and 
centrifuged as before. Lastly, the ethanol was removed and the pellet air-dried 
for 5 min, before dissolving in 300 pi of sterile H 2 O. 4 pi of this was added to 1 
pi of DNA gel-loading buffer and electrophoresed in a 1% agarose gel to check 
the recovery of cDNA (section 2.5.3).
2.5.13 Preparation of Small Am ounts of Single Stranded cDNA from M13.
A plaque of interest was selected and stabbed with a sterile pipette tip. 
This was dropped into 1 ml of LB medium, containing 10 p g /m l tetracycline, 
in a 30 ml sterile "Universal" container. This was vortexed extensively and 
left at room tem perature for 1 hour. 0.7 ml of this was removed and stored at 
4°C as a primary phage stock. A further 2 ml of LB medium and also 100 ml 
of an overnight culture of MRF' E. coli were added to the Universal, which 
was then placed in a 37°C shaking incubator for 5 hours at 200 rpm. This 
resulted in both E. coli containing double-stranded rfDNA and bacteriophage 
particles comprising single-stranded cDNA with a protein coat. 1.5 ml of 
culture was rem oved and centrifuged for 15 min in a microfuge. The 
supernatant was recovered, leaving the last 100 pi and the bacterial pellet. 
The supernatant was centrifuged once more to remove all residual bacteria, 
and again the final 100 pi was left behind. 200 pi of 20% Polyethylene glycol 
(PEG) 6000/ 2.5 M NaCl was added to the supernatant to precipitate the phage
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particles. This was mixed by inversion and left at room tem perature for 20 
min. The phage were harvested by 15 min centrifugation in a microfuge, 
discarding the supernatant. The pellet was resuspended in 100 pi of TE buffer 
(Table 2.1). 5 pi of this solution was stored as a bacteriophage stock.
Ribonuclease A (1 m g /m l) was added  to the rem aining solution and 
incubated for 15 min at 37°C to remove cellular RNA. Then, 100 pi of Tris­
w ashed phenol was added to the tube w hich was vortexed for 1 min, 
centrifuged for 1 min in a microfuge, and the upper aqueous layer removed 
w ith a pipette. This fraction contained the ssDNA. 100 pi of 1:1 (v /v) 
phenol/chloroform  was added; the tube vortexed and centrifuged; and the 
aqueous phase saved. Lastly, 100 pi of 24:1 (v /v ) chloroform /isoam yl- 
alcohol was added to remove traces of phenol from the aqueous phase. This 
w as repeated  tw ice, each tim e invo lv ing  extensive vortex ing  and 
centrifugation. 0.3 volum es of 3 M sodium  acetate and 2.5 volum es of 
absolute ethanol were added to the remaining ssDNA solution. The tube was 
vortexed and incubated at -20°C for 1 hour. The precipitated cDNA was 
centrifuged for 30 min in a microfuge, the ethanol removed and 0.5 ml of 70% 
ethanol added to wash the pellet. The cDNA was pelleted by centrifugation 
for 15 min in a microfuge; the ethanol supernatant was discarded. The pellet 
was resuspended in 10 pi of water by vortexing. 1 pi in 3 pi of gel loading 
buffer was run on a 1% agarose gel (section 2.5.3). Bands were visualised as 
described in section 2.5.3. A further 1 pi of ssDNA was taken and diluted in 1 
ml of w ater and its absorbance at 260 nm  read by spectrophotom etry to 
determ ine the concentration. However, the calculation was adjusted such 
that a reading at 260 nm of 1.0 = 40 pg /m l of cDNA.
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2.6 Site-Directed Mutagenesis.
The m ethod used for site-directed m utagenesis involved use of the 
Am ersham  "Sculptor™ in vitro mutagenesis system- RPN 1526" kit.
2.6.1 Com ponents.
The kit contained:-
native T7 DNA polymerase; T4 DNA ligase; T5 exonuclease; Nci I 
restriction enzyme; exonuclease III; DNA polym erase I; Buffer A (1.4 M 
MOPS, pH  8 and 1.4 M NaCl); Buffer B (70 mM Tris, pH  8, 10 mM MgCl2, 45 
mM NaCl); Buffer C (700 mM Tris, pH  8, 350 mM EDTA, 20 mM DTT); Buffer 
D (250 mM Tris, pH  8, 150 mM NaCl and 500 mM EDTA); dNTP mix A (1.01 
mM dATP, dCTPy-S, dGTP, dTTP, 2.02 mM ATP and 20 mM MgCl2); dNTP 
mix B (1.25 mM dATP, dCTP, dGTP, dTTP, 2.5 mM ATP and 25 mM MgCl2); 
sterile water; lyophilised E. coli TGI host cells; M13mp8 control rfDNA; 
con tro l tem p la te  cDNA (sin g le-s tran d ed ); and  contro l m u tagen ic  
oligonucleotide (phosphorylated).
Besides the components of the kit, the following were required:-
ssDNA tem plate (2 pg); m utant oligonucleotide (1.6 pm ole/p l); LB 
m edium  with tetracycline; glucose/m inim al m edium  agar plates; H  top agar; 
LB agar plates with tetracycline; 20% polyethylene glycol (6000)/2.5 M NaCl 
solution; TE buffer; 3 M sodium acetate solution; polynucleotide kinase and 
polynucleotide kinase lOx buffer; 100 mM rATP; [y-32P]ATP (5000 Ci/m m ole; 
10 m C i/m l); DE-81 filter paper; 50 mM CaCl2 solution; lOx TAE 
electrophoresis buffer; ethidium  brom ide solution; and 5x DNA gel loading 
dye solution.
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2.6.2 Phosphorylation of Oligonucleotides.
Oligonucleotides (18-24'mers) with sequence identical to the antisense 
strand  of GLUT3 in the region of putative transm em brane helix 8 were 
synthesised  (Dr. V. M ath, D epartm ent of B iochem istry, U niversity  of 
Glasgow). However these oligonucleotides had 1-3 bases altered, compared 
w ith wild-type GLUT3, so that one amino acid was altered to alanine (Table 
5.1). Oligonucleotides were supplied in an am m onium  hydroxide solution. 
360 pi of each oligonucleotide solution was added to 1.2 ml of ethanol and 40 
pi of 3 M sodium acetate in a microfuge tube, mixed and incubated at -20°C for 
at least 1 hour. This was then centrifuged for 30 min in a microfuge, washed 
w ith 70% ethanol, centrifuged again, dried and resuspended in 360 pi of 
sterile H 20 . Absorbance values at a w avelength of 260 nm  (A26o) were 
m easured for 25 pi of purified oligonucleotide in 1 ml sterile H 20 .  The 
oligonucleotide was then diluted to 1.6 pm ole/p l, the concentration required 
for mutagenesis. 30 pi of the oligonucleotide solution, 3.6 pi of lOx kinase 
buffer, 2 pi of 100 mM ATP and 2 units of polynucleotide kinase were added 
to a microfuge tube. This was mixed and incubated for 15 min at 37°C to 
phosphorylate the 5'-hydroxyl group of the first base in the oligonucleotide 
sequence, and then incubated at 70°C for 10 min to inactivate the kinase. 
P hosphory la ted  o ligonucleo tides w ere sto red  at -20°C. To confirm 
phosphorylation, 2 pi of [y-32P] dATP (10 pC i/p l, 5000 C i/m m ole) was used 
instead of ATP in an otherwise identical reaction. The procedure was also 
identical, except 2 pi of the reaction product was loaded onto the origin (about 
1 cm from the bottom narrow end) of a 2 cm x 10 cm strip of DE-81 filter paper. 
The spot was dried using a hair-dryer and the strip suspended over a beaker so 
that the bottom  was immersed in 3 M am m onium  formate, pH  8.0. The 
solvent was run until almost at the top and the location of the solvent front
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m arked before air-drying the strip. The paper was then cut into 1 cm sections 
and placed into 20 ml scintillation vials. The radioactive decay (dpm) 
produced was m easured with a program  designed to m easure 32P emissions 
on a scintillation counter. If a high percentage of the counts rem ained at the 
origin, this showed that m ost of the label had been incorporated into the 
oligonucleotide since, unlike free nucleotides, this w as not mobile in the 
solvent.
2.6.3 Sculptor Protocol.
See Figure 5.2. 2 jil of single-stranded tem plate cDNA (1 m g /m l
M13mpl8GT3), 1 pi of phosphorylated oligonucleotide (1.6 pm oles/pl), 1 pi of 
buffer A and 5 pi of sterile H 2 O were added to a microfuge tube and mixed. 
The reaction mix was incubated for 3 min at 70°C, and then placed in a beaker 
of w ater at 55°C and cooled slowly to room  tem peratu re , allowing the 
oligonucleotide to anneal to the single-stranded tem plate cDNA. 10 pi of 
dNTP mix A, 2.5 units of T4 DNA ligase, and 0.8 units of T7 DNA polymerase 
were added to the annealing reaction. This was incubated for 10 min at room 
tem perature, 30 min at 37°C to allow the extension and ligation of the m utant 
strand (containing dCTPy-S), and finally 15 min at 70°C to inactivate the 
enzymes. A 1 pi sample was removed for analysis by gel electrophoresis. 50 
pi of buffer B and 2000 units of T5 exonuclease were added to the extension 
reaction. This was incubated for 30 m in at 37°C to rem ove the single­
stranded , non-m utant DNA and for 15 m in at 70°C to inactivate the 
exonuclease. A 5 pi sample was removed for analysis. 5 pi of buffer C and 5 
units of Nci I were added to the digestion. This was mixed and incubated at 
37°C for 90 min to allow the nicking of the non-m utant strand. A 10 pi 
sample was taken for analysis. 20 pi of buffer D and 160 units of exonuclease
75
Ill were added to the nicking reaction, the tube mixed and incubated at 37°C 
for 30 min to digest the non-m utant strand, then heat inactivated at 70°C for 
15 min. 10 pi was removed for analysis. 20 pi of dNTP mix B, 3.5 units of 
DNA polymerase I and 2.5 units of T4 DNA ligase were added to the tube and 
mixed. This was incubated for 60 min at 37°C to repolymerise the cDNA. A 
15 pi sample was taken for analysis. 3 pi of 5x DNA gel-loading buffer was 
added to each of the five samples and mixed. These were electrophoresed on 
a 1% agarose gel in lx  TAE buffer (Table 2.1), and then stained with 5 pi of 10 
m g /m l ethidium  brom ide per 100 ml buffer. The bands were analysed to 
check that each step of the mutagenesis reaction had proceeded as expected 
(Figure 2.4). 10 pi of the final reaction was diluted to 100 pi with sterile H 2 O 
and used to transform  300 pi of competent E. coli XLl-Blue MRF' cells as 
described in section 2.5.8. M13mp8 rfDNA (100 ng /p l) was included in the 
A m ersham  Sculptor™ site-directed m utagenesis kit. This was used as a 
positive control for transformation. 1 ng of rfDNA produced 200-300 plaques 
if the cells were competent. Each control and transform ation reaction was 
carried out in duplicate.
Plaques were isolated, and small am ounts of single-stranded cDNA 
were isolated and sequenced as described (section 2.5.13 and section 2.8).
2.7 Recombinant Polymerase Chain Reaction.
2.7.1 Primary Polymerase Chain Reactions using Taq DNA Polymerase.
2.7.1.a Synthesis of Oligonucleotides.
Oligonucleotides (18-24'mers) with sequence identical to GLUT3 in the
region of putative transm em brane helix 8 were synthesised (Dr. V. Math,
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D epartm ent of Biochemistry, U niversity  of Glasgow). H ow ever these 
oligonucleotides had 1-3 bases altered, compared with wild-type GLUT3, so 
that one codon was altered to alanine (Table 5.1). Pairs of oligonucleotides 
were constructed: one sequence representing the sense strand and another the 
complementary sequence, both incorporating the same codon change. These 
will be referred to subsequently as internal prim ers. A dditionally, one 
oligonucleotide (a 37'mer) was constructed which had positive polarity and a 
sequence complementary to the antisense strand of the untranslated region at 
the 5' end of GLUT3. Likewise, an antisense oligonucleotide (a 37'mer) was 
synthesised which bound to the positive strand of cDNA at the untranslated 
region at the 3' end of GLUT3 (Figure 5.3). Both these oligonucleotides 
incorporated  a Sal I restriction site at their 5' ends (Table 5.1) and are 
subsequently referred to as external primers.
2.7.1.b Reaction Conditions.
1.6 pg "internal" primer.
1.6 pg "external" primer.
10 ng template pSPGT3 dsDNA
1 pi nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 pi lOx Taq polymerase reaction buffer (Mg-free)
6 pi 25 mM MgCl2
2.5 units Taq polymerase
sterile water to give a final volume of 100 pi
Reactions were carried out in 0.5 ml microfuge tubes, adding the Taq 
polymerase last. Upon completion of the thermal cycling (see below), 20 pi of
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5x DNA gel loading buffer was added to each reaction and mixed, before 
loading the entire reaction m ixture onto a 1.5% agarose gel. Following 
electrophoresis, cDNA bands were excised, electro-eluted (section 2.7.4), 
purified (section 2.7.6) and ethanol precipitated (section 2.5.1), combining the 
contents of 3-6 reactions, and finally resuspending each pellet into 40 pi of 
sterile water. 5 pi of this was then electrophoresed on another 1.5% agarose 
gel to determine the recovery of purified prim ary product.
2.7.1.C Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was program m ed into the machine:-
Initial Extension 95°C 3 min
Cycling- (30 cycles total, with a l°C /sec  ramp rate.) 
Separation 95°C 1 min
R eannealing X°C 1 min
Extension 72°C 2 min
Final Extension 72°C 5 min
Soak 4°C Hold
"X" = 0-5°C below the melting tem perature of the oligonucleotide having the 
lower melting temperature.
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2.7.2 Secondary Polymerase Chain Reactions.
2.7.2.a Reaction Conditions.
0.8 pg "external-sense" prim er
0.8 pg "external-antisense" prim er
1-2 pi template (5' prim ary product)
1-2 pi template (3' prim ary product)
1 pi nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 pi lOx Taq polymerase reaction buffer (Mg-free)
6 pi 25 mM MgCl2
2.5 units Taq polymerase
sterile water to give a final volume of 100 pi
Secondary reactions were carried ou t in a sim ilar way to prim ary 
reactions except that there were two prim ary product templates instead of one. 
The 3’ end of the 5' prim ary product (encoding the N-term inal portion of 
GLUT3) and the 5' end of the 3' prim ary product (encoding the C-terminal 
portion of GLUT3) were single-stranded, com plem entary and overlapped 
(Figure 5.3). The first few cycles of the chain reaction involved the association 
of the two prim ary products as well as the polymerisation between the two 
external primers, so the reaction protocol was m odified (see below), having 
three cycles with lower annealing temperatures. The reactions were treated 
exactly in the same way as the prim ary reactions, except that the final pellet 
was resuspended in 10 pi of sterile water.
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2.7.2.b Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was program m ed into the machine:-
Initial Extension 95°C 3 min
Cycling- (3 cycles total, with a l°C /sec  ram p rate.) 
Separation 95°C 1 min
R eannealing 37°C 1 min
Extension 72°C 2 min
Cycling- (27 cycles total, with a l°C /sec  ramp rate.) 
Separation 95°C 1 min
R eannealing X°C 1 min
Extension 72°C 2 min
Final Extension 72°C 5 min
Soak 4°C Hold
"X" = 0-5°C below the melting tem perature of the oligonucleotide having the 
lower m elting temperature.
2.7.3 Polymerase Chain Reactions using Pfu DNA Polymerase.
2.7.3.a Conditions for Primary Reactions.
0.8 pg "internal" prim er.
0.8 pg "external" primer.
100 ng template pSPGT3 dsDNA
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1 pi nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 pi lOx Pfu DNA polymerase reaction buffer
2.5 units Pfu DNA polymerase
sterile water to give a final volume of 100 pi
Oligonucleotides used were identical to those used w ith  reactions 
involving Taq DNA polym erase. Reactions w ere carried out in 0.5 ml 
microfuge tubes, adding the Pfu polymerase to the reactions after the initial 10 
min annealing step. This is referred to as "Hot Start PCR". Upon completion 
of the thermal cycling (section 2.7.3.b), 20 pi of 5x DNA gel loading buffer was 
added to each reaction and mixed, before loading the entire reaction mixture 
onto a 1.5% agarose gel. Following electrophoresis, DNA bands were excised, 
electro-eluted (section 2.7.4), purified (section 2.7.6) and ethanol precipitated 
(section 2.5.1), combing the contents of 3-6 reactions and finally resuspending 
each pellet into 40 pi of sterile water. 5 pi of this was then electrophoresed on 
another 1.5% agarose gel to determ ine the recovery of purified  prim ary 
product.
2.7.3.b Conditions for Secondary Reactions.
0.8 gg "external- sense" prim er
0.8 gg "external- antisense" prim er
1-2 gl template (5' primary product)
1-2 gl template (3' primary product)
1 gl nucleotide mix (20 mM dATP, 20 mM dGTP, 20 mM dTTP,
20 mM dCTP)
10 gl lOx Pfu DNA polymerase reaction buffer
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2.5 units Pfu DNA polymerase 
sterile water to give a final volume of 100 pi
Secondary reactions were carried ou t in a sim ilar w ay to prim ary 
reactions except that there were two primary product templates instead of one. 
The 3' end of the 5' prim ary product (encoding the N -term inal portion of 
GLUT3) and the 5' end of the 3' prim ary product (encoding the C-terminal 
portion of GLUT3) were single-stranded, com plem entary and overlapped 
(Figure 5.3). The first few cycles of the chain reaction involved the association 
of the two prim ary products as well as the polym erisation betw een the two 
external prim ers, but uses the same reaction protocol as that used for the 
generation of prim ary products w ith Pfu polymerase. The reactions were 
treated exactly in the same way as the prim ary reactions, except that the final 
pellet was resuspended in 10 pi of sterile water.
2.7.3.C Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was program m ed into the machine:- 
Initial Extension 95°C 10 min
A ddition of Pfu DNA polymerase.
Cycling- (3 cycles total, with a l°C /sec  ramp rate.)
Separation 95°C 1 min
Reannealing 37°C 5 min
Extension 72°C 5 min
Cycling- (27 cycles total, with a 1°C/ sec ramp rate.)
Separation 95°C 1 min
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R eannealing 56°C 2 min
Extension 72°C 5 min
Final Extension 72°C 10 min
Soak 4°C Hold
2.7.4 Elution of DNA from Gel Fragments by Electrophoresis.
The gel fragm ent containing the DNA band of interest was pu t into 
dialysis tubing (section 2.7.5) which had been clipped shut at one end. Then 1 
ml of TAE buffer was added to the tubing and the other end secured, ensuring 
that no air bubbles rem ained within. This tubing was then placed into an 
electrophoresis tank containing 1 litre of TAE buffer. The tubing was laid at 
an angle perpendicular to the direction of current and the voltage increased to 
150 V for 2 hours. Next, the voltage polarity was reversed so that the current 
flowed in the opposite direction for 30 sec to ensure that the cDNA was 
removed from the membrane and was present in solution. The solution was 
removed from the tubing with a sterile pasteur pipette and placed into a 5 ml 
"bijou” tube. Then a further 1 ml of TAE buffer was added to the tubing and 
pum ped up and dow n vigorously to rem ove any residual cDNA, before 
adding this to the same bijou tube.
2.7.5 Preparation of Dialysis Tubing.
Dialysis tubing (Visking size 1-8/32”) was cut into lengths of approximately 6 
cm. 10 g of this was placed in a beaker with 500 ml of 2% sodium  hydrogen 
carbonate, 10 mM EDTA and boiled for 10 min. The solution was then 
poured away and the tubing washed twice in distilled water. The tubing was
stored at 4°C in 50% ethanol, 50% water, 1 mM EDTA. When required, the 
tubing was washed by boiling in distilled water.
2.7.6 Purification of DNA using Elutip-D Affinity Columns.
Com ponents:-
High salt solution (see below)
Low salt solution (see below)
Sterile 10 ml syringes 
Sterile 1 ml syringes 
Sterile Acrodisc® 0.2 pm filters 
Elutip-D columns
Low salt solution H igh salt solution
0.2 M NaCl 1 M NaCl
20 mM Tris, pH  7.4 20 mM Tris, pH  7.4
1 mM EDTA 1 mM EDTA
A 10 ml syringe was loaded with 2 ml of high salt solution, the Elutip-D
column attached to the syringe and the solution passed through the column
to remove any DNA which m ight be present. A second syringe was loaded
with 5 ml low salt solution and this was passed down the column to remove
all traces of high salt solution. The cDNA sample in TAE buffer (section 2.7.4)
was taken up into the same syringe. A 0.2 pm filter was attached between this
syringe and the column and the cDNA passed through the column at a flow
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rate no faster than 1 m l/m in . The column was then washed with 3 ml of low 
salt solution, again using the same syringe and filter. Finally the cDNA was 
eluted from the column in 0.4 ml of high salt solution into a sterile microfuge 
tube. 1.2 ml of ethanol was added to the tube, mixed and incubated at -20°C 
for 1 hour. The precipitated cDNA was collected by centrifugation in a 
microfuge tube for 30 min, washed with 70% ethanol, centrifuged again for 
another 30 min, the pellet dried and resuspended in a suitable volum e of 
sterile water, generally 20 pi.
2.8 Taq DyeDeoxy™ Term inator Cycle Sequencing Protocol.
This protocol was used with the Applied Biosystems Taq DyeDeoxy™ 
T erm inator Cycle Sequencing Kit, in conjunction w ith  the A pplied  
Biosystems Model 373A Automated Sequencer.
2.8.1.a Kit Reagents.
100 pi G DyeDeoxy™ Terminator
100 pi A DyeDeoxy™ Terminator
100 pi T DyeDeoxy™ Terminator
100 pi C DyeDeoxy™ Terminator
100 pi dNTP mix- (750 pM dGTP, 150 pM dATP, 150 pM dTTP,
150 pM dCTP)
400 units AmpliTaq® DNA Polymerase, 8 units /p i
400 pi 5x Terminator Ammonium Cycle Sequencing (TACS) Buffer-
(400 mM Tris-HCl, 10 mM MgCl2, 100 mM (NH4)2S 0 4 pH  9.0)
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6 pg pGEM®-3Zf(+) double-stranded DNA Control Template, 0.2
Hg/Hl
50 pi -21M13 Forward Primer, 0.8 pm oles/pl
2. 8.1. b Other Reagents.
Distilled water
De-ionised form am ide
P heno l/H 2O /Chloroform  (68:18:14, v /v /v )
Alconox™ detergent 
Ethanol
A / Gel Reagents- Sequagel-6™ 6% Sequencing Gel Solution
Sequagel™ Complete Buffer Reagent 
10% Am m onium  persulphate solution 
B/ Gel Reagents- 40% Acrylamide stock solution (19:1 Acrylamide: Bis
acrylamide)
lOxTBE Buffer (8.2 g EDTA, 107.8 g Tris, 55.0 g Boric acid 
per l itre )
10% Am m onium  persulphate
50 mM EDTA
TEMED
Urea
dH20
Mixed Bed Resin
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2.8.2 Preparation of Templates.
M13mpl8GT3 ssDNA was prepared from plaques using the m ethod 
described previously  (section 2.5.13). The quantities of tem plate and 
sequencing oligonucleotide prim er used per reaction were 1 pg ssDNA 
tem plate and 1.6 pmoles of primer. The prim er used was invariably prim er 
"G3 2B+" (Table 5.2).
pSPGT3 dsDNA was prepared from colonies as described previously 
(section 2.5.10). The quantities of tem plate and sequencing oligonucleotide 
prim er used per reaction were 2 pg dsDNA tem plate and 3.2 pm oles of 
primer. The primers used are listed in Table 5.2.
In either case the combined volume of tem plate and prim er did not 
exceed 10.5 pi since 9.5 pi of reaction premix was added to bring the final 
volume to 20 pi. The total volume was adjusted to 20 pi by the addition of 
sterile water. A reaction premix sufficient for 20 reactions consisted of:-
Reagents
5x TACS Buffer 
dNTP mix
DyeDeoxy™ A Terminator 
DyeDeoxy™ T Terminator 
DyeDeoxy™ G Terminator 
DyeDeoxy™ C Terminator 
AmpliTaq® DNA Polymerase
80 H*
20 Hi
20 Hi
20 Hi
20 Hi
20 Hi
10 Hi
The reagents were mixed in a 0.5 ml microfuge tube- 
Reaction Premix 9.5 pi
* Template DNA 5.0 pi
** Primer 
dH20
Final volum e
4.0 pi 
1.5 ill 
20 j j .1
* ssDNA solution concentration = 0.2 m g/m l
dsDNA solution concentration = 0.4 m g /m l 
** Primer concentration with ssDNA tem plate = 0.4 pm oles/p l
Primer concentration with dsDNA tem plate = 0.8 pm oles/p i
2.8.3 Thermal Cycling.
The tubes were placed in a Techne PHC-3 Thermal Cycler with a heated 
lid. The following procedure was program m ed into the machine:-
Initial Extension 96°C 3 min
Cycling
Separation 96°C 30 sec
Reannealing 50°C 15 sec
Extension 60°C 4 min
(30 cycles total, with a l°C /sec  ramp rate.)
Soak 4°C Hold
2.8.4 Acrylamide Gel Preparation.
The gel needed at least 2 hours polymerisation time before pre-running 
so the gel was prepared whilst the reactions underw ent thermal cycling.
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2.8.4.a Preparing the Gel Plates.
The plates, spacers and comb were washed with Alconox™ and dH 20 . 
Only the plates were then w iped with absolute ethanol. The plates were 
aligned with the spacers between them along the outside of the longer edges. 
The plates were clamped in that position and Permacel™ tape applied along 
the short bottom edges of the plates and the lower ends of both longer edges 
so that the corners were covered and a seal was formed. The plates were 
balanced on a rest so that open top was raised and the angle between the plane 
of the plates and that of the desktop surface was 30-45°.
2.8.4.b Casting the Gel.
There were two separate methods used for casting the gel. Method 1 is 
the simplest m ethod which was routinely used. M ethod 2 was initially used 
before the pre-made gel reagents used in Method 1 were made available.
M ethod 1.
This involved using Gel Reagents A. 80 ml of Sequagel-6™ 6% 
Sequencing Gel Solution was mixed w ith 20 ml of Sequagel™ Com plete 
Buffer Reagent and 0.8 ml of 10% am m onium  persulphate solution was 
added while stirring.
M ethod 2.
This involved using Gel Reagents B. 40 g urea, 12 ml 40% acrylamide 
stock solution, 23 ml of dH 20 , and 1 g of mixed bed resin were stirred together
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in a beaker in a 37°C waterbath until all the ingredients had dissolved. The 
solution was then filtered through a 0.2 |im cellulose acetate filter unit under 
vacuum  and then degassed for 5 min. 8 ml of filtered lOxTBE buffer was 
added and the solution volume increased to 80 ml by the addition of dH 2 0 . 
400 |il of 10% amm onium  persulphate and 45 |il of TEMED were added and 
swirled.
Here both m ethods were the same. The gel was imm ediately poured 
between the glass plates up to the top edge of the notched plate, with the aid of 
a 60 ml syringe. All air bubbles were removed by tapping the plates or with 
the aid of a Promega "Bubble Hook". The plates were lowered so that fhey 
were lying flat on the bench and the gel casting comb carefully inserted. The 
comb was secured by clamping the top of the gel w ith two binder clamps. It 
was left to polymerise completely- this took at least 2 hours.
2.8.5 Setting Up for a Run.
All the clamps and tape were rem oved from the gel plates and the 
casting comb carefully taken out. Excess acrylamide was cleaned off the plates 
which were then washed with Alconox™, distilled water and ethanol making 
sure that the plates were especially clean in the region where the laser read 
(about a third of the way from the bottom of the plates). A 24-well-shark's 
tooth comb was carefully placed on the gel surface so that it indented the gel 
but did not puncture it. The 373A DNA Sequencer and the M acintosh Ilci 
com puter were sw itched on. The gel was placed onto the lower buffer 
chamber and the beam-stop rack locked. The "Start Pre-run" button on the 
373A keypad was pressed followed by "Plate Check". "Scan" and "Map" on 
the Macintosh Menu were opened. If the baselines were flat, then there was
judged to be no dirt on the plates- if they were not then the plates were
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cleaned again. Next, "Abort Run" was pressed and the upper buffer chamber 
and the alignment brace were secured. 1.5 litres of lxTBE buffer, pH  8.3 was 
prepared and about half added to the upper buffer chamber and the remainder 
poured into the bottom chamber. The wells were rinsed with a syringe fitted 
with a 18-gauge needle containing lx  TBE buffer. The electrode leads were 
attached and "Start Pre-run" and then "Pre-run Gel" selected. Pre-running 
took at least 5 min but longer if required. "Abort Run" was pressed to stop.
2. 8. 6 Sample Extraction and Precipitation.
After the cycling (section 2.8.3) was complete, 80 pi of sterile water was 
added to each reaction mixture. 100 pi of phenol/w ater/chloroform  (68:18:14, 
v /v /v )  was added to each tube and vortexed for at least 1 min, and then 
centrifuged for 2 min in a microfuge. The upper aqueous phase was retained, 
discarding the lower organic phase. This process was repeated. The extracted 
aqueous phase was transferred to a fresh microfuge tube and precipitated by 
the addition of 15 pi of 2 M sodium  acetate and 300 pi of absolute ethanol 
(stored at -20°C). Tubes were vortexed to mix the contents and then placed at 
-20°C for 30 min to ensure complete precipitation. The tubes were centrifuged 
in a microfuge for 15 min to pellet the cDNA, the pellets washed in 70% 
ethanol, and dried by centrifugation under vacuum.
2.8.7 Preparing and Loading the Samples.
4 pi of de-ionised form am ide/10 mM EDTA was added to each of the 
samples and mixed well. This was heated at 90°C for 2 min, and placed onto 
ice immediately. The wells of the gel (section 2.8.5) were flushed out with 
lxTBE and 4 pi of each odd-numbered sample added to its corresponding well
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in the gel. The door was closed and "Start Run" pressed. This was left for 10 
min. "Interrupt Run" was pressed and all the wells flushed out again. The 
even-num bered samples were loaded and the sequencer restarted. "Collect" 
on the Controller panel on the Macintosh display was clicked and the details 
of the samples filled out on a "New Sample Sheet".
2.8.8 Analysis of Samples.
The samples were electrophoresed at a constant tem perature of 40°C for 
1 2  hours, passing through the "read window" area of the gel where laser light 
was periodically passed along this area of the gel. The resulting fluorescence 
em itted by the DyeDeoxy™ Term inator dyes over a period of time were 
measured by the 373A sequencer and incorporated by the ABI Data Collection 
Program on the Macintosh Ilci computer. After the data was collected, it was 
analysed by the ABI Data Analysis Program. Sequences were determ ined by 
use of this program. When different sequences were generated by the use of 
various sequencing primers (Table 5.2) with the same tem plate cDNA, these 
were compared using the Genejocky II (Biosoft) program.
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Table 2.1 Table of Buffers.
Buffer
50xTris-acetate (TAE) buffer 
lOxTris-borate (TBE) buffer 
TE buffer (pH 8.0)
STE buffer
lOxPhosphate Buffered Saline 
(PBS)
Glucose buffer 
SDS buffer
3 M Potassium /5 M acetate buffer 
5x DNA gel-loading buffer 
Barths buffer
Constituents
242 g Tris base; 57.1 ml glacial acetic 
acid, 100 ml 0.5 M EDTA, pH  8.0 
108 g Tris base; 55.0 g Boric acid; 40 ml 
0.5 M EDTA, pH  8.0 
10 mM Tris.Cl, pH  8.0, 1 mM EDTA, 
pH  8.0
0.1 M NaCl; 10 mM Tris.Cl, pH  8.0,
10 mM EDTA, pH  8.0
80 g NaCl; 2 g KC1; 14.4 g N a2 H P 0 4;
2.4 g KH2PO4 , pH  7.4
50 mM glucose; 25 mM Tris.Cl,
pH 8.0,10 mM EDTA, pH 8.0
0.2 M NaOH; 1% SDS
60 ml 5 M potassium  acetate; 11.5 ml
glacial acetic acid; 28.5 ml water
0.25% b ro m o p h en o l b lue; 30%
glycerol in water
8 8  mM NaCl; 1 mM KC1; 2.4 mM
N aH C 03; 0.82 mM M gS04; 0.41 mM
CaCl2; 0.33 mM C a(N 03)2; 5 mM
HEPES-NaOH, pH  7.6.
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Table 2. 2 Bacterial Media and Agar.
Type
Luria-Bertani m edium  (LB)
2xYT m edium
H m edium  
H top agar
LB plates
2xYT plates
H plates 
lx  M9 Salts
Glucose/M inim al media plates
Constituents (per litre)
10 g Tryptone (Bactotryptone); 5 g 
Yeast extract; 10 g NaCl 
16 g Tryptone; 10 g Yeast extract; 5 g 
NaCl
10 g Tryptone; 8  g NaCl
10 g Tryptone; 8  g NaCl, 7 g Agar
(Bactoagar)
10 g Tryptone; 5 g Yeast extract; 10 g 
NaCl, 15 g Agar
16 g Tryptone; 10 g Yeast extract; 5 g 
NaCl, 15 g Agar
10 g Tryptone; 8  g NaCl, 15 g Agar 
6  g Na2HPC>4 , anhydrous; 3 g 
KH2PO4 ; 1 g NH 4CI; 0.5 g NaCl 
1 litre M9 salts; 15 g Agar (oxoid agar); 
1 ml 1 M MgSC>4 ; 1 ml thiamine HC1; 
1 ml 0.1 M CaCl2 ; 10 ml 20% glucose
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Figure 2.1
This shows a photograph of 2 pi samples of in vitro s y n th e s is e d  
mRNA which have been electrophoresed on a 1% denaturing agarose gel and 
stained with ethidium  brom ide. Lane 1 shows GLUT1 mRNA, lane 2 is 
GLUT3 mRNA, lane 3 is RNA markers (360-9,490 bases), and lane 4 is GLUT2 
m RNA.
The size of all mRNA bands are approximately 1,700 bases.
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Figure 2.1 -
In Vitro synthesised mRNA after electrophoresis on a 1% Agarose gel.
mRNA
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Figure 2.2
Diagrammatic Representation of pSPGT3. GLUT3 cDNA was cloned 
into pSP64T as a Bgl II/BamH  I fragment into the untranslated regions of the 
Xenopus p-globin gene, which had previously been cloned into the m ultiple 
cloning site of pSP64 (Krieg & Melton, 1984). The 5' untranslated region 
(UTR) is 89 bp long and the 3' untranslated region is 141 bp long. These 
function to stabilise the in vitro synthesised mRNA in Xenopus oocytes. The 
GLUT3 cDNA and its flanking sequences are located 3' of the SP6  polymerase 
prom oter.
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Figure 2.2
Diagrammatic Representation of pSPGT3.
5' Xenopus UTR
BstX I 761
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Resistance
Sac 11029 
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Sac 12312
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Figure 2.3
Diagram matic Representation of M13mpl8GT3. The entire GLUT3 
sequence and its 5' and 3' untranslated regions are cloned into the m ultiple 
cloning site of M 13m pl8 rfDNA as a B am H l /X ba  I fragm ent. This 
bacteriophage vector exists as both double-stranded and single-stranded DNA 
forms. The various open reading frames of this vector are shown as Roman 
num erals. These encode enzym es necessary for phage replication and 
bacteriophage coat proteins. Note that this vector contains no SP6  RNA 
polym erase prom oter, and hence GLUT3 cDNA m ust be subcloned into 
another vector to allow synthesis of its mRNA.
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Figure 2.3-
Diagrammatic Representation of M13mpl8GT3.
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Figure 2. 4
Diagram showing the banding pattern expected at various stages of a 
site-directed mutagenesis reaction after electrophoresis of the samples (section 
2.6) on a 1% agarose gel. The DNA species present at each stage of the reaction 
are shown schematically underneath each "lane". The substituted bases are 
indicated by an "x".
Lane 1. This shows the banding pattern on an agarose gel after annealing 
of the mutagenic oligonucleotide to the template and the extension reaction. 
Most of the ssDNA should be converted to double-stranded DNA, in relaxed 
and nicked form s (but not supercoiled since this is not p roduced by 
polymerase and ligase alone).
Lane 2. This is the gel pattern after the T5 exonuclease digestion has
removed unpolym erised tem plate DNA.
.Lane 3. Nci I digestion produces both nicked and linear double-stranded
DNA. The latter is formed from previously nicked DNA.
Lane 4. Exonuclease III digests the nicked non-m utant strand to give a
smeared band which is approximately the same size as single-stranded DNA. 
An 800 bp fragm ent of the original strand remains bound to the m utan t 
strand which acts as a prim er for repolymerisation. A proportion of the linear 
DNA has single-stranded overhangs, which makes it Exonuclease III resistant. 
Lane 5. This is the replicating form DNA (rfDNA) which is produced
after repolym erisation. There is a mixed population of intact and nicked 
DNA.
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Figure 2.4
Diagram Showing the Pattern Observed on a 1% Agarose Gel after 
Electrophoresis of Samples from Various Stages of a Site-Directed Mutagenesis 
Reaction.
4 5  BE dS
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CHAPTER 3
Measurement of the Kinetic Parameters of 2- 
Deoxv-D-glucose and D-Fructose Transport by 
GLUT2 Expressed in Xenopus  Oocytes.
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3.1 Aims.
1. To investigate some basic kinetic param eters of GLUT2 to provide 
"baseline" values for comparison with kinetic values obtained from potential 
chimeric GLUT2/GLUT3 transporters and those incorporating single amino 
acid point mutations.
a. To m easure Km values for 2-deoxy-D -glucose and  D-fructose 
transport (zero-trans entry) by GLUT2, expressed in Xenopus oocytes.
b. To m easure Kj values for D-glucose, m altose, D-fructose and 
cytochalasin B on 2-deoxy-D-glucose transport by GLUT2.
c. To measure Ki values for D-glucose, maltose, and cytochalasin B on 
D-fructose transport by GLUT2.
2 . To investigate the inhibitory effects of various D-fructose analogues 
on 2-deoxy-D-glucose transport by GLUT2, in an attem pt to determ ine which 
ring form of D-fructose is transported.
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3.2 Background.
3.2.1 Kinetic Characterisation of Glucose Transporters.
At the outset of this work, although abundant kinetic information was 
available for the erythrocyte-type transporter (GLUT1), relatively little was 
known about other transporter isoforms. This is mainly due to the fact that 
GLUT1 is the sole transporter isoform in erythrocytes, where it is present in as 
m uch as 5% of the total membrane protein. This provides a system which 
allow s sugar tran sp o rt k inetics to be m easu red  unam biguously , 
uncomplicated by the actions of other transporter isoforms. Most native cell 
types express more than one isoform, hence confusing analysis. GLUT1 has 
also been purified  (Kasahara & H inkle, 1977) from  erythrocytes and 
reconstituted into phospholipid vesicles (W heeler & Hinkle, 1981) where 
both its steady-state and pre-steady-state kinetics for sugar transport have been 
m easured (Lowe & Walmsley, 1986; A pplem an & Lienhard, 1989; see also 
section 1.5.2).
However, the isolation of the GLUT1 cDNA by Mueckler et al. in 1985 
led to the isolation of cDNAs encoding GLUTs 2, 3, 4, 5 and 7. By inserting 
these sequences into various expression vectors, it has been possible to express 
each mem ber of the facilitative glucose transporter family in foreign cell 
types. Expression has been achieved in m any cell systems, including 3T3-L1 
adipocytes, CHO-K1 cells, and Xenopus oocytes (review ed in Gould & 
Holman, 1993).
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3.2.2 Use of Xenopus Oocytes for the Expression of Glucose Transporters.
The Xenopus oocyte expression system was initially used for kinetic 
analysis of GLUT1 (Gould & Lienhard, 1989). Many groups have since utilised 
oocytes for the expression of both wild-type and chimeric glucose transporter 
isoforms. The low endogenous glucose transport rates in these cells, together 
w ith the ease of microinjection of mRNA make the oocyte an ideal system 
w ith which to undertake a kinetic analysis of the heterologously expressed 
transporter.
Each oocyte is a large single cell of 1 mm diameter, visibly divided into 
tw o hem ispheres: a dark pigm ented "animal" pole, containing the large 
nucleus, and a lighter coloured "vegetable" pole, which is mainly cytoplasmic, 
densely populated  w ith  ribosom es and the m achinery responsible for 
translation, protein processing and targeting. Stage V and VI oocytes are those 
which translate injected mRNA most efficiently. These are isolated from the 
toad by surgery and dissected m anually from the surrounding vasculature 
network (section 2.3.4).
Expression of foreign proteins can be achieved in two ways: either by 
the microinjection of DNA into the nucleus, or by microinjection of mRNA 
into the cytoplasm. Although both methods result in adequate expression of 
proteins, it is much less dem anding to inject mRNA into the cytoplasm, and 
so this is the method which has been chosen. Typically, 40 nl of ~1 m g/m l 
mRNA was injected into each oocyte, which are then left in physiological 
m edium  (Barths- Table 2.1) to express protein for 48 hours. Zero-trans en try  
assays were conducted by the add ition  of various concentrations of 
radiolabelled 2-deoxy-D-glucose, D-fructose or D-galactose for 30 m in 
incubation times, for which transport has been shown to be linear (section 2.4 
and Figure 3.1). Hence, by subtracting transport values for water-injected
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oocytes from values obtained with oocytes injected with mRNA encoding a 
particular isoform, kinetic data for essentially a single transporter isoform can 
be generated. It has been previously shown that the rates of sugar transport 
into water-injected oocytes and non-injected oocytes are identical (Gould & 
Lienhard, 1989).
Recently, GLUTs 1, 2, 3 and 4 have been successfully expressed in 
Xenopus oocytes (Gould et al, 1991). They found oocytes expressing GLUT2 or 
GLUT3 exhibited high 3-O-methyl-D-glucose transport rates, typically giving a 
20-fold increase in transport rates over non-injected oocytes. Transport rates 
were much lower with GLUT4, which was thought to be consistent w ith the 
proposed intracellular distribution of GLUT4. These workers also m easured 
transport of other radiolabelled sugars such as 2-deoxy-D-glucose, D-galactose 
and D-fructose, and demonstrated that the transporters have varying abilities 
to transport these secondary substrates. For example, only GLUT2 was found 
to transport D-fructose and GLUT3 transported D-galactose to a greater extent 
than the other transporter isoforms. The Km value obtained for 3-O-m ethyl- 
D-glucose equilibrium  exchange transport by GLUT1 (20 mM) correlated 
closely to that found in erythrocytes (17 mM) (Lowe & Walmsley, 1986).
The Km value for equilibrium  exchange transport of 3-O -m ethyl-D - 
glucose by GLUT4 in oocytes was measured in two separate studies and found 
to be 1.8 mM (Keller et al., 1989) and 4.3 mM (Nishimura et al., 1993). The 
value for zero-trans entry of 2-deoxy-D-glucose by GLUT4 into oocytes was 
found to be 4.6 mM (Burant & Bell, 1992).
GLUT2 was found to have a value of 17 mM for zero-trans entry of 3-O- 
methyl-D-glucose (Johnson et al., 1990) but equilibrium exchange values were 
not measured. Zero -trans entry of 2-deoxy-D-glucose in oocytes expressing 
GLUT2 was determined concurrently with the work described here, and the
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Km value reported was 13 mM (Burant & Bell, 1992), which correlates well 
with the figure of 11 mM obtained herein ( Table 3.1).
The Km values of 3-O-methyl-D-glucose and 2-deoxy-D-glucose for 
zero -trans entry by GLUT3 have since been m easured in Chinese ham ster 
ovary cells (Asano et al., 1992) and found to be about 3.5 mM and 0.9 mM, 
respectively. Km values obtained for zero -trans entry of 2-deoxy-D-glucose 
into GLUT3-injected oocytes are 1.8 mM (Burant & Bell, 1992) and 1.4 mM 
(Colville et al, 1993).
A kinetic analysis of the liver-type glucose transporter (GLUT2) 
expressed heterologously in Xenopus oocytes is presented, and contrasted 
with data obtained concurrently for the brain-type transporter (GLUT3) by Dr. 
Carol Colville. Km values for zero -trans entry of 2-deoxy-D-glucose and D- 
fructose have been determ ined for GLUT2, in addition to values for 
maltose, D-glucose, D-fructose and cytochalasin B inhibition of 2-deoxy-D- 
glucose transport by GLUT2. Kj values have also been measured for maltose, 
D-glucose and cytochalasin B inhibition of zero -trans D-fructose entry by 
GLUT2. Km values for zero-trans entry of 2-deoxy-D-glucose and D-galactose 
by GLUT3, and the effects of inhibition by maltose, D-glucose, D-galactose and 
cytochalasin B are shown for the purposes of comparison.
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3.3 Results.
3.3.1 Measurement of Km Values for 2-Deoxy-D-glucose and D-Fructose
Transport by GLUT2  and the Effects of the Presence of Various Sugars 
and Cytochalasin B.
The values for 2-deoxy-D-glucose, D-fructose and D-galactose transport 
by GLUTs 2 and 3 were determined by measuring the rate of transport of trace 
radiolabelled sugar over a range of external sugar concentrations into oocytes 
which had been incubated in sugar-free m edium  for at least 48 hours (section 
2.4). By m easuring the rates of zero -trans entry as a function of substrate 
concentration Lineweaver-Burk plots were constructed, and hence Km values 
determined for the transport of these sugars by GLUT2. Oocytes were exposed 
to 2-deoxy-D-glucose for 15 min, or D-fructose or D-galactose for 30 min. It has 
been shown that the am ount of label accum ulating w ithin the oocyte 
increases linearly with time, suggesting that transport of the sugar is the rate 
limiting step and not phosphorylation of the sugar by hexokinase (Figure 3.1). 
This was confirmed by the measurement of both relative and absolute levels 
of phosphorylated and non-phosphorylated sugars w ithin the oocyte under 
the conditions used for analysis. In no case was a significant portion of the 
radiolabel associated with the oocyte due to non-phosphorylated sugar 
(Thomas et al., 1993). Hence, the term 'transport' will be used here, rather 
than 'uptake', as the latter suggests both transport and phosphorylation 
processes.
Figure 3.2 shows a typical Lineweaver-Burk analysis of 2-deoxy-D- 
glucose transport by GLUT2 in the presence and absence of cytochalasin B, 
Figure 3.3 shows its transport inhibited by D-glucose, and Figure 3.4 shows the 
inhibitory effects of maltose and D-fructose. As can be seen from the graphs,
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cytochalasin B is a non-competitive inhibitor of 2-deoxy-D-glucose transport 
by GLUT2, w hereas m altose, D-fructose and D-glucose are com petitive 
inhibitors. Similar results were obtained with D-fructose transport studies, its 
transport was non-com petitively inhibited by cytochalasin B (Figure 3.5) 
w hilst maltose and D-glucose exhibited competitive inhibition (Figures 3.6 
and 3.7, respectively). The Km values for 2-deoxy-D-glucose, D-fructose and D- 
galactose zero -trans entry by GLUT2 expressed in Xenopus oocytes are shown 
in Table 3.1. In addition, K jvalues obtained for the inhibition of both 2- 
deoxy-D-glucose and D-fructose transport by GLUT2 using D-glucose, maltose, 
D-fructose and cytochalasin B are shown. Kj values for both competitive and 
non-competitive inhibition were calculated by application of the equation:-
gradient of line (inhibitor) = Km/  Vmax . (1 + [ I ] /  K j)
For the purposes of comparison, and because of its relevance to later 
work, the kinetic analysis of GLUT3 is also sum m arised in Table 3.1. Km 
values are shown for 2-deoxy-D-glucose and D-galactose transport, w ith Ki 
values for the inhibition of these sugars by cytochalasin B, D-glucose and 
maltose. The Kj value of D-galactose inhib ition  of 2-deoxy-D-glucose 
transport by GLUT3 is also shown. Cytochalasin B acted as a non-competitive 
inhibitor w ith  2-deoxy-D-glucose and D-galactose transport by GLUT3. 
Maltose, D-glucose and D-galactose acted as competitive inhibitors of 2-deoxy- 
D-glucose transport.
The effects of increasing concentrations of cytochalasin B on the 
transport of 2-deoxy-D-glucose and D-fructose by GLUT2, and 2-deoxy-D- 
glucose and D-galactose by GLUT3 are presented in Figure 3.8.
The effect of addition of 50 mM L-glucose, D-glucose, D-fructose and D- 
galactose on the transport rate of 2-deoxy-D-glucose by GLUT2-injected oocytes
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is shown in Table 3.2. Note that these values are not adjusted for transporter 
protein levels, and show a typical experiment in which the average transport 
value of six oocytes has been determined.
3.3.2 M easurement of the Effects of the Presence of 2,5-Anhydro-D-mannitol
and L-Sorbose on 2-Deoxy-D-glucose Transport by GLUT2.
To investigate which ring form of D-fructose is transported by GLUT2, 
the inhibitory effects of 2,5-anhydro-D-mannitol, a fixed-ring furan-analogue 
of D-fructose, and L-sorbose, which exists mainly in the pyranose ring form, 
on the transport of 2-deoxy-D-glucose by GLUT2-injected oocytes were 
compared. The Lineweaver-Burk plot of the data obtained is shown as Figure 
3.9. 2,5-anhydro-D-mannitol has a Ki of 26 mM and L-sorbose has a Kj of 170 
mM on 2-deoxy-D-glucose transport by GLUT2. The structures of 2,5-anhydro- 
D-mannitol, L-sorbose and the pyranose and furanose ring  form s of D- 
fructose can be seen in Figure 3.10.
I l l
Table 3.1
Km and Kj values were determ ined from Lineweaver-Burk plots such 
as that shown in Figure 3.2. All values above are the m ean and standard 
deviations from between 3 and 10 separate experiments for each condition. 
Note that values for GLUT3 were obtained by Dr. Carol Colville.
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Table 
3.1
K
inetic Param
eters 
for Transport of Sugars 
by 
GLUT 
2 
and 
GLUT 
3.
Table 3.2
Effects of D-Fructose, D-Glucose and D-Galactose on 2-Deoxy-D-glucose 
Transport by GLUT2 .
Com peting Sugar Transport Rate (pm oles/min/oocyte)
50 mM L-glucose 2.61 ± 0.35
50 mM D-galactose 2.25 ± 0.15
50 mM D-fructose 1.60 ± 0.10
50 mM D-glucose 0.30 ± 0.05
Groups of 6  oocytes injected with GLUT2 mRNA were incubated in 450 |il of 
Barths buffer containing 50 mM of the sugars indicated. 2-deoxy-D-glucose 
(0.1 mM, 1 jiC i/m l) was added and transport rates determ ined as described. 
The experim ent shown is representative of three separate experiments and 
the values are mean ± standard deviation of the rate of transport into six 
oocytes.
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Figure 3.1
Each point is the mean of the transport rate determined from 6  oocytes 
as described in section 2.4. Uptake was determined by exposure of 2-deoxy-D- 
glucose to the oocytes for 5, 10, 15, 20 and 30 min and the counts per oocyte 
determ ined as described. For each experim ent parallel incubations were 
carried out in oocytes which were not injected with mRNA ('control oocytes'), 
and the values obtained from this oocyte population subtracted from the 
values obtained from injected oocytes to obtain the true heterologous uptake. 
Uptakes in 'control oocytes' were typically 5 to 10% of injected oocytes. The 
range of error was typically + 10% at each point. Error bars are om itted for 
clarity.
(O.lmM, l^C i/m l)
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! Accumulation of 2-Deoxy-D-glucose by GLUT2-Injected 
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Figure 3.2
Each point is the mean of the transport rate determined from 6  oocytes 
as described in section 2.4. Transport was determined by 15 min exposure of 
the 2-deoxy-D-glucose to the oocytes and the counts per oocyte determined as 
described. For each experim ent parallel incubations were carried out in 
oocytes which were not injected with mRNA ("control oocytes'), and tie  
values obtained from this oocyte population subtracted from the values 
obtained from injected oocytes to obtain the true heterologous transport ra:e. 
Transport rates in 'control oocytes' were typically 5-10% of injected oocytes. 
The range of error was typically + 10% at each point. Error bars are omitted 
for clarity. In the above experiment, (6 ) represents the plot obtained in the 
absence of inhibitors, (P) in the presence of 10 pM cytochalasin B.
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Figure 3.2
Lineweaver-Burk Plot of Transport of 2-Deoxy-D-glucose 
into GLUT2-Injected Oocytes in the Presence and Absence 
of Cytochalasin B.
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Figure 3.3
Transport rates of 2-deoxy-D-glucose into oocytes expressing GLUT2 
were determined as described. Each point is the mean of six separate oocytes 
at each concentration of sugar. Values presented  are corrected for the 
transport of 2-deoxy-D-glucose by non-injected oocytes as described in Figure
3.2. In the representative experiment shown, (❖) represents the plot obtained 
in the absence of inhibitors, and (O) in the presence of 10 mM D-glucose. The 
range of error was typically + 10% at each point. Error bars are om itted for 
clarity.
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Figure 3.3
Lineweaver-Burk Plot of Transport of 2-Deoxy-D-glucose by 
GLUT2-Injected Oocytes in the Presence and Absence of D-Glucose.
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Figure 3.4
Transport rates of 2-deoxy-D-glucose into oocytes expressing GLUT2 
were determined as described. Each point is the mean of six separate oocytes 
at each concentration of sugar. Values presented are corrected for the 
transport of 2-deoxy-D-glucose by non-injected oocytes as described in Figure
3.2. In the representative experiment shown, (D) represents the plot obtained 
in the absence of inhibitors, (-0-) in the presence of 50 mM D-fructose, and (o) in 
the presence of 150 mM maltose. The range of error was typically + 10% at 
each point. Error bars are omitted for clarity.
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Figure 3.4
Linewever-Burk Plot of Transport of 2-Deoxy-D-glucose 
by GLUT2-Injected Oocytes in the Presence of Maltose 
or D-Fructose or in the Absence of Inhibitors.
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Figure 3.5
T ransport rates of D-fructose into oocytes expressing GLUT2 were 
determined as described. Each point is the mean of six separate oocytes at each 
concentration of sugar. Values presented are corrected for the transport of 
fructose by non-injected oocytes as described in Figure 3.2 for 2-deoxy-D- 
glucose. In the representative experim ent shown, (□ ) represents the plot 
obtained in the absence of inhibitors, and (O*) in the presence of 2 pM 
cytochalasin B. The range of error was typically + 10% at each point. Error 
bars are om itted for clarity.
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Figure 3.5
Linweaver-Burk Plot of Transport of D-Fructose into 
GLUT2-Injected Oocytes in the Presence and Absence of 
Cytochalasin B.
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Figure 3. 6
Transport rates of D-fructose into oocytes expressing GLUT2 were 
determined as described. Each point is the mean of six separate oocytes at each 
concentration of sugar. Values presented are corrected for the transport of 
fructose by non-injected oocytes as described in Figure 3.2 for 2-deoxy-D- 
glucose. In the representative experiment shown, ( Q) represents the plot 
obtained in the absence of inhibitors, and ($•) in the presence of 150 mM 
maltose. The range of error was typically + 10% at each point. Error bars are 
omitted for clarity.
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Figure 3.6
Lineweaver-Burk Plot of Transport of D-Fructose by 
GLUT2-Injected Oocytes in the Presence and Absence 
of Maltose.
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Figure 3.7
Transport rates of D-fructose into oocytes expressing GLUT2 were 
determined as described. Each point is the mean of six separate oocytes at each 
concentration of sugar. Values presented are corrected for the transport of 
fructose by non-injected oocytes as described in Figure 3.2 for 2-deoxy-D- 
glucose. In the representative experim ent shown, (O) represents the plot 
obtained in the absence of inhibitors and (a )  in the presence of 10 mM D- 
glucose. The range of error was typically + 10% at each point. Error bars are 
omitted for clarity.
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Figure 3.7
Lineweaver-Burk Plot of T ransport of D-Fructose by 
GLUT2-Injected oocytes in the Presence and Absence of 
D-Glucose.
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Figure 3.8
Oocytes expressing GLUT2 were assayed for 2-deoxy-D-glucose and D- 
fructose transport, and oocytes expressing GLUT3 assayed for 2-deoxy-D- 
glucose and D-galactose transport (by Carol Colville) as described. Transport 
rates were determ ined in the absence or presence of cytochalasin B in the 
bathing m edia at the indicated concentrations. Groups of 6 oocytes were 
assayed as described in section 2.4, and the mean rate per oocyte is presented. 
Transport rates were expressed as a percentage of the rate obtained in the 
absence of cytochalasin B.
(#) 2-deoxy-D-glucose by GLUT2; (o) D-fructose by GLUT2; (A)  2- 
deoxy-D-glucose by GLUT3; (A) D-galactose by GLUT3. For clarity, error bars 
have been included only for one of the curves, the errors in the other 
experiments were similar.
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Figure 3.8
Dose-Response of Cytochalasin B on the Inh ib ition  of T ransport Rates in 
GLUT2 and GLUT3-Injected Oocytes.
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Figure 3.9
Transport rates of 2-deoxy-D-glucose into oocytes expressing GLUT2 
were determined as described. Each point is the mean of six separate oocytes 
at each concentration of sugar. Values presented are corrected for the 
transport of 2-deoxy-D-glucose by non-injected oocytes as described in Figure
3.2. In the representative experiment shown, (o) represents the plot obtained 
in the absence of inhibitors, (d )  in the presence of 25 mM 2,5-anhydro-D- 
mannitol, and ($) in the presence of 25 mM L-sorbose. The range of error was 
typically + 10% at each point. Error bars are omitted for clarity.
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Figure 3.9
Lineweaver-Burk Plot of Transport of 2-Deoxy-D-glucose 
in the Presence of 2,5-Anhydro-D-Mannitol or L-Sorbose 
or in the Absence of Inhibitors.
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Figure 3.10
Structures of pyranose and furanose sugars.
Structural comparisons of pyranose and furanose sugars used in the analysis 
of substrate b ind ing  to the transporters. Com pound I is p -D -g lu co se , 
com pound II is P-D-fructopyranose, com pound III is a -L -so rbopy ranose , 
com pound IV is p-D -fructofuranose and com pound V is 2,5-anhydro-D- 
m annito l.
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Figure 3.10
Structures of some Pyranose and Furanose Sugars.
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Figure 3.10 (cont.)
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Figure 3.11
Model for the Interaction of P-D-Fructose with GLUT2.
The proposed interaction of the furanose ring form of P-D -fructose and 
GLUT2 is shown.
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Figure 3.11
Model for the Interaction of P-D-Fructose with GLUT2.
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3.4 Conclusions.
3.4.1 Effects of Various Sugars on Zero-trans Entry of 2-Deoxy-D-glucose and
D-Fructose by GLUT2 and D-Galactose by GLUT3.
Previous work from this laboratory has dem onstrated that as well as 
transporting D-glucose, GLUT2 is capable of m ediating the transport of both 
D-galactose and D-fructose, and that GLUT3 also mediates the transport of D- 
galactose (Gould et ah, 1991; Colville et ah, 1993).
Here, Km values for zero-trans entry of 2-deoxy-D-glucose into Xenopus 
oocytes by GLUT2 in the presence and absence of transport inhibitors have 
been determined. GLUT2 has a Km for 2-deoxy-D-glucose of about 11 mM. 
The corresponding Km value for GLUT3 is 1.4 mM. The ratio of these values 
are comparable to those obtained for 3-O-methyl-D-glucose of 45 mM and 10 
mM for GLUTs 2 and 3 respectively (determined under equilibrium  exchange 
conditions). Thus, it is interesting to note that the relative affinities of both 
analogues for these isoforms are similar, i.e. GLUT3 has about a 4- to 6-fold 
higher affinity than GLUT2. These values are significantly different from 
each other and that of GLUT1. The values are in agreem ent w ith parallel 
studies carried out w ith oocytes in other laboratories (Burant et a l, 1992; 
Nishim ura et al., 1993; Keller et al., 1989).
The Km value of 11 mM for 2-deoxy-D-glucose transport by GLUT2 is 
consistent with its proposed function as a bidirectional, high capacity glucose 
transporter in the liver, where it can export as well as im port glucose. It is 
also present in the basolateral membranes of the transepithelial cells of the 
small intestine and the proximal tubules of the kidney, w here it is proposed 
to transport glucose down its concentration gradient into the blood, after 
active transport by sodium-linked sym porters into these cells. This high Km
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coupled to its expression in pancreatic (5-cells has been proposed to enable 
GLUT2 to act as a "blood glucose sensor" bu t this is an unresolved issue 
(section 1.2.3).
The relatively low Km of 1.4 mM for 2-deoxy-D-glucose transport by 
GLUT3 closely correlates with data from GLUT3 expressed in Chinese hamster 
ovary cells (Asano et al, 1992) and conforms with its proposed role as a high 
affinity glucose transporter in the brain and neural tissue.
Of course, these values are not necessarily identical to the values found 
in the native cells, since different patterns of glycosylation m ight occur in 
oocytes and influence transport kinetics. Additionally, we are looking at the 
transport of an analogue of D-glucose rather than the sugar itself, at 25°C 
rather than at 37°C. 2-deoxy-D-glucose was used as a substrate rather than 
glucose since it cannot be com pletely m etabolised by the cell bu t is 
phosphorylated enforcing its retention. Hence the Km value being measured 
is a function of the affinity of the substrate for the outw ard facing binding site 
alone. Nevertheless it is likely that the Km values approxim ate actual values 
in native cells.
Km values for D-fructose and D-galactose transport by GLUT2 have been 
measured, and the Km value for D-galactose transport by GLUT3 has also been 
calculated (Colville et a l, 1993). The data show that for GLUT2, the relative 
affinity for sugars is 2-deoxy-D-glucose »  D-fructose > D-galactose (Km values 
of 11 mM, 67 mM and 85 mM respectively- Table 3.1). Similarly, for GLUT3, 
the Km for D-galactose (8.5 mM) is much higher than that of 2-deoxy-D- 
glucose (1.4 mM) (Table 3.1).
Ideally it w ould be more instructive to m easure kcat values in addition 
to Km values since they would provide a fuller description of the kinetics of 
the transporters, giving both affinity of the transporter binding site to the
sugar and a rate of transporter turnover rather than just a m easure of the
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affinity. However, to do this an accurate m ethod of determining the num ber 
of transporters at the cell surface would be required in order to calculate the 
turnover num ber from the overall Vmax- This could be achieved by applying 
S catchard  analysis to d a ta  g enera ted  by eq u ilib riu m  b in d in g  of 
[3H]cytochalasin B to isolated oocyte plasma membranes, or [3H]ATB-BMPA 
equilib rium  bind ing  w ith  intact oocytes, to determ ine the num ber of 
transporter molecules at the cell surface. A lternatively, the am ount of 
transporter in oocyte plasm a m em brane fractions could be determ ined by 
SDS-PAGE, blotting onto nitrocellulose, addition of a specific anti-hum an- 
GLUT2 or -GLUT3 antibody, and a radiolabelled  secondary antibody. 
C om parison  of these sam ples w ith  s tandard  m em brane p reparations 
containing known quantities of transporter protein, m easured by the above 
m ethods, w ould determ ine the am ount of transporter present. This is 
possible for GLUT3 since m embranes from a cell-line engineered to stabily 
express GLUT3, containing known quantities of GLUT3, are available (Maher 
et al., 1992) . Unfortunately, the lack of a suitable standard for GLUT2 makes it 
impossible to accurately quantitate this isoform. This is due to the high Kd 
value of cytochalasin B for GLUT2 (Axelrod & Pilch, 1983) which makes it 
technically difficult to perform  equilibrium  studies w ith this transporter 
isoform. Additionally, it has so far proved impossible to obtain pure plasma 
m em brane fractions from  oocytes, w hich is necessary  w hen using 
cytochalasin B binding studies. This and the non-commercial availability of 
ATB-BMPA has m ade quantification of transporters difficult, so Km and Ki 
values alone were measured.
The effect of the fungal metabolite cytochalasin B, a well characterised 
inhibitor of glucose transport, on the transport of 2-deoxy-D-glucose and D- 
fructose by GLUT2 was examined (Figures 3.2 and 3.5). This was performed in 
parallel for 2-deoxy-D-glucose and D-galactose by Dr. Carol Colville for
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GLUT3. Cytochalasin B is known to be non-com petitive for glucose entry 
m ediated by GLUT1, GLUT2 and GLUT4, and Deves and Krupka found that it 
competitively inhibited efflux of sugar in zero -trans exit studies perform ed in 
erythrocytes, suggesting that its site of action is the endofacial sugar binding 
site (Deves & Krupka, 1978). It is well established that GLUTs 1 and 4 can be 
irreversibly photolabelled with cytochalasin B, and that this labelling may be 
prevented by D- but not L-glucose. Photolabelling of GLUT2 with cytochalasin 
B has been reported, though under modified conditions (Axelrod and Pilch, 
1983). It has also been show n that GLUT3 can be photolabelled w ith 
cytochalasin B in the presence of L- but not D-glucose (Thomas et a l, 1993). 
There is a compelling body of evidence to suggest that this labelling occurs at, 
or close to, the endofacial glucose binding site (Deves & Krupka, 1978). Here it 
is show n that cytochalasin B displayed a non-com petitive inhibitory effect 
with 2-deoxy-D-glucose transport by both GLUT2 and GLUT3, consistent with 
the hypothesis that it binds the endofacial binding site. Moreover, as can be 
seen from Table 3.1, as previously reported, the K, for cytochalasin B 
inhibition of 2-deoxy-D-glucose is higher for GLUT2 than either GLUT1 or 
GLUT4, and the value for GLUT3 is intermediate. It is interesting to note that 
the Ki values of cytochalasin B on the inhibition of transport of D-fructose 
and D-galactose by GLUT2 and GLUT3, respectively, are sim ilar, if not 
identical, to K[ values on the inhibition of transport of 2-deoxy-D-glucose 
w ith the same transporter (Table 3.1). Thus, one in terpretation of these 
results is that since cytochalasin B exhibits identical Ki values regardless of the 
substrate, then the inward-facing substrate binding sites used by 2-deoxy-D- 
glucose and D-galactose (GLUT3) or 2-deoxy-D-glucose and D-fructose 
(GLUT2) are the same.
The effects of m altose on sugar up take  by GLUT2 w ere also 
investigated. Maltose is proposed to inhibit transport by binding to the
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exofacial binding site (Appleman & Lienhard, 1989). It cannot be transported 
itself since it is a disaccharide, bu t could possibly bind reversibly to the 
exofacial b inding site and com petitively block glucose uptake. In d e e d , 
m altose was determ ined to be a competitive inhibitor of both 2-deoxy-D- 
glucose transport and that of D-fructose. The Ki values obtained are presented 
in Table 3.1. Similarly, D-glucose itself was found to inhibit 2-deoxy-D-glucose 
and D-fructose competitively (Table 3.1). Similar findings were reported with 
m altose and D-glucose competitive inhibition of 2-deoxy-D-glucose and D- 
galactose transport by GLUT3 (Colville et al., 1993). These observations are 
interpreted to imply that the alternative substrates tested in these analyses 
utilise the same outw ard  facing substrate b inding  site as the preferred  
substrate (2-deoxy-D-glucose). This conclusion is further supported  by the 
observations that D-fructose is a competitive inhibitor of 2-deoxy-D-glucose 
transport by GLUT2 (Figure 3.4), and D-galactose is a competitive inhibitor of 
2-deoxy-D-glucose transport by GLUT3 (Colville et al, 1993).
It is also interesting to note that D-galactose is a more potent inhibitor 
of GLUT3 than GLUT2, and D-fructose is m ore effective at inhibiting 
transport m ediated by GLUT2 than GLUT3 (Table 3.2), consistent w ith the 
relative Km values reported above (Table 3.1).
3.4.2 p-D-Fructose Transport Conformation.
A recent study (Fry et al., 1993) has shown that the sugar transporter of 
the parasite Trypanosoma brucei transports both D-glucose and D-fructose 
with equal efficiency. Various furanose and pyranose sugars were used to 
inhibit 6-deoxy-D-glucose zero -trans entry and it was discovered that D-
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glucose is transported in the pyranose form, but D-fructose is transported in 
the furanose conformation.
It has been reported that GLUT2 can also effectively transport D- 
fructose, albeit w ith low efficiency (Gould et al., 1991). As noted in this 
chapter, D-glucose is a competitive inhibitor of D-fructose zero -trans entry, 
and D-fructose a competitive inhibitor of 2-deoxy-D-glucose zero -trans entry. 
This suggests that D-glucose and D-fructose probably share the same exofacial 
binding site. It has been shown that 4,6-O-ethylidene-D-glucose [a glucose 
analogue know n to interact only w ith  the outw ard-facing  b ind ing  site 
(Applem an & L ienhard, 1989)] and 2,5-anhydro-D -m annitol (a reduced 
fructose analogue) inhibited both 2-deoxy-D-glucose and D-fructose transport 
by GLUT2 (Colville et al, 1993). W hile these data do indicate that the 
transport of D-fructose and D-glucose are m ediated by the sam e exofacial 
binding site on GLUT2, it is not clear which of the ring forms of D-fructose are 
transported. In aqueous solutions, D-fructose exists predom inantly (about 
70%) in the pyranose form; 2,5-anhydro-D-mannitol is however, locked in the 
furanose form (Figure 3.10).
In order to address this, L-sorbose and 2,5-anhydro-D-mannitol, which 
are fructose analogues, were used to inhibit 2-deoxy-D-glucose transport by 
GLUT2. L-sorbose exists naturally predom inantly in the pyranose ring form 
(>98%), whereas 2,5-anhydro-D-mannitol has a locked furanose ring. It was 
found that 2,5-anhydro-D-mannitol has a m uch lower Ki (26 mM) than L- 
sorbose (170 mM) (Figure 3.9), or D-fructose (200 mM) (Table 3.1), on 2-deoxy- 
D-glucose tran sp o rt. This indicates that the furanose ring binds preferentially 
to GLUT2, since the two inhibitors are identical in other aspects (Figure 3.10). 
The low affinity of D-fructose itself is likely to be due to the fact that only 30% 
of the population are in the furanose form at any given point in time (Fry et 
al., 1993). Thus, for fructose binding, hydrogen bonding at C-3 and C-4
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positions are important, but not at C-2. Compared to the binding of D-glucose, 
the most significant difference is likely to be the absence of a hydrogen bond 
between the transporter and the C-l position of D-glucose. This m ay account 
in part for the lower affinity of D-fructose for the transporter. A model 
depicting the interaction of (3-D-fructofuranose with the exofacial binding site 
of GLUT2 is shown as Figure 3.11 (also Figure 4.4). It is interesting to note that 
the sequence QLS, which is highly conserved in transm em brane helix 7 of 
GLUTs 1, 3 and 4, which accept D-glucose with high affinity, is not present in 
those transporters which accept D-fructose, such as GLUT2, GLUT5, or the 
trypanosom e transporter (Fry et al., 1993). The QLS residues may therefore be 
involved in the hydrogen bonding to the C-l position of D-glucopyranose.
3.5 Sum m ary.
In conclusion, som e kinetic p roperties of the hum an  liver-type 
facilitative glucose transporter (GLUT2) have been analysed and the results 
com pared w ith those obtained by Dr. Carol Colville w ith the brain-type 
transporter (GLUT3). These data show that GLUT3 has a significantly lower 
K m for 2-deoxy-D-glucose than that recorded for GLUT2. The relative 
affinities of D-fructose and D-galactose for GLUT2 have also been determined, 
and the affinity of D-galactose for GLUT3 analysed by Dr. Carol Colville. 
These had been determ ined to be the major alternative substrates of these 
isoform s (Gould et al., 1991). It was found that cytochalasin B is a non­
competitive inhibitor of the transport of 2-deoxy-D-glucose and D-fructose 
uptake by GLUT2, and that the Ki values for inhibition of 2-deoxy-D-glucose 
and D-fructose are similar (about 7 ^M). Indeed, although GLUT3 had lower 
Ki values for cytochalasin B inhibition of 2-deoxy-D-glucose and D-galactose 
uptake, the Ki values were similar for both transported sugars (about 2 pM).
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These results suggest that the endofacial substrate binding sites used by 2- 
deoxy-D-glucose and D-fructose (GLUT2) or D-galactose (GLUT3) are similar 
or overlap. D-glucose and maltose are competitive inhibitors of both 2-deoxy- 
D-glucose and D-fructose transport by GLUT2, and 2-deoxy-D-glucose and D- 
galactose transport by GLUT3, suggesting that all transported sugars are likely 
to use the same exofacial sugar binding site on the transporter molecule. 
Furtherm ore, each of the alternative substra tes for each isoform  is a 
competitive inhibitor of 2-deoxy-D-glucose transport, and D-glucose is a 
competitive inhibitor of the transport of the alternative substrates. 2,5- 
anhydro-D-m annitol has a significantly low er Kj value than L-sorbose for 
inhibition of 2-deoxy-D-glucose transport by GLUT2, indicating that D-fructose 
is probably transported  in the furanose ring  form  w hilst D-glucose is 
transported in the pyranose ring form.
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CHAPTER 4.
Analysis of the Structural Requirements of 
Sugar Binding to the Liver-tvpe Glucose 
Transporter (GLUT2) Expressed in Xenopus
O ocytes.
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4.1 Aims.
1. To investigate the structural basis of sugar binding to GLUT2 using a 
range of hexoses, halogeno- and deoxy-glucose analogues to inhibit the 
transport of 2-deoxy-D-glucose by GLUT2 expressed heterologously in 
Xenopus oocytes.
2. To compare the results obtained for GLUT2 w ith those published for 
GLUT1 and GLUT4, and with GLUT3 in oocytes.
3. To produce a model for the interactions of D-glucose and D-fructose 
with the exofacial binding site of GLUT2.
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4.2 Background.
Although GLUTs 1 to 4 all function to transport glucose, the nature of 
the glucose binding sites on these proteins are subtly different (Gould et al., 
1991; Colville et al., 1993). For example, GLUT2 is able to m ediate the 
transport of D-fructose quite efficiently as well as D-glucose. Additionally, 
although GLUTs 1, 2 and 3 all transport D-galactose (Gould et al., 19^1; 
Colville et al., 1993), they do so with distinctly different Km values. These and 
o ther observations suggest that the na tu re  of the in teraction  of the 
transported  sugars w ith the transport proteins may be different betw een 
isoforms.
Studies attem pting  to investigate the b ind ing  of glucose to the 
erythrocyte sugar transporter were perform ed in the early 1970s (Barnett et al., 
1973; Barnett et al., 1975; Kahlenberg & Dolansky, 1972). It had been apparent 
for many years that glucose entry into cells was protein-mediated, as transport 
in erythrocytes, for example, was found to be saturable, stereospecific and 
bidirectional. D-glucose was proposed to reversibly bind to a specific protein 
site, translocate across the plasm a m em brane in an aqueous pocket by a 
protein conformational change, and be released into the cytoplasm from an 
endofacial site. The m ethod of sugar transport was proposed to involve 
transient association between sugar hydroxyl groups and polar amino acid 
side-chains of the transporter (LeFevre, 1961). Therefore investigation of the 
importance of hydrogen bonding at these positions w ould involve studying 
relative binding after their removal or modification.
Such m ethods w ere em ployed to characterise the na tu re  of the 
interaction of D-glucose with the exofacial binding site of GLUT1 (Barnett et 
al., 1973; Kahlenberg & Dolansky, 1972). Derivatives of D-glucose were 
synthesised, altering each of the hydroxyl groups in turn. Epimers were
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created by exchanging the axial hydroxyl groups for equatorial groups or vice 
versa, deoxy-analogues were produced by the removal of each hydroxyl group 
and different alkyl groups or halogeno-groups were also used as substituents.
Kahlenberg and Dolansky investigated the ability of these compounds 
to inhibit radiolabelled D-glucose uptake by isolated hum an erythrocyte 
membranes. In a parallel study, Barnett et al. m easured inhibition constants, 
Ki's, for the inhibition of uptake of radiolabelled L-sorbose into erythrocytes 
by these specifically substituted analogues of D-glucose. M easurements of Kj’s 
were preferential to Km ’s since the former gives a better description of the 
dissociation constant of the transporter exofacial binding site even when the 
rate of translocation is similar to the rate of form ation of the sugar-protein 
complex (Levine et a l, 1971). L-sorbose had previously been show n to be 
taken up by erythrocytes, albeit with much lower affinity than D-glucose itself 
(LeFevre & Davies, 1951; Sen & W iddas, 1962). By using this sugar inhibitory 
effects with relatively weakly binding analogues could easily be measured. 
The ability of each analogue to inhibit L-sorbose uptake was investigated, not 
uptake of the analogue itself.
If a deoxy-analogue (D-glucose lacking a given hydroxyl group) has an 
impaired ability to bind to the transporter then that deoxy-sugar will inhibit L- 
sorbose uptake to a lesser extent than D-glucose. However, if the extent of 
inhibition is similar to that of D-glucose, then the absent hydroxyl group is 
unlikely to significantly inhibit the binding of D-glucose to the exofacial 
binding site.
The epimerisation of a group tells us about the spatial requirements of 
binding. For example, an epimer with a higher Ki for L-sorbose uptake than 
D-glucose indicates that the hydroxyl group has probably moved to a position 
which is not optim al for hydrogen bonding to the transporter. Hydrogen 
bond optimal distances vary depending on the particular hydrogen acceptor,
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the average distance being 2.8A (Stryer, 1981). It is also possible that the new 
position of the hydroxyl group might cause steric hindrance though this is 
less likely due to the hydroxyl group's small size.
Substitution of a hydroxyl with fluoride is a test of the directionality of 
a particular hydrogen bond. Due to their chemical nature, hydroxyl groups 
can act as hydrogen acceptors through the oxygen atom , or as hydrogen 
donors via the hydrogen moiety. Hence, consider a hydroxyl position which 
has proved to be im portant in transporter binding, i.e. the corresponding 
deoxy-analogue poorly inhibits L-sorbose transport. If an analogue with a 
fluoride substitution at this position restores the inhibition of L-sorbose to 
levels com parable to D-glucose then binding to the transporter has been 
restored. That would indicate that the hydrogen is donated by the transporter. 
Conversely, if the pattern of inhibition resembled that of the deoxy-analogue 
then the direction of the hydrogen bond w ould be predicted to be from the 
sugar hydrogen to some electronegative transporter residue side-chain. Of 
course, steric hindrance could also play a part in the lack of inhibition of L- 
sorbose binding  by halogen analogues. This is unlikely  for fluoride- 
substituted sugars, as fluoride is similar in size to the replaced hydroxyl group. 
H owever, the substitution of hydroxyl group by brom ide or iodide groups 
m ight cause more steric problems. Steric effects can also be analysed by 
substitution with alkyl groups of various sizes for each of the sugar hydroxyl 
groups; w ith the aim of giving some indication of the shape of the exofacial 
binding site.
In an analysis of GLUT1, Barnett et al. found that the hydroxyl groups 
at the C-l and C-3 positions and to a lesser extent, the C-4 and C-6 ring 
positions, were im portant for hydrogen bonding to GLUT1 although no single 
position was critical for binding (Barnett et a l, 1973). The binding of 1-deoxy- 
D-glucose to the transporter confirmed that sugars are transported in the
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pyranose ring form. They discovered that a large substituent group could be 
added at positions C-4 and, to a lesser extent, at C-6 and C-3 w ithout any 
further loss of affinity for the transporter. This indicated large spaces at these 
positions. These workers also noted that analogues w ith alkyl substituents at 
C-6 had a greater affinity for the transporter than D-xylose. D-xylose has 
identical stereochemistry to D-glucose except it lacks the -CH 2 OH at the C-5 
position. Hence, it was postulated that hydrophobic interactions at the C-5/C- 
6 position were likely to be im portant in the binding of D-glucose. A model 
was constructed where glucose enters the transporter b inding site C -l first 
w ith the C-4 position last, utilising hydrogen bonding and hydrophobic 
interactions but forming no covalent bonds (Figure 4.1). A similar model was 
also proposed independently  (Kahlenberg and Dolansky, 1972) w ho also 
found that substitution of the ring oxygen by su lphur led to a decrease in 
binding.
The model was reinforced by a later study (Barnett et a l, 1975) where it 
was found that D-glucose and L-sorbose entry into, and exit from erythrocytes 
was blocked by analogues with large C-4 and C-6 substituents only when 
present outside the cells. Moreover, analogues substituted at the C-l position, 
such as propyl-p-D-glucopyranoside, were found to competitively inhibit exit 
of D-glucose but not affect entry (Barnett et al, 1975). Hence, it was concluded 
that the transporter has two distinct asymmetric binding sites. Effects of the 
presence of various sugars on l-fluoro-2,4-dinitrobenzene inactivation of the 
transporter showed that some sugars stim ulated inactivation w hilst others 
protected against inactivation, depending w hether they bound the exofacial 
binding site or the endofacial one. It was concluded that the transporter 
undergoes a conform ational change upon  sugar b in d in g  from  one 
asym m etric state  to ano ther, exposing or b u ry in g  the l-fluo ro -2 ,4- 
dinitrobenzene inactivation site. The presence of two conformational states
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had previously been proposed by other groups (Bowyer & W iddas, 1958; 
Krupka 1971; Krupka, 1972; Shimmin & Stein, 1970; Edwards, 1973).
This approach has also been used successfully to examine the nature of 
the binding site for glucose in insulin-stim ulated rat adipocytes (GLUT4) 
(H olm an et al., 1981; Rees & Holman, 1981; Holm an & Rees, 1982). The same 
techniques were used, measuring Kj values for the inhibition of radiolabelled 
D-allose uptake by substituted analogues of D-glucose. D-allose is the C-3 
position epimer of D-glucose and has a relatively poor affinity for both GLUTs 
1 and 4. Hence, as was the case with L-sorbose, relatively weak binding by an 
analogue can lead to a measurable decrease in D-allose uptake by GLUT4. To 
sum m arise their results, a m odel was predicted w here the C-3 and C-4 
hydroxyl groups are im portant for sugar /tran sp o rte r interaction; there are 
hydrophobic interactions at C-6: and the ring oxygen also plays a part in 
transporter binding. Experiments were also perform ed w ith a series of 6-0- 
alkyl-D-glucose and 6-O-alkyl-D-galactose analogues in addition to propyl-p-D- 
glucopyranoside. Their behaviour with GLUT4 was found to be similar to 
that found w ith GLUT1 (Barnett et al., 1975) in that these C-6 position 
substituents inhibited D-allose uptake only when present outside the cells, 
and propyl-p-D -glucopyranoside again had inhibitory effects only when 
preincubated w ith the cells so that it was present internally. So the final 
mode of D-glucose binding by GLUT4 was shown to be almost identical to that 
of GLUT1, where the sugar enters the exofacial binding pocket C-l first and 
binds the endofacial binding site C-6 first during sugar exit. This general sugar 
orientation is predicted to vary little during transport, whilst conformational 
changes in the transporter cause the translocation of D-glucose across the 
m em brane.
The results of a similar analysis of GLUT2, expressed heterologously in 
Xenopus oocytes is presented here. In addition, results obtained from parallel
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experiments performed by Carol Colville with GLUT3 are shown, and models 
depicting the interaction of the substrate, D-glucose, w ith these different 
transporter isoforms are proposed.
4.3 Results.
In all the following analysis, the effects of different analogues of D- 
glucose on the transport of 2-deoxy-D-glucose into oocytes expressing GLUT2 
have been m easured. The transport of 100 pM radiolabelled 2-deoxy-D- 
glucose into oocytes was determ ined for 30 m in (see section 2.4). It has 
previously been shown that under these conditions, the transport of 2-deoxy- 
D-glucose is rate  lim iting, and not its subsequent phosphorylation  by 
hexokinase (Thomas et al., 1993; Colville et aL, 1993). 2-deoxy-D-glucose was 
chosen as the substrate for this analysis since it is only partially metabolisable 
and because it has been shown to inhibit L-sorbose and D-glucose uptake by 
GLUT1 (Barnett et al., 1973; Kahlenberg and Dolansky, 1972) and D-allose 
uptake by GLUT4 (Holman et al., 1981) as well as D-glucose itself. These 
observations, together w ith the previous dem onstration that 2-deoxy-D- 
glucose is transported with a lower Km than other sugar analogues such as 3- 
O-m ethyl-D-glucose (Gould et ah, 1991; Colville et al., 1993) all point to an 
insignificant role of hydrogen bonding at the C-2 position in the recognition 
of the transported sugar by all transporter isoforms (see below). Moreover, 
the use of 2-deoxy-D-glucose rather than 3-O-methyl-D-glucose enables an 
analysis of the outward-facing binding site of the transporter, since 2-deoxy-D- 
glucose is rapidly phosphorylated by hexokinase, and thus, unlike 3-O- 
methyl-D-glucose, is trapped inside the oocyte resulting in a negligible efflux
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of sugar. Thus, the results of this study are interpreted in terms of inhibition 
at the exofacial binding site.
4.3.1 Effects of C-l and C-2 Position Analogues on 2-Deoxy-D-glucose 
Transport.
The ability of 1-deoxy-D-glucose, D-mannose, 2-chloro-D-glucose and 
2-deoxy-D-glucose to inhibit the transport of 0.1 mM radiolabelled 2-deoxy-D- 
glucose mediated by GLUT2 were examined. The results of this analysis are 
presented in Table 4.1. In this table and each of the others, results obtained for 
GLUT3 by Dr. Carol Colville are presented for the purpose of comparison.
4.3.2 Effects of C-3 Position Analogues on 2-Deoxy-D-glucose Transport
The effects of C-3 position analogues on the transport of 2-deoxy-D- 
glucose by GLUT2 are shown in Table 4.2. The analogues studied were D- 
allose (the C-3 epimer of D-glucose), 3-deoxy-D-glucose, 3-bromo-D-glucose, 3- 
fluoro-D-glucose, 3-O-methyl-D-glucose and 3-O-propyl-D-glucose. Table 4.5 
shows a comparison of the effects of both 2 mM and 10 mM 3-fluoro-D- 
glucose and 3-deoxy-D-glucose on transport mediated by GLUT2 and GLUT3.
4.3.3 Effects of C-4 and C-6 Position Analogues on 2-Deoxy-D-glucose 
Transport.
Table 4.3 shows the effect of D-galactose, maltose, cellobiose, lactose and 
4,6-O-ethylidine-D-glucose on the transport of 2-deoxy-D-glucose by GLUT2. It 
has been established that GLUT2 transports D-galactose (Gould et al.f 1991; 
Burant & Bell, 1992) as does GLUT3, but note that the disaccharides are not
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transported substrates, neither is 4,6-O-ethylidine-D-glucose (Barnett et al, 
1973; H olm an et a l 1981). Table 4.4 shows the effects of a range of C-6 
position analogues on 2-deoxy-D-glucose transport.
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Table 4.1
G roups of 6 oocytes expressing the transporter of interest were 
incubated in Barths buffer containing the competing sugar for approximately 
5 min prior to the addition of [2,6-3H]2-deoxy-D-glucose (100 jiM, 1 pCi/m l). 
Transport was determ ined for 60 min. After this time, the oocytes were 
w ashed and the radiolabel associated w ith each oocyte determ ined as 
described in section 2.4. The data shown above are from typical experiments, 
repeated at least twice for each analogue /transporter. Rates are expressed as a 
percentage of the rate m easured in the presence of 10 mM L-glucose, and are 
the mean of six oocytes for each analogue (± SD). Note that the inclusion of L- 
glucose did not alter the transport rate compared to oocytes assayed in the 
absence of any other sugars. Values which are significantly different from the 
L-glucose rates (determ ined by an unpaired  t-test) are indicated by *. 
Transport rates were between 3 and 5 pm oles/m in /oocyte  for both GLUT2 
and GLUT3.
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Table 4.1
Effects of C-l and C-2 Position Analogues on 2-Deoxy-D-glucose Transport by
GLUTs 2 and 3.
2-deoxyglucose transport rate 
GLUT2 GLUT3
Com peting Sugar 
10 mM L-glucose 
10 mM D-glucose 
10 mM 1-deoxy-D-glucose
100%
24 ± 4%* 
109 ± 10%
100%
10 ±  2%* 
104 ± 12%
10 mM 2-chloro-D-glucose 76 ± 5%* 42 ± 3%
10 mM 2-deoxy-D-glucose 20 ± 2%* 12 ± 2%
10 mM D-mannose 29 ± 3%* 14 ± 2%
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Table 4.2
The data show n is from a typical experiment, repeated at least two 
times for each analogue/transporter. In all cases, competing sugars were at 10 
mM in the assay, and the assay conditions were as described in the legend to 
Table 4.1. Values which are significantly different from the L-glucose rates 
(determined by an unpaired t-test) are indicated by *.
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Table 4.2
Effects of C-3 Position Analogues on 2-Deoxy-D-glucose Transport by GLUTs 2
and 3.
2-deoxyglucose transport rate
GLUT2 GLUT3
Competing sugar
(all at 10 mM)
L-glucose 100% 100%
D-glucose 18 ± 3%* 8 ± 2%*
3-deoxy-D-glucose 103 ± 12% 85 ± 7%
3-bromo-D-glucose 95 ± 10% 75 ± 4%
3-fluoro-D-glucose 85 ± 5%* 14 ± 2%
3-O-methyl-D-glucose 73 ± 6%* 17 ± 3%
3-O-propyl-D-glucose 100 ± 12% 80 ± 7%
D-allose 59 ± 6%* 96 ± 7%
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Table 4.3
The data shown is from a typical experiment, repeated at least two 
times for each analogue/transporter. Rates are expressed as a percentage of 
the rate m easured in the presence of 10 mM L-glucose, and are the mean of at 
least six oocytes for each analogue (± SD). Values which are significantly 
different from the L-glucose rates (determined by t-test analysis) are indicated 
by *.
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Table 4.3
Effects of C-4 Position Analogues on 2-Deoxy-D-glucose Transport by GLUTs 2
and 3.
2-deoxyglucose transport rate
Competing sugar
GLUT2 GLUT3
10 mM L-glucose 100% 100%
10 mM D-glucose 17 ± 2%* 9 ± 2%*
10 mM D-galactose 110 ± 12% 57 ± 5%*
10 mM 4,6-O-ethylidine-D-glucose 102 ± 9% 73 ± 6%*
20 mM maltose 105 ± 8% 75 ± 7%*
20 mM lactose 110 ±9% 112 ± 9%
20 mM cellobiose 113 ± 12% 82 ± 6%*
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Table 4.4
The data show n is from a typical experim ent, repeated at least two 
times for each analogue/transporter. Rates are expressed as a percentage of 
the rate m easured in the presence of L-glucose, and are the m ean of six 
oocytes for each analogue (SD was typically betw een 5 and 15%). Note 
however, that the concentration of competing sugars used in these analyses 
w ere 50 mM for GLUT2, and 25 mM for GLUT3. Values w hich are 
significantly different from the L-glucose rates (determined by an unpaired t- 
test) are indicated by *.
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Table 4.4
Effects of C-6 Position Analogues on 2-Deoxy-D-glucose Transport by GLUTs 2
and 3.
Competing sugar
L-glucose
D-glucose
6-deoxy-D-glucose
D-xylose
L-arabinose
D-fucose
D-galactose
6-0 -methyl-D-galactose 
6-0 -propyl-D-galactose 
6-fluoro-D-galactose
2-deoxyglucose transport 
GLUT2
100%
24 ± 5%*
33 ± 9%*
106 ± 9%
138 ± 22%
65 ± 18%*
63 ± 7%*
57 ± 10%* 
n.d.
50 ± 12%*
GLUT3
100%
10 ±  1%*
46 ± 7%* 
78 ± 6%*
63 ± 7%* 
25 ± 2%* 
16 ± 2%* 
109 ±11% 
93 ± 17% 
30 ± 9%*
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Table 4.5
Comparison of the Inhibitions of 2-deoxy-D-glucose Transport mediated by 
GLUT2 and GLUT3 induced by C-3-substituted sugars.
Relative 2-deoxy-D-glucose transport (%)
GLUT2 GLUT3
Competing Sugar 2 mM 10 mM 2 mM lOmM
L-glucose
3-deoxy-D-glucose
3-fluoro-D-glucose
100 100
102 ± 4  100 ± 5
96 + 5  85 +5
100 100
101 ±  7 85 ±  7
6 0 + 6  18 + 3
Transport of 2-deoxy-D-glucose was measured in oocytes expressing GLUT2 or 
GLUT3 as described in section 2.4. The extent of inhibition in the presence of 
either of two concentrations of 3-fluoro-D-glucose or 3-deoxy-D-glucose was 
determined and the result expressed as a percentage of the transport in the 
presence of an equal concentration of L-glucose. Results from  a 
representative experiment are shown each value representing the mean + SD 
for six oocytes at each point.
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Figure 4.1
Model for the Interaction of (i-D-Glucose with GLUT1.
A m odel for the hydrogen bonding of D-glucose to GLUT1 is shown as 
proposed by Barnett et al. Hydrogen bonds are illustrated by dotted lines and 
the C-6 hydrophobic interactions are shown by a dashed area.
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Figure 4.1
Model of the Interaction of p-D-Glucose with GLUT1.
o
X
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Figure 4.2
Model of the Interaction of p-D-Glucose with GLUT2.
A model for the hydrogen bonding of p-D-glucose to GLUT2 is illustrated. 
H ydrogen bonds are represented  by dotted  lines and the hydrophobic 
interaction between the transporter and the C-6 position methylene group is 
indicated by dashed lines.
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Figure 4.2
Model of the Interaction of (i-D-Glucose with GLUT2.
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Figure 4.3
Model of the Interaction of p-D-Glucose with GLUT3.
A generalised model showing (3-D-glucose binding to GLUT3. Note that the 
hydrogen bond at the C-3 position hydroxyl has a different nature to that of 
GLUT2. Also, the C-4 position hydrogen bond is likely to be less significant in 
substrate binding than with the other transporter isoforms since GLUT3 binds 
D-galactose, the C-4 epimer of D-glucose.
Figure 4.3
Model of the Interaction of P-D-Glucose with GLUT3.
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Figure 4.4
Model for the Interaction of P-D-Fructose with GLUT2.
The proposed interaction of the furanose ring form of p-D-fructose and 
GLUT2 is shown.
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Figure 4.4
Model for the Interaction of p-D-Fructose with GLUT2.
o ***„
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4.4 Discussion.
The nature of the interaction of D-glucose with the various glucose 
transporters is proposed to involve hydrogen bonds betw een the sugar 
hydroxyl groups and polar side chains of the transporter. However, there 
m ight also be associations between w ater and the sugar binding site of the 
transporter. The dissociation constant for the D -glucose/transporter complex 
m ay also represent an equilibrium between solvated sugar in bulk solution, 
and sugar bound to the transporter. If the hydroxyl groups on the sugar are in 
the appropriate stereochemical configuration for binding, that is, they occupy 
the correct regions in space for interaction with the appropriate groups within 
the transporter binding site, then the activation energy required for binding 
will be reduced such that the equilibrium will lie tow ards transporte r/sugar 
complex formation.
Analysis of the participation of each hydroxyl group can be examined by 
the effective replacement of that group by hydrogen (i.e. the deoxy-analogue). 
If a hydroxyl group im portant for binding is rem oved then the affinity of this 
analogue for the transporter will be significantly reduced. This sugar should 
inhibit the transport of 2-deoxy-D-glucose to a lesser degree than D-glucose 
itself does. Replacement of the hydroxyl with a strongly electronegative atom 
such as fluorine should restore the affinity of the sugar for the transporter if 
the protein is the hydrogen atom donor, but not if the that sugar hydroxyl 
group is the donor. To presum e this it m ust be assum ed that the 
stereochemistry is retained, and that the fluorine substituent is not too large, 
avoiding steric hindrance. The ability of fluoro-, alkoxy-, chloro- and bromo- 
substituted analogues, altered at specific sites in the hexose ring, to inhibit 
transport by GLUT2 have been examined.
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Ideally, a complete analysis of the K* values of each sugar analogue on 
2-deoxy-D-glucose transport by GLUT2 into oocytes w ould  have been 
performed. However, this was impractical due to the small am ounts of some 
sugar analogues available for this study. Instead, the percentage inhibition of 
2-deoxy-D-glucose transport by these analogues has been m easured, and 
com pared w ith the relative extents of inhibition using D-glucose and L- 
glucose within the same experiment. The extent of inhibition is a reflection 
of the Ki for the different analogues. When the Ki is high, the percentage 
inhibition will be small. It has previously been shown that at positions where 
hydrogen bonds appear im portant for the binding of D-glucose to GLUT1, 
substitution of a hydroxyl by hydrogen results in an approxim ate 10-fold 
increase in Ki (Kahlenberg and Dolansky, 1972; Barnett et al., 1973).
It would also have been preferable to use a substrate such as L-sorbose 
or D-allose rather than 2-deoxy-D-glucose. These sugars have been shown to 
bind GLUT1 and GLUT4, respectively, with relatively poor affinity compared 
to 2-deoxy-D-glucose, so that inhibition by D-glucose analogues w ould give 
more measurable results. However, the expense of obtaining radiolabelied L- 
sorbose proved to be prohibitive.
The results of this analysis have been in terpreted  to reflect sugar 
interaction at the exofacial sugar binding site of the transporter molecule. 
This assumption is based upon the fact that changes in the rates of 2-deoxy-D- 
glucose tran spo rt are m easured . Since th is g lucose ana logue  is 
phosphorylated by hexokinase and hence trapped inside the oocyte, the rate of 
sugar exit is assumed to be minimal. No significant accum ulation of non- 
phosphorylated 2-deoxy-D-glucose has been observed in oocytes w ith 
concentrations of 2-deoxy-D-glucose far in excess of the 100 (iM used in this 
analysis. This indicates that hexokinase is not rate lim iting under these 
conditions (Thomas et a l, 1993; Colville et al, 1993).
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4.4.1 Binding at the C-l Position.
10 mM 1-deoxy-D-glucose did not inhibit 2-deoxy-D-glucose transport to 
any significant extent by GLUT2. This suggests the presence of a hydrogen 
bond at this position in the transporter which is im portant for substrate 
recognition/binding. 20 mM 1-deoxy-D-glucose produced a small level of 
inhibition (less than 20%- data not shown). Therefore a lthough the C-l 
hydroxyl group is important, it is not essential for sugar transport. 1-deoxy-D- 
glucose has a ring which is locked in the pyranose form, indicating that, as 
was expected based on studies of GLUTs 1 and 4 (Barnett et al., 1973; Rees & 
Holm an, 1981), the pyranose form of glucose binds to the carrier. Similar 
results were found with GLUT3 (Table 4.1).
4.4.2 Binding at the C-2 Position.
Studies of GLUT1 have suggested that the C-2 position is not important 
for hydrogen bonding (Kahlenberg & Dolansky, 1972; Barnett et al., 1973). 
This was also confirmed to be the case for GLUT4 (Rees & Holman, 1981). The 
affinity of 2-deoxy-D-glucose for both GLUT2 and GLUT3 is higher than that 
of 3-O-methyl-D-glucose, and p-D-mannose (the C-2 epimer of D-glucose) is as 
effective as D-glucose in inhibiting transport by both isoforms (Table 4.1; see 
also Gould et al., 1991). Additionally, 2-chloro-D-glucose did not bind to the 
transporter with any greater affinity than 2-deoxy-D-glucose itself. This can be 
seen by comparing the inhibition of 0.1 mM 2-deoxy-D-glucose by 10 mM 2- 
chloro-D -glucose w ith  the effective inh ib ition  of 2-deoxy-D -glucose 
isotopically diluted to 10 mM (Table 4.1). The possibility that the reduction of 
affinity for the transporter caused by the chloride substitution, relative to 2-
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deoxy-D-glucose, is due to steric hindrance cannot be ruled out. The space 
surrounding the C-2 position of GLUT1 was shown to be limited (Barnett et 
al., 1973), so it is possible that this is also true in the case of GLUT2. However, 
the C-2 position is not im portant for binding to GLUT2, suggesting that 
hydrogen bonding at this position is unlikely to play a significant role in sugar 
binding. Again these results were identical to those obtained in a parallel 
analysis of GLUT3.
4.4.3 Binding at the C-3 Position.
See Table 4.2. 3-deoxy-D-glucose was found to be a poor inhibitor of 2- 
deoxy-D-glucose transport by GLUT2, indicating that hydrogen bonding at the 
C-3 position is im portant for sugar binding to this transporter. However, 
comparison of the extent of inhibition of transport in the presence of identical 
concentrations of either 3-deoxy-D-glucose or 3-fluoro-D-glucose indicated no 
significant difference in the affinity for GLUT2 (Tables 4.2 and 4.5). Unless the 
replacem ent of the hydroxyl w ith a fluoro-substituen t has caused the 
analogue to be sterically incompatible with the binding site, then the relative 
lack of affinity for the transporter m ust be attributable to impaired hydrogen 
bonding. Therefore it is likely that the hydrogen bond formed at position C-3 
is formed by donation of the hydrogen atom from the sugar hydroxyl, not 
from the transporter. The observation that 3-halogeno substituted sugars are 
better inhibitors of GLUTs 1, 3 and 4 than 3-deoxy-D-glucose (Barnett et al, 
1973; Rees & Holm an, 1981; and Table 4.2) w ould suggest that steric 
constraints are unlikely, since binding to these transporters shows no steric 
hindrance. In addition, the fluoro-group is not much bigger than a hydrogen. 
Seemingly, the C-3 position hydroxyl is involved in hydrogen bonding of the 
transported sugar to GLUT2, but the nature of this hydrogen bonding is
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unique, since 3-halogeno substituted sugars have higher affinity for the 
GLUTs 1, 3 and 4 than 3-deoxy-D-glucose.
D-allose, the C-3 position epimer of D-glucose, is an effective inhibitor 
of 2-deoxy-D-glucose transport by GLUT2 (Table 4.2). This is not the case with 
GLUTs 1, 3 or 4 (Barnett et al, 1973; Rees & Holm an, 1981; and Table 4.2). 
With GLUT2, the displacement of the C-3 hydroxyl in space has not reduced 
the affinity of the sugar for the transporter to the same extent as its removal,
i.e. 3-deoxy-D-glucose. It is possible that the C-3 hydroxyl is able to weakly 
participate in hydrogen bonding in the allo-configuration. This does no 
appear to be the case with the other transporter isoforms.
3-deoxy-D-glucose was found to be a poor inhibitor of transport 
m ediated by GLUT3 (Carol Colville, Table 4.2), indicating that the C-3 position 
is involved in hydrogen bonding. Replacem ent of the hydrogen with a 
fluoride restored the affinity of the analogue for the transporter, suggesting 
the direction of the hydrogen bond is such that the transporter is the 
hydrogen donor. Comparison of 2 mM and 10 mM 3-deoxy- and 3-fluoro- 
analogues (Table 4.5) demonstrate that the fluoro-analogue inhibits the rate of 
2-deoxy-D-glucose transport to a greater extent than the deoxy-analogue. 
W ith GLUT2, the inhibition in the presence 3-deoxy-D -glucose w as 
comparable to that with 3-fluoro-D-glucose at concentrations of 10 mM and 20 
mM.
3-O-methyl-D-glucose and 3-O-propyl-D-glucose have been shown to 
bind to GLUTs 1, 3 and 4 and inhibit transport by these isoforms to a greater 
extent than 3-deoxy-D-glucose (Barnett et al., 1973; Rees & Holman, 1981; and 
Table 4.2), presumably since hydrogen bonds at the C-3 position can still be 
form ed. The C-3 position is able to accom m odate rela tively  large 
substitutions before steric effects significantly effect b inding w ith these 
isoforms. Although GLUT2 transports 3-O-methyl-D-glucose with reasonable
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affinity (Km for equilibrium  exchange is 30 mM, Gould et al., 1991) it has 
lower affinity for this sugar than GLUT3. Additionally, at the concentrations 
tested (10 mM), 3-O-propyl-D-glucose did not bind appreciably to GLUT2 at all. 
This confirms the difference observed in binding exhibited at the C-3 position 
between GLUT2 and the other transporter isoforms.
4.4.4 Binding at the C-4 Position.
4-deoxy-D-glucose was not available for this analysis. Instead, D- 
galactose, the C-4 position epimer of D-glucose was used. D-galactose is a 
transported substrate of GLUT2 having a Km value of about 85 mM (see Table 
3. 1). However, no inhibition of 2-deoxy-D-glucose transport by GLUT2 was 
observed in the presence of 10 mM D-galactose (Table 4.3), in contrast to a 
m arked inhibition in the presence of 10 mM D-glucose. A greater inhibition 
was observed by 50 mM D-galactose (Table 4.4). In contrast, GLUT3, which has 
a relatively high affinity for D-galactose (Km of 8.5 mM), was effectively 
inhibited by 10 mM D-galactose, but to a significantly lesser extent than that 
measured in the presence of 10 mM D-glucose (Table 4.3). This is confirmed 
by comparison of the Kj values of D-glucose and D-galactose inhibition of 2- 
deoxy-D-glucose transport by GLUT3 (1.6 mM and 15.5 mM respectively, see 
Table 3.1). The interpretation of these results suggests the presence of a 
hydrogen bond between the C-4 position hydroxyl in the gluco-configuration 
of D-glucose and GLUT2, similar to the results proposed by Barnett et al. for 
GLUT1 (Barnett et al, 1973) and confirmed for GLUT4 (Rees & Holman, 1981). 
However, the interaction of the C-4 position hydroxyl with GLUT3 seems to 
be much less im portant than with GLUTs 1, 2 or 4 since D-galactose is an 
effective inhibitor of transport. This result is consistent with the observed 
decreasing order of affinities of D-galactose reported to date, GLUT3 > GLUT1
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> GLUT2 (Burant & Bell, 1992; Colville et al, 1993). The model of D-glucose 
binding to the exofacial biding site of GLUT1 envisaged by Barnett et al. 
showed a large space at the C-4 position and hydrogen bonding to the C-4 
hydroxyl was proposed to be relatively important but not vital. Perhaps the C- 
4 hydroxyl is required to the same extent in GLUT3 as the other isoforms, but 
the repositioning of the C-4 hydroxyl does not affect the interaction of D- 
galactose with GLUT3 because the stereochemistry of the appropriate bonding 
group of that transporter is such that hydrogen bonding is still possible 
although not to the extent as with D-glucose itself.
20 mM maltose, cellobiose and 4,6-O-ethylidine-D-glucose (which can 
be regarded as C-4 analogues of D-glucose) are not good inhibitors of 2-deoxy- 
D-glucose transport by GLUT2, unlike GLUT3 (Table 4.3). Maltose has been 
shown to be a competitive inhibitor of 2-deoxy-D-glucose transport by GLUTs 
2 and 3, albeit w ith relatively high Kj values of 124 mM and 37 mM, 
respectively (Table 3.1). It is therefore likely that the regions of the exofacial 
binding sites of GLUTs 2 and 3 responsible for interacting w ith  the C-4 
position of the D-glucose, like that of GLUT1, each incorporate a relatively 
large 'space' which is able to accommodate bulky derivatives. Again, these 
results suggest that the model of Barnett et al. for GLUT1 where the sugar 
enters the binding site C-l position first, with C-4 oriented such that it faces 
out of the sugar binding site, is also valid for both GLUT2 and GLUT3. This 
has also been proposed for GLUT4 (Holman & Rees, 1982).
4.4.5 Binding at the C-6 Position.
50 mM 6-deoxy-D-glucose is a good inhibitor of 2-deoxy-D-glucose 
transport by GLUT2 (Table 4.4). Likewise, 25 mM 6-deoxy-D-glucose is a good 
inhibitor of 2-deoxy-D-glucose transport by GLUT3. This suggests that
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hydrogen bonding at the C-6 position with either isoform is not crucial for 
transport. Nevertheless, the lower affinity of 6-deoxy-D-glucose than D- 
glucose itself does suggest the presence of a hydrogen bond at this position. 
The same concentration of D-xylose (which lacks the C-5 hydroxym ethyl 
group of D-glucose) elicited significantly less inhibition than 6-deoxy-D- 
glucose with GLUT2 and GLUT3. The potential for hydrophobic interactions 
between the transported sugar and the protein around the C-6 position has 
been suggested for GLUT1 (Barnett et al., 1973). The above results support a 
similar interaction between D-glucose and GLUTs 2 and 3.
A sim ilar pa ttern  of inhibition was seen using a series of C-6 
substituted analogues of D-galactose to inhibit 2-deoxy-D-glucose transport by 
GLUT2. 50 mM D-galactose itself produced a m easurable level of inhibition 
and was used as a standard to compare w ith inhibition by L-arabinose (D- 
galactose w ithout the C-5 hydroxym ethyl group), D-fucose (6-deoxy-D- 
galactose), 6-O-methyl-D-galactose, and 6-fluoro-D-glucose. Replacement of 
the C-6 hydroxym ethyl group with a hydrogen (L-arabinose) resulted in a 
complete loss of affinity for the transporter. In contrast, removal of the C-6 
hydroxyl group (D-fucose) resulted in no loss of affinity for the transporter 
relative to D-galactose itself. This suggests that a C-5 substitutent is im portant 
for binding, and hydrogen bonding plays comparatively little part. Addition 
of methyl and fluoro- substituents to the C-6 hydroxyl did not lead to any 
significant decrease of inhibition of 2-deoxy-D-glucose transport relative to D- 
galactose or any significant increase relative to D-fucose. This again suggests 
the unimportance of the C-6 hydroxyl and also shows that a methyl group can 
be accommodated at this position by GLUT2. Unfortunately, insufficient 6-0- 
propyl-D-galactose was available to test the size of the pocket at this position.
Similar results were obtained for GLUT3 (Carol Colville). In this case, 
D-galactose is a better inhibitor of transport (consistent w ith the less
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significant role of the gluco-C-4 in hydrogen bonding suggested above). As 
can be seen in Table 4.4, inhibition of 2-deoxy-D-glucose transport by 25 mM 
D-fucose than is slightly less than that observed with 25 mM D-galactose, but 
25 mM L-arabinose is a significantly weaker inhibitor than D-fucose itself. 
Again this suggests that hydrophobic interactions are more im portant than 
hydrogen bonding at this position with GLUT3, at least when the C-4 hydroxyl 
is in the galacto-conformation.
One notable difference betw een the isoforms is that 6-O -m ethyl-D - 
galactose is not an effective inhibitor of GLUT3 but is with GLUT2 (Table 4.4). 
Similar studies by this group also suggest that 6-O-methyl-D-galactose is a 
better inhibitor of 2-deoxy-D-glucose than D-galactose itself (Colville et al., 
1993b), how ever this result is in contrast to the results of Holm an & Rees 
(1981) who found that 6-O-methyl-D-galactose was a poor inhibitor of GLUT4. 
Presumably, the alkoxy-analogues are not effective inhibitors of GLUT3 due to 
steric considerations, and the space m ight be larger at this position of the 
GLUT2 exofacial binding site.
4.4.6 Models of the Interaction of p-D-Glucose with the Exofacial Binding 
Sites of GLUT2 and GLUT3 .
Transport of glucose is restricted to the P-D-enantiomer, since L-glucose 
does not bind appreciably to any known transporter. p-D-glucose has also 
been proposed to be transported in the pyranose ring form (LeFevre, 1961). In 
addition, it has been noted that the most favourable conformation consists of a 
ring in the Cl chair conform ation w ith the hydroxyls in the equatorial 
position (Kahlenberg & Dolansky, 1972). Models for the interaction of p-D- 
glucopyranose with GLUT2 and GLUT3 are presented in Figure 4.2 and 4.3, 
respectively. These are based on the data obtained in this chapter and the
181
model of the GLUT1/D-glucose complex proposed by Barnett et al. (Figure 4.1) 
is included for comparison. For both GLUT2 and GLUT3, some degree of 
hydrogen bonding between the C-l, C-3 and C-4 positions is indicated by the 
results presented above. One significant difference between the action of the 
transporters involves the direction of the hydrogen bond at the C-3 position 
of GLUT2 compared to GLUTs 1, 3, or 4 (see above; Barnett et al, 1973; Rees & 
Holman, 1981). Another notable difference between transporter isoforms is 
hydrogen bonding at the C-4 position. This position plays a relatively minor 
role in sugar binding by GLUT3, consistent with the ability of this transporter 
to transport D-galactose, the C-4 epim er of D-glucose, w ith relatively high 
affinity.
The ability of 6-deoxy-D-glucose to inhibit 2-deoxy-D-glucose uptake by 
both GLUT2 and GLUT3 suggests that hydrogen bonding is not im portant at 
the C-6 position of either isoform. H ydrophobic interactions have been 
established using a series of C-6 D-galactose analogues. Since D-fucose is as 
effective as D-galactose in inhib iting  glucose transport, hydrophobic 
interactions at this position seem to be more im portant than hydrogen bonds. 
Similar results have also been obtained for GLUTs 1 and 4 (Barnett et al, 1973; 
Rees & Holman, 1981).
A proposed model for the interaction of p-D-fructose and the exofacial 
binding site of GLUT2 is shown in Figure 4.4. This is based on the model for 
D-glucose binding to GLUT2 and results obtained with D-fructose analogues 
(section 3.3.2). These suggest that D-fructose binds and is transported by 
GLUT2 in the furanose ring form. Hydrogen bonding at the C-3 and C-4 
positions are probably important, but not at C-2. Com pared to the binding of 
D-glucose, the most significant difference is likely to be the absence of a 
hydrogen bond between the transporter and the C-l position of D-glucose.
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This model is reasonably speculative and m ore fructose-analogue studies 
need to be carried out to investigate whether this model is correct.
4.5 Sum m ary.
The patterns of hydrogen bonding of p-D-glucose to GLUT2 and GLUT3 
(Carol Colville) have been investigated. The results indicate that hydrogen 
bonding at the C -l, C-3 and C-4 positions occur during glucose binding and 
transport, and that hydrophobic interactions betw een the C-6 position of the 
sugar and each transporter also occur. Slight differences in the pattern of 
binding were found between isoforms, as was predicted by the individual 
specific range of substrates transported by each isoform.
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CHAPTER 5
Analysis of the Role of Putative 
Transmembrane Helix 8 in GLUT3, the Brain-
Type Transporter.
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5.1 Aims.
1. To use Site-directed mutagenesis and Recombinant Polymerase Chain 
Reaction (PCR) technology to construct a series of nineteen m utant GLUT3 
cDNAs. These will contain single codon changes such that each cDNA will 
encode a p ro te in  w ith a particu lar am ino acid, located in pu tative  
transmembrane helix 8, altered to alanine.
2. These transporter cDNAs will then be used as a tem plate for in vitro 
synthesis of mRNA which will be injected into Xenopus oocytes.
3. By investigating the transport kinetics of each m utant in relation to 
kinetics of w ild-type GLUT3, it should be possible to determ ine whether or 
not each amino acid residue is directly involved in sugar uptake.
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5.2 Introduction.
5.2.1 Structure-Function Analyses of GLUT1 using M utagenic Techniques.
Specific substitution of individual amino acids in protein sequences 
has recently em erged as a powerful tool for the investigation of reaction 
mechanisms. The availability of the cloned cDNAs for each of the sugar 
transporters and powerful expression systems (such as Xenopus oocytes), 
allow the expression of heterologous transporter proteins, prov id ing  an 
excellent basis for the investigation of transporter structure and function by 
the mutagenesis of specific amino acid residues. Residues of interest can be 
changed to determ ine w hether they are functionally im portant, a loss of 
transport activity or a perturbation of certain ligand binding indicating that 
they are somehow involved in the transport process. Obviously, residues are 
not chosen random ly for mutagenesis. Those which are invariant, i.e. they 
occur at the same position in all transporter isoform s, or at least highly 
conserved are good candidates (for example see Figure 5.1.a). The bulk of 
mutagenic studies of this nature have been carried out on GLUT1.
5.2.1.1 Substitution of Conserved Polar Residues.
Conserved polar residues in the transm em brane helices are prim e 
targets for substitution since they are most likely to interact w ith glucose, 
especially if they are capable of forming hydrogen bonds. Hydropathy analysis 
of the sequence of GLUT1 (Mueckler et al., 1985) predicts that putative 
transmembrane helices 3, 5, 7, 8, and 11 are moderately am phipathic and have 
been proposed to bundle together forming a protein pore, enabling glucose 
traverse the membrane through a polar environment. These helices contain
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several conserved serine, threonine, asparagine, glutam ine, and tyrosine 
residues which have polar side chains capable of hydrogen bonding with D- 
glucose.
The bis-mannose derivative, ATB-BMPA, which has been shown to 
interact specifically with the transporter exofacial binding site (section 1.7.2), 
has been shown to bind in the proximity of putative transmembrane helices 7 
and 8 (Davies et al., 1991). In addition, helices 7 and 8 contain many 
conserved po lar residues, for exam ple helix 7 contains the m otif, 
QQXSGXNXXXYY.
Three of these residues in GLUT1 w ere substitu ted  in one study: 
asparagine-288 (Asn288) and glutamine-282 (Gin282), in transm em brane helix 
7, w ere replaced by isoleucine (lie) and  leucine (Leu), respectively 
(Hashiramoto et al., 1992). In transmembrane helix 8, asparagine-317 (Asn317) 
was replaced by isoleucine. It was discovered that the Asn288 -> lie and Gin282 
-> Leu mutants exhibited 2-deoxy-D-glucose uptakes reduced to about 50% of 
wild-type levels. Although all three clones were labelled by cytochalasin B at 
levels equivalent to wild-type GLUT1, only the two asparagine m utants were 
labelled with ATB-BMPA at levels comparable with wild-type. The Gin282 -> 
Leu m utant was labelled at only 5% of wild-type levels. Also the Kj value for 
4 ,6 -0 -ethylidene-D -glucose inhib ition  of 2-deoxy-D -glucose tran spo rt 
increased from about 12 mM for wild-type GLUT1 to 120 mM for this m utant 
alone. Both these findings pointed to the fact that glutamine-282, which is 
located in putative transmembrane helix 7, is located in the exofacial binding 
site. The lack of perturbation of cytochalasin B binding in relation to wild- 
type levels suggests that, as postulated, the exofacial and endofacial glucose 
binding sites are structurally distinct (see chapter 1).
A sim ilar approach was adopted  to investigate the properties of 
conserved GLUT1 residues A sn100, G ln l61, G in200, Tyr292, and Tyr293
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(M ueckler et al., 1994a) which w ere sequentially  rep laced  by various 
hydrophobic or polar residues. 2-deoxy-D-glucose transport was largely 
im paired  only w ith  the substitu tion  of G in161 , w hich is located in 
transm em brane helix 5. Replacem ent of this residue w ith  leucine or 
asparagine reduced 2-deoxy-D-glucose transport into Xenopus oocytes by 50- 
fold and 5-fold, respectively, when compared with wild-type GLUT1 transport 
levels. Further characterisation of the Gin161 -> Asn m utan t revealed that 
although no alteration of Km for zero-trans entry of 2-deoxy-D-glucose was 
detected, the turnover num ber was decreased by 7.5-fold and the Kj for 
binding the exofacial ligand 4,6-O-ethylidene-D-glucose was increased by 18- 
fold. The authors concluded from these data that Gin161 m ust comprise part 
of the exofacial binding site of GLUT1, since the affinity for 4,6-O-ethylidene- 
D-glucose is greatly reduced, but the rate-limiting conformational changes of 
sugar translocation m ust also be affected since the transport rate  is also 
markedly reduced.
GLUT4 residues Tyr28, Tyr148, Tyr292, Tyr293, Tyr308, and Tyr432 have all 
individually been substituted with phenylalanine (Wandel et al, 1994). It was 
found that their subcellular d istribu tion  and  expression  levels w hen 
transiently expressed in COS-7 cells were comparable w ith w ild-type levels. 
[125I]IAPS-forskolin binding was not affected by each m utation. Glucose 
transport activity was reduced in the Tyr143 and Tyr293 m utants but not in any 
of the others. Cytochalasin B binding was reduced with the Tyr143, Tyr292 and 
T yr293 m utants. The authors concluded tha t Tyr143 and Tyr293 m ight be 
im portant for transporter function and tha t Tyr292 m ight be part of the 
cytochalasin B binding site.
Another residue which appears to be im portant is asparagine-415 in 
transmembrane helix 11 of GLUT1, as indicated by the m utation, Asn415 -> 
Asp (Ishihara et al., 1991), which severely im paired tran sp o rt activity.
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However, this loss of activity might be due to a perturbation of transporter 
tertiary structure caused by the in troduction of a positive charge into a 
m em brane-spanning helix.
5.2.1.2 Substitution of Conserved Tryptophan Residues.
Attention was again draw n to transm em brane helix 11 by a study 
investigating the effects of sequentially m utating all the tryptophan residues 
in GLUT1 to glycine or leucine (Garcia et al., 1992). The rationale for this 
approach was that a tryptophan residue has been implicated as being near the 
cytochalasin B binding site. Only the Trp388 -> Leu and Trp412 -> Leu mutants 
show ed any d isru p tio n  of tran sp o rt activ ity  in X e n o p u s  oocytes. 
Immunolabelling w ith confocal microscopy showed that the targeting of the 
Trp388 -> Leu m utant to the plasma m em brane was impaired, accounting for 
most of the reduction of transport associated w ith  this m utant. W estern 
blotting of plasm a m em branes show ed that the Trp412 -> Leu m utant, 
however, was expressed at the same quantities as wild-type transporter levels, 
and therefore loss of 2-deoxy-D-glucose transport was attributed to a loss of 
intrinsic activity. A dose response of the ability of cytochalasin B to inhibit 2- 
deoxy-D-glucose transport by the Trp388 -> Leu m utant showed a decrease in 
affinity of that m utant for cytochalasin B relative to w ild-type levels. The 
authors concluded that Trp412, which is located in transm em brane helix 11, 
might comprise part of the aqueous channel utilised for the passage of D- 
glucose, and that Trp388, in helix 10, m ust comprise part of, or lie near to, the 
endofacial glucose binding site.
Parallel studies were carried ou t investigating the T rp412 -> Leu 
(Katagiri et al, 1991) and Trp388 -> Leu (Katagiri et al, 1993) mutations. These 
workers observed that the 2-deoxy-D-glucose transport was reduced to 15-30%
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of w ild-type levels w ith the Trp412 m utant, displaying a 2.5-fold increase in 
Km and a 3-fold decrease in turnover number. ATB-BMPA binding of this 
m utant was identical wiibwild-type GLUT1, but cytochalasin B labelling was 
40% lower, contrasting to the results of Garcia et al.. Since Trp388 had been 
proposed to be involved in forskolin binding (Wadzinski et al., 1990), Katagiri 
et a l  tested this hypothesis by attem pting to photoaffinity-label this m utant 
w ith [125I]IAPS-forskolin. It was discovered that this residue w as not 
photolabelled, but 3-O-methyl-D-glucose zero-trans entry was im paired, with 
an increase in Km and decrease in turnover num ber relative to wild-type. In 
contrast, zero -trans exit was not altered. These authors concluded that this 
residue is not the site of forskolin binding, but subsequent cytochalasin B 
labelling experiments showed that labelling was reduced relative to wild-type 
GLUT1 (Inukai et al, 1994). However, contrary to the result of Garcia et al., no 
decrease in targeting to the plasma membrane was observed with the Trp388 
mutant. This work was followed by a study in which both Trp412 and Trp388 
were altered to leucine in the same GLUT1 protein (Inukai et a l,  1994). 
Glucose transport was reduced to similar levels as found with the Trp412 
m utant. Cytochalasin B labelling of the Trp412T rp388 m utant was abolished 
and cytochalasin B binding reduced to 30% of wild-type levels. These authors 
concluded that cytochalasin B binds to GLUT1 in the helix 10-11 region and 
can covalently bind to the transporter by photolabelling at either residue 
Trp412 or Trp388.
Similarly, the m utation of Trp410 of GLUT3 has been reported (Burant 
& Bell, 1992). This m utation led to a large loss of 2-deoxy-D-glucose transport 
activity relative to w ild-type GLUT3 w hen expressed heterologously in 
Xenopus oocytes.
190
5.2.1.3 Substitution of Conserved Proline Residues.
Diverse studies investigating both the protection of GLUT1 from 
proteases by ligand binding, and the quenching of tryptophan fluorescence by 
D-glucose transport and specific ligands by GLUT1, have suggested that the 
conformational change associated w ith sugar transport is sufficiently large 
that it cannot be accounted for by localised m ovem ent of am ino acid side- 
chains alone (reviewed in Gould & Holman, 1993). Molecular modelling and 
m olecular dynam ics techniques suggest that transm em brane helix 10 of 
GLUT1 may undergo large conformational changes which could account for 
the ability of the transporter to assum e tw o d istinct glucose-binding 
conformations (Gould and Holman, 1993). The same m odelling predicts that 
P ro383, Pro385 and Pro387 would probably act as the pivot necessary for this 
conform ational change. The putative transm em brane dom ains of several 
m em brane transporters are repo rted  to contain  a larger num ber of 
m em brane-buried proline residues than other integral m em brane proteins 
which do not function as transporters (Brandi & Deber, 1986) and the cis-trans 
isomerism of these prolines could provide the transporter w ith sufficient 
flexibility to undergo conformational change.
P ro 385 has been substituted w ith isoleucine, alanine, glutam ine or 
glycine (Tamori et al., 1994; Wellner et al, 1994b). Tamori et al. found that 
transport activity was m arkedly reduced by substitution w ith isoleucine but 
unaffected by substitution by glycine. In addition ATB-BMPA labelling was 
abolished in the Pro385-> lie m utan t relative to w ild-type GLUT1, but 
cytochalasin B labelling was una ltered , suggesting  th a t this m utan t 
transporter is locked into an inward-facing conformation.
Substitution of Pro385, Pro383 and Pro387 with alanine had no effect on 
transport activity, but substitution of any of these residues w ith glutamine
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almost abolished transport activity (Wellner et al., 1994b). It therefore appears 
that the substitution of one of these proline residues w ith an amino acid 
possessing a large side-chain hinders transport and presum ably transporter 
conformational changes, but substitution of a single proline with an amino 
acid possessing a small side-chain does not affect transport. Tamori et al. 
suggested that the substitution of Pro385 with glycine did not affect transporter 
operation since glycine's side chain is small enough not to hinder mobility of 
the adjacent Pro383 and Pro387 residues, unlike that of isoleucine. Presumably 
the effects of substitution of either of Pro383 and Pro387 with alanine (Wellner 
et al., 1994b) did not affect the mobility of the remaining two prolines.
Three proline residues in GLUT1 helix 6 are conserved in the other 
transporter isoforms, with the exception of GLUT2. The effects of substituting 
GLUT1 residues P ro 187, P ro196 and Pro205 w ith either alanine or the 
equivalent GLUT2 residue, histidine, arginine or phenylalanine, respectively, 
have also been investigated (Wellner et al., 1994b). N one of these m utants 
displayed any differences in transport activity with respect to wild-type levels 
except the Pro196-> Arg m utant, which caused a decrease in transport activity. 
This might be due to the insertion of a polar amino acid into a non-polar 
environment, but this residue occurs naturally in GLUT2. It is possible that 
the presence of the arginine residue in GLUT2 might contribute to its lower 
affinity for transported substrates by destabilising the protein, though this is 
unlikely.
5.2.1.4 Substitution of GLUT1 Cysteine Residues.
Cysteine residues have been postu lated  to be involved in protein 
conformational stability (reviewed by Walmsley, 1988; Carruthers, 1990) and 
also might have a role in oligomerisation of glucose transporters (Herbert &
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C arruthers, 1992). W ellner et al. instituted the following changes by site- 
directed mutagenesis into six different GLUT1 proteins: Cys133 -> Ser, Cys20* -> 
Gly, Cys207 -> Ser, Cys347 -> Ser, Cys421 -> Arg, and Cys429 -> Ser (Wellner et al., 
1994a). N one of these m utants exhibited any perturbation  of transport 
activity. Binding of the thiol-group-reactive reagent p -ch lo ro m erc u ri-  
benzenesulphonate (pCMBS) to either the endofacial or exofacial surface of 
plasm a membranes containing these m utants showed that only Cys429, in the 
sixth external loop, and Cys207, in the large intracellular loop, are the residues 
w hich are involved in the inhibition of transport by various thiol-group- 
reactive agents.
5.2.1.5 Substitution of Residues Predicted to Lie in Extramembranous Loops.
Not all studies are restricted to the transmembrane helices. It has been 
dem onstrated that the substitution of Asn45 by Asp, Trp or Gin abolished N- 
linked glycosylation of GLUT1 (Asano et al., 1991), and that this led to a 2-fold 
loss of affinity for D-glucose. Therefore, this raises the possibility that the 
glycosylation state of the transporter affects its ability to transport glucose. 
Thus, in systems such as Xenopus oocytes where the glycosylation pattern of 
heterologously expressed transporters has been shown to be different from 
that found in native cells, the kinetic parameters of transport may be affected.
The C-terminal cytoplasmic dom ain has also been implicated in sugar 
transport. In an im portant study, Oka et al. showed that the deletion of the C- 
term inal 37 amino-acids of GLUT1 resulted in a transporter which lost all 
tran spo rt activity and  appeared  to be locked into an inw ard-facing 
conformation, since ATB-BMPA binding was abolished bu t cytochalasin B 
was still able to bind (Oka et al, 1990). Removal of only the last 12 amino 
acids had no effect on GLUT1 activity (Lin et al, 1992), so one region of the
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GLUT1 sequence responsible for proper activity m ust lie between residues 460 
and 480. Since the C-terminal domain is very variable in length and sequence 
betw een transporter isoforms, Katagiri et al. decided to test w hether this 
region accounts for the difference in transporter kinetics betw een GLUTs 1 
and 2 (Katagiri et al., 1992). GLUT2 had previously been shown to have much 
higher Km and Vmax values than other isoforms (Craik & Elliot, 1979; Johnson 
et al, 1990; Bell et al, 1990), and bind cytochalasin B with a Kd in the order of 
10-fold higher than GLUT1 (Axelrod & Pilch, 1983). Katagiri et al. expressed a 
GLUT1 clone in Chinese ham ster ovary cells w hich had  its C-term inal 
dom ain replaced w ith that of GLUT2. This chim era d isplayed 3.8-fold 
increase of Km and a 4.3-fold increase in Vmax values for 2-deoxy-D-glucose 
uptake com pared to w ild-type GLUT1. H ow ever, the Kd value for 
cytochalasin B binding was unchanged relative to GLUT1. This suggests that 
the C-terminal dom ain m ight at least partially confer some of the kinetic 
properties specific to each isoform , although how  this is achieved is 
unknow n.
5.2.1.6 Naturally-Occurring M utations.
Two polym orphism s in the GLUT2 gene that result in am ino acid 
changes have recently been described (Tanizawa et al., 1994). One of these, 
T h r ll°  -> lie, has been found at equal frequencies in patients with non­
insulin-dependent diabetes (NIDDM) and control subjects. In all other 
members of the facilitative glucose transporter family, residue-110 is normally 
isoleucine. The other polym orphism , V all97-> lie, was discovered in one 
female patient with gestational diabetes, who recovered after pregnancy. Both 
these m utations were individually created in plasm id encoded GLUT2, and 
expressed in Xenopus oocytes (Mueckler et a l ,  1994b). The ThrH ° -> He
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m utant had identical 2-deoxy-D-glucose transport activity to wild-type GLUT2, 
but the Val197-> lie m utation  com pletely abolished 2-deoxy-D -glucose 
transport. This is su rp rising  given the conservative n a tu re  of the 
substitution, but the increased size of the isoleucine side chain relative to the 
wild-type residue may block the transport of glucose. Interestingly, in GLUT1, 
V a l165 was also altered to isoleucine, again resulting  in a large loss of 
transport activity. This residue is predicted to lie one helical turn  from the 
conserved residue G lnl6l which is also im portant in transport (Mueckler et 
a l , 1994a).
5.2.1.7 M utations Induced in the Yeast SNF3 Transporter.
The yeast glucose transporter, SNF3, which is structurally related to the 
mammalian glucose transporter family, has also been m utated  (Marshall- 
Carlson et al., 1990). M utations included substitutions of two conserved 
glycine residues located in transmembrane helices 1 and 2, which correspond 
to Gly27 and Gly75 of GLUT1, with Asp and Arg, respectively. The effect of 
each mutation resulted in a transporter which was not targeted to the plasma 
membrane. This is either due to the im portance of the glycine residues, or 
the effects of inserting a polar or charged amino acid into a hydrophobic 
environment, or both. Replacement of the non-conserved helix 8 residue, 
Val402, with lie caused a large decrease in the protein's transport ability. This 
is somewhat surprising, considering both the lack of conservation of this 
residue betw een different transporters and the conservative nature of the 
substitution. It also contrasts strongly with the substitution of GLUT1 helix 8 
residue Asn317, which has no observed effects (Hashiramoto et al, 1992).
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5.2.2 Transmembrane Helix 8.
Although hydropathy analysis predicts twelve transm em brane helices 
in GLUT1 and the other members of the glucose transporter family, only five 
are predicted to be amphipathic. These are helices 3, 5, 7, 8 and 11. Helices 7 
and 11 have been implicated in sugar binding and translocation by ligand 
binding and mutagenesis studies with GLUT1 (see above). These two helices 
are proposed to lie in close proximity in transporter tertiary structure, perhaps 
forming a sugar binding cleft. Helix 8 obviously lies next to the supposedly 
im portant helix 7 in transporter tertiary structure due to the short length of 
the stretch of connecting residues. Helices 7 and 8 have been proposed to be 
the photolabelling site of the exofacial-specific ligand ATB-BMPA (Gould & 
Holman, 1993). Helix 8 also contains several residues conserved throughout 
the glucose transporter family, including one tyrosine, one asparagine and 
two threonines (Figure 5.1.a), of which Thr308, Asn315 and Thr319 (GLUT3 
residue num bers) are predicted to lie on the polar face of the putative 
transmembrane helix (Figure 5.1.b).
To investigate the im portance of these residues, an approach was 
utilised that was identical to that used to investigate various residues in 
GLUT1, namely site-directed mutagenesis. Each residue in putative helix 8 of 
GLUT3 was sequentially altered to alanine.
GLUT3 was chosen in preference to GLUT1 simply due to the relative 
lack of investigation of this isoform. GLUT3 also has distinct advantages over 
GLUT2 as a tem plate for amino acid substitution. Firstly, any alteration of 
transport kinetics induced by mutagenesis would be more m easurable in the 
case of GLUT3, since it displays a relatively low Km value for zero -trans 2- 
deoxy-D-glucose entry into Xenopus oocytes com pared to that of GLUT2. 
Secondly, the inhibitory effects cytochalasin B on 2-deoxy-D-glucose transport
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by GLUT3 have been demonstrated to be greater than by GLUT2, suggesting 
tighter binding to GLUT3. Again, any perturbation of cytochalasin B binding, 
induced by m utagenesis, should be m ore easily m easurable in the case of 
GLUT3. A third concern is that, to date, successful photolabelling of GLUT2 
by cytochalasin B has not been reported, except under vastly  m odified 
conditions (Axelrod & Pilch, 1983). Im m unoprecipitation of GLUT2 is also 
problem atical (Jordan & Holm an, 1992; and  Gw yn G ould, personal 
communication). In order to calculate the quantity of m utant or wild-type 
transporters expressed in oocyte plasma m em brane fractions by comparative 
im m unoblotting procedures, a standard sam ple of protein w ith a known 
concentration of transporter is required. The concentration of transporter in 
this sample also requires to be quantified. This would typically be attained by 
perform ing an equilibrium  binding study w ith [3H]cytochalasin B, in the 
presence of various concentrations of non-labelled cytochalasin B, with D- 
glucose present or absent. The num ber of available D-glucose-sensitive 
cytochalasin B b ind ing  sites, w hich is equ ivalen t to the num ber of 
transporters, w ould then be calculated by Scatchard analysis. This can be 
performed successfully with GLUT3, but not GLUT2 since the of GLUT2 
for cytochalasin B is so high (1.7 pM- A xelrod & Pilch, 1983) that 
concentrations required for equilibrium binding studies exceed the solubility 
limit of cytochalasin B in aqueous solution (about 50 pM).
5.3 Mutagenesis, Subcloning and Sequencing of cDNA.
Two very different m ethods have been used for the production of 
mutant GLUT3 cDNAs, each differing from wild-type GLUT3 sequence by 1-3
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base pairs, encoding a single am ino acid change from a particu lar 
transmembrane helix 8 residue to alanine.
One m ethod was site-directed m utagenesis, using Am ersham 's "RPN 
1526 Oligonucleotide Directed Mutagenesis kit".
The second m ethod used was the recom binant polym erase chain
reaction (PCR) technique, using sets of prim ers incorporating the m utations
)
to be introduced into the GLUT3 cDNA.
5.3.1 Vectors.
There are several vectors incorporating  cDNAs, each encoding 
individual m em bers of the hum an facilitative transporter family (GLUT) 
available in the laboratory. These have been described in section 2.5.1. These 
cDNAs are linearised by restriction digestion (section 2.5.2) and used as 
templates for the synthesis of transporter mRNAs to be injected into Xenopus 
laevis oocytes. In this chapter, only mutagenic techniques carried out using 
GLUT3 cDNA as a template will be discussed.
Two constructs have been used - M13mpl8GT3 and pSPGT3, which are 
constructs with GLUT3 cDNA cloned into the m ultiple cloning sites of 
M13mpl8 and pSP64T (described by Kayano et al., 1990), respectively. These 
are shown in diagrammatic format in Figures 2.2 and 2.3. In pSPGT3, the 
GLUT3 cDNA is under the transcriptional control of the pow erful SP6 
promoter. SP6 RNA polymerase is commercially available.
5.3.2 Site-directed Mutagenesis.
The method used for site-directed mutagenesis utilised the Amersham 
"Sculptor in vitro m utagenesis system- RPN 1526" kit. The basis of this
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m ethod is show n in Figure 5.2 (see also section 2.6 for m ethodology). 
M13mpl8GT3 single-stranded DNA (ssDNA) was used as a tem plate for 
mutagenesis. A series of oligonucleotides with sequences complementary to 
part of the GLUT3 putative helix 8 sequence were constructed (Dr. V. Math- 
Dept. of Biochemistry, University of Glasgow), except having bases altered to 
encode alanine instead of the native residue (Table 5.1). These oligo­
nucleotides were 5'-phosphorylated using polynucleotide kinase and then 
annealed to the ssDNA M13mpl8GT3 tem plate and used as prim ers for the 
production of second cDNA strands using T7 DNA polym erase, T4 DNA 
ligase and dNTPs. One of the nucleotides used in this extension was dC T Pa- 
S, which contains a sulphur atom in place of an oxygen at the a -p h o s p h a te  
group. W hen incorporated into a DNA strand  this nucleotide conveys 
resistance to restriction digestion as the phosphate  backbone cannot be 
hydrolysed. Hence, what was produced was replicating form DNA (rfDNA) 
with one wild-type strand and one m utated strand incorporating dCTPa-S. T5 
exonuclease was used to remove rem aining ssDNA. Digestion of the rfDNA 
with Nci I produced a single "nick" in the wild-type strand only. Exonuclease 
III was then used to digest the vulnerable wild-type strand until it was judged 
that only a small fragment remained to act as a prim er for re-extension. This 
was performed using DNA polymerase I, T4 DNA ligase and dNTPs.
This DNA was then transform ed into XLl-blue MRF’ E. coli (section 
2.5.8), plaques isolated and propagated to produce small amounts of ssDNA 
(section 2.5.13). Single-stranded DNA was chosen for the purpose of screening 
mutants, by autom ated sequencing, although double-stranded DNA is also a 
perfectly good tem plate for this m ethod (section 2.8). An oligonucleotide 
complementary to sequence at the 3' side of the intended m utation was used 
as a sequencing prim er (G3 2B+, Table 5.2 and Figure 5.8). Positive clones
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were further propagated (section 2.5.11) and larger quantities of double­
stranded DNA produced (section 2.5.12.a).
Positive clones were then restricted with BstX l/Apa  I or BstX 1/EcoR V 
(section 2.5.4) to produce fragm ents which contained the m utan t GLUT3 
sequence which were then ligated (section 2.5.6) into similarly restricted and 
alkaline phosphatase-treated (section 2.5.5) pSPGT3 vector w ith the wild type 
sequence fragment removed. This was necessary since M13mpl8GT3 has no 
prom oter for the production  of mRNA. The ligation m ix w as again 
transformed into XLl-blue E. coli (section 2.5.9), colonies were selected for by 
virtue of am picillin resistance, isolated and sm all am ounts of dsDNA 
produced (section 2.5.10). Colonies were then screened by sequencing this 
cDNA using the same oligonucleotide prim er as previously used (G3 2B+, 
Table 5.2 and Figure 5.8). The insert region of positive clones was completely 
sequenced (section 2.8; Table 5.2; Figure 5.8). If no m isincorporations were 
found, the clones were propagated to produce large am ounts of dsDNA 
(section 2.5.12.b) and portions linearised with Xba I (section 2.5.2) to be used as 
a template for the synthesis of mRNA (section 2.2).
5.3.2.1 Results.
Eight of the nineteen m utant cDNAs were obtained by this method. 
Although the cDNA sequence of each subclone isolated by this m ethod was 
error-free, the ratio of m utan t/w ild -type  M 13mpl8GT3-containing plaques 
was extremely low. Theoretically, no w ild-type cDNA should remain after 
the digestion of single-stranded cDNA by T5 exonuclease, bu t this was never 
the case in practice. Even trea tm ent of the reaction w ith  h igher 
concentrations of T5 exonuclease for extended periods did not increase the 
ratio of m utants to w ild-type colonies. Similarly, alteration of any of the
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other reaction steps did  not increase the yield  of m u tan t colonies. 
Additionally, it was necessary to screen plaques/colonies twice- initially in 
M13mpl8GT3, and then after subcloning into pSPGT3. This second screening 
step was necessary due to inevitable incomplete digestion of pSPGT3 vector 
prior to ligation which seemed to be due to a low efficiency of the EcoR V and 
Apa I enzymes. Since the size of the fragment being excised is small relative 
to the size of the vector, single-cut and double-cut cDNA migrate practically 
identically on agarose gel electrophoresis. This makes contam ination of 
double-cut cDNA with single-cut cDNA unavoidable. Since self-ligation of 
single-cut vector is much more efficient than ligation of vector and insert, 
this also reduces the ratio of m utant colonies to w ild-type colonies on this 
second screen. The problem of vector self-ligation was reduced by alkaline 
phosphatase treatm ent of the vector (see section 2.5.5), but even this process 
was never 100% efficient. The final ratio of m u tan t/w ild -ty p e  GLUT3 
colonies in this second screen, using these methods, averaged at 1:3.
5.3.3. Recombinant Polymerase Chain Reaction.
This a modification of the m ethod described by Katagiri et al. (Katagiri 
et al., 1992). This approach was used as an attem pt to address the inefficiency 
problem s encountered w ith the previous m ethod. O ligonucleotides (20- 
24'mers) were constructed with sequences corresponding to positive strand 
GLUT3 cDNA sequence of putative transmembrane helix 8 with base changes 
introduced to encode a protein with alanine substituted for a particular amino 
acid. These oligonucleotides w ere com plem entary in sequence to oligo­
nucleotides constructed for use with the site directed m utagenesis m ethod 
which correspond to GLUT3 negative strand sequence (Table 5.1). Two 
37'mer oligonucleotides were also constructed w ith sequences corresponding
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to untranslated regions of the GLUT3 cDNA at the 5' sides of the positive and 
negative strands, named G3-Start and G3-End, respectively (Table 5.1).
5.3.3.1 Primary Reactions.
See Figure 5.3.a. In initial polymerase chain reactions, G3-Start, which 
is com plem entary to the negative strand in the 3' un translated  region of 
GLUT3, and a m utagenic oligonucleotide com plem entary to the GLUT3 
positive strand in the region encoding putative transm em brane helix 8, were 
added to pSPGT3 plasmid dsDNA. Under certain conditions, (sections 2.7.1.b;
2.7.3.a) a PCR fragment "a" was produced (Figure 5.3.a)
Likewise, identical reactions were perform ed using G3-End, which 
binds the 3' untranslated region of the GLUT3 positive strand, a mutagenic 
oligonucleotide com plem entary to GLUT3 negative strand  in the region 
complementary to that encoding transm em brane helix 8, and pSPGT3. This 
led to the production of a PCR fragm ent "b" (Figure 5.3.a). M utagenic 
oligonucleotides used in parallel reactions were complementary to each other 
but differed from the wild-type GLUT3 sequence by 1-3 base pairs, encoding 
alanine (Table 5.1).
PCR reactions were separated by electrophoresis in agarose gels and the 
correct bands corresponding to the prim ary products identified by size and 
excised. The sizes of reaction products "a" and "b" were 900 and 700 base pairs 
long, respectively. These were purified (as described in sections 2.7.4, 2.7.5, 
and 2.7.6) and used as templates for secondary polymerase chain reactions.
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5.3.3.2 Secondary Reactions.
Purified  p rim ary  PCR p ro d u cts  "a" and  "b" from  reactions 
incorporating identical m utations w ere included as tem plate cDNA for 
secondary PCR reactions (sections 2.7.2 and 2.7.3.b). The sequences of the 
prim ary products were such that the final 20-24 bp of the product "a" were 
repeated as the initial bases of product "b". This sequence overlap is the basis 
of the secondary PCR reaction. As can be seen in Figure 5.3.b, m elting of the 
cDNA double helix and subsequent cooling allows the 3* end of the "a" 
positive strand to bind to the 3' end of the "b" strand. Each strand acts as a 
prim er for extension of the opposite strand w ith Taq or Pfu polym erase, 
resulting in a full length GLUT3 m utant cDNA. This acts as a tem plate for 
further PCR extension using G3-Start and G3-End primers.
This final linear cDNA product (Figure 5.4) m ust be cloned into an 
expression vector to enable production of mRNA. As with the site-directed 
mutagenesis procedure, the enzymes chosen were BstX I and EcoR V. pSPGT3 
vector was also restricted with these enzymes and the fragments ligated and 
transformed into XLl-Blue E. coli (Figure 5.5). Colonies were screened for 
mutant cDNAs by sequencing as described above (G3 2B+; Table 5.2, Figure 5.8 
and section 2.8).
5.3.3.3 Results using Taq DNA Polymerase.
The majority of the point m utants (ten) w ere created by this m ethod 
using Taq DNA polymerase. After cloning into pSPGT3, the frequency of 
m u:ant co lo n ies /w ild -ty p e  colonies averaged  abou t 1:3 b u t varied  
dramatically between different mutants, being as high as 5:1 and as low as 1:40.
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H ow ever, although m any m utan t colonies w ere isolated by this 
m ethod, complete sequencing of each cDNA between the BstX I and EcoR V 
restriction sites (section 2.8) revealed that the error rate of Taq polymerase was 
such that two base pairs in every thousand, on average, were misincorporated 
into the final product. Hence, the amino acid sequence was frequently altered 
by these random  changes. This is due to the absence of a 3' to 5' proof-reading 
exonuclease element within Taq. Thus, it was frequently necessary to excise 
these erroneous m utations by restriction digestion of the cDNA, if possible. 
This involved searching the cDNA sequence of pSPGT3 for unique restriction 
sites to excise either the erroneous m isincorporations from  the m utant 
cDNA, or excise the intended m utation out of this cDNA and insert this 
fragm ent into a sim ilarly cut pSPGT3 vector w hich w as free of the 
misincorporation (see Figures 5.6 and 5.7). This technique was only possible 
w here the m isincorporations were few or clustered together in a position 
reasonably far from the helix 8 m utation such that a suitable restriction site 
was present in the intervening sequence.
5.3.3.4 Further Subcloning.
Only cDNAs which possessed m isincorporations to the 3' of the Stu I 
site at position 1265 or to the 5' side of the Sac I site at position 1029 were 
considered for restriction digestion (Figure 2.2). The former were digested 
with Stu I and Pvu I to produce a vector backbone and an insert of 2596 base 
pairs containing the desired alanine m utation (Figure 5.6) which was purified 
as described previously (sections 2.7.4-2.7.6). This was then ligated with 
sim ilarly d igested  w ild-type pSPGT3 vector backbone to p roduce a 
m is in c o rp o ra tio n -fre e  m u ta n t. L ikew ise , m u ta n ts  p o sse ss in g  
misincorporations to the 5' side of position 1029 were digested w ith Sac I,
204
which also cuts at position 2312. This generates an insert of 1283 base pairs 
containing the alanine mutation (Figure 5.7) which again can be ligated to the 
vector backbone of similarly digested wild-type pSPGT3. These ligations were 
once more transform ed into XLl-Blue E. coli and screened by autom ated 
sequencing (G3 2B+; Table 5.2, Figure 5.8 and section 2.8).
As is usual with cloning procedures, the efficiency of production of the 
desired product was never 100%. Colonies containing wild-type GLUT3 and 
GLUT3 with m isincorporations still present w ere produced in addition to 
those which contained the desired m utation alone. The overall efficiency of 
this process was typically about 30% although this varied from m utant to 
m utant.
5.3.3.S Results using Pfu DNA Polymerase.
Pfu DNA polym erase was used to attem pt to address the infidelity 
problems encountered with Taq polymerase. One m utant (the last one) was 
created using this enzyme. The procedure for use of Pfu polym erase was 
similar to that used with Taq polym erase bu t there w ere differences in 
protocols (sections 2.7.1-2.7.3). A major difference in the procedures was the 
step at which the enzym e was added to the reaction. Due to its low 
thermostability (relative to Taq), Pfu polym erase was added only after the 
initial 95°C melting step. This had been found to increase its activity. Since 
Pfu was less stable than Taq, the quantity of PCR product obtained was 
noticeably less when using the former enzym e rather than the latter. This 
was especially true of the yields of secondary PCR reactions, which tend to be 
poorer than those of prim ary PCR reactions in any case (Figure 5.4). In 
general, it proved difficult to produce sufficient secondary PCR product for 
cloning into pSPGT3, and this problem was elevated by the poor yields from
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reactions using Pfu . However, upon cloning, the ratio of m utants to wild- 
type colonies was 9:1. In addition, sequencing of the entire EcoR V /B s tX  I 
"insert" in four separate clones of the sam e point m utan t revealed no 
misincorporations. The fidelity of this enzyme is due to a 3' to 5' exonuclease 
proof-reading activity w hich is lacked by the m ore therm ostable Taq 
polymerase.
5.3.4 Sequencing of Subclones.
Automated DNA sequencing was carried out as described in section 2.8. 
This m ethod can be used to sequence up to 500 bp of single-stranded or 
double-stranded cDNA from the site of prim er binding, although only the 
first 300-350 bp is generally accurate. Therefore, although only a single 
oligonucleotide prim er was necessary for screening of m utants (G3 2B+; Table 
5.2 and Figure 5.8), the length of the cloned m utant EcoR V /B s tX  I or Apa 
1/BstX I insert (871 bp and 678 bp, respectively) in pSPGT3 required several 
oligonucleotide prim ers for complete sequencing (Table 5.2). Due to the 
nature of sequencing, such as band compressions on the gel due to GC-rich 
regions, sequencing one DNA strand alone often produces specific recurring 
errors in the sequence. This problem  can be averted by indiv idually  
sequencing both strands and comparing sequences. The annealing sites of the 
primers used are such that the sequence obtained from use of one primer 
overlaps that of another, which allows further com parison of sequences 
(Figure 5.8). Sequence alignments and comparisons were analysed using the 
Biosoft Genejockey II softw are package on an A pple M acintosh LCIII 
computer.
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5.4 Transport of 2-Deoxy-D-glucose by GLUT3 M utants into Xenopus
Oocytes.
After isolating and checking each m utant (section 5.3), these cDNAs 
were linearised with Xba I (section 2.5.2) and an in vitro synthesis of mRNA 
was carried out (section 2.2). In addition, w ild-type GLUT3 mRNA was also 
synthesised. The concentrations of mRNA were assessed by comparison on a 
1% agarose gel and each adjusted to ~1 m g / ml (section 2.5.3 and Figure 2.1). 
50 nl of each mRNA was then injected into Xenopus oocytes (section 2.3.4), 
incubated in Barths buffer (Table 2.1) for 48 hours, and oocytes were assayed 
for transport of [3H]2-deoxy-D-glucose (0.1 mM, 2 pC i/m l) for a period of 30 
min (section 2.4).
Since the nineteen m utants were isolated over a period of time, only 
four or five m utant mRNAs were individually injected into oocytes isolated 
from a single toad. Groups of seven oocytes were assayed for 2-deoxy-D- 
glucose transport. In each case, oocytes were also assayed which had been 
injected w ith an identical quantity  of w ild-type GLUT3 mRNA or not 
injected. Non-injected oocytes were used to m easure non-specific transport 
and that of the native oocyte transporter(s) (section 2.4). W ild-type GLUT3- 
injected oocytes provided some means with which to compare the transport 
associated with mutant-injected oocytes. The results can be seen in Figure 5.9. 
Since not all GLUT3 m utant mRNAs w ere assayed in a single oocyte 
preparation and concentrations of m utant and w ild-type GLUT3 protein in 
oocyte plasma mem branes were not m easured, transport levels cannot be 
directly compared. Therefore the level of 2-deoxy-D-glucose transport by each 
mutant is expressed as a percentage of transport by wild-type GLUT3, after the 
subtraction of transport values for non-injected oocytes. Typical rates of wild- 
type GLUT3 2-deoxy-D-glucose transport were 4.5-5.0 pm oles/m in/oocyte.
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Rates of 2-deoxy-D-glucose transport by non-injected oocytes averaged 0.7 
pm oles/m in/oocyte. Transport rates by m utants were in the range of 2-9 
pmoles /  min /  oocyte.
It must be stressed that since the protein levels of each transporter in 
oocyte plasm a m em branes and kinetic param eters, such as Km and Vmax 
values for 2-deoxy-D-glucose entry and exit, have not yet been m easured, no 
conclusions regarding the binding affinities or intrinsic activities possessed by 
these m utant proteins can be derived. Analysis of these properties m ust await 
a more exhaustive study. However, since oocytes expressing each m utant 
transported 2-deoxy-D-glucose at least twice as well as non-injected oocytes, it 
can be concluded that each m utan t tran spo rte r has been successfully 
expressed, although no inform ation on the relative targeting  of these 
transporters can be derived from this preliminary transport data.
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Table 5.1
This lists the oligonucleotides used in the site-directed mutagenesis 
and PCR protocols. The sequences are shown reading from the 5' end to the 
3' end. The codon which encodes the substitu ting alanine residue is 
underlined. Each sense-strand oligonucleotide is exactly complementary to 
one antisense oligonucleotide, and these are used individually to generate 
primary PCR products which are combined as templates for a secondary PCR 
reaction.
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Table 5.1-
Mutagenesis Oligonucleotides.
Oligonucleotide
1453c (antisense strand)
1454 (antisense strand)
1455 (antisense strand)
1456 (antisense strand)
1457 (antisense strand)
1460 (antisense strand)
1461 (antisense strand)
1462 (antisense strand)
1463 (antisense strand)
1466 (antisense strand)
1467 (antisense strand)
Sequence Mutation
GGTGGCATATGCG
GGCTCTTG
GATGGTGGCGGCG
ATGGGCTC
CGCGCCGATTGCG
GCATAGAT
CGCGCCTGCGGTG
GCATA
GATAGTATTTGCC
ACACCCGC
AAGATAGTTGCA
ACCACACC
GTGAAGATTGCAT
TAACCAC
TACAGTGAATGCA
GT ATT A AC
CCCTTTCCACTGCA
AATAGAGAAA
CCTTTCCACCAGTG
CT AGAGAAAC
AACTACAGTTGCG
ATAGTATT
Ile305->Ala
Tyr306_>Ala
Thr308->Ala
He309_>Ala
Val314->Ala
Asn3l5->Ala
Thr316->Ala
He317_>Ala
Leu325->Ala
Phe324->Ala
Phe318->Ala
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Table 5.1 (cont)
Oligonucleotide
1468 (antisense strand)
1470 (antisense strand)
1471 (antisense strand)
1473 (antisense strand)
1474 (antisense strand)
1476 (antisense strand)
1477 (antisense strand)
1478 (antisense strand)
1643 (sense strand)
1644 (sense strand)
1645 (sense strand)
Sequence
AGAAACTACTGCG
AAGATAGT
AAATAGAGATGC
TACAGTGAA
CAGAAATAGTGC
AACTACAGT
CACCAGAAATGCA
GAAACTAC
TAGAGAAACTGC
AGTGAA
CACACCCGCTGCG
ATGGTGGC
AGTATTAACTGCA
CCCGCGCC
ATTAACCACTGCC
GCGCCGAT
CAAGAGCCCGCAT
ATGCCACC
GAGCCCATCGCCG
CCACCATC
ATCTATGCCGCAA
TCGGCGCG
M utation/
Complementary
oligonucleotide
Thr319->Ala 
Val312->Ala
Ser322->Ala 
Leu323-> Ala 
Val320->Ala 
Gly3lO_>Ala 
Val313->Ala 
Gly312->Ala 
1453c
1454
1455
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lie 5.1 (cont.)
Sequence Complementary
oligonucleotide
'{onucleotide
IS (sense strand)
17 (sense strand)
ii (sense strand)
19 (sense strand)
50 (sense strand)
51 (sense strand)
52 (sense strand)
53 (sense strand)
3 End (antisense strand)
3 Start (sense strand)
GCGGGTGTGGCAA
ATACTATC
TTTCTCTATTTGCA
GTGGAAAGGG
GGTGTGGTTGCAA
CTATCTT
GTGGTTAATGCAA
TCTTCAC
AATACTATCGCAA
CTGTAGTT
GTTTCTCTAGCACT
GGTGGAAAGG
TTCACTGTAGCAT
CTCTATTT
GTAGTTTCTGCAT
TTCTGGTG
GTCGACGTCGACG
AGGGAGAGGTGGC
TTTCCCATGCC
GTCGACGTCGACT
CACCCCTAGATCT
TTCTTGAAGAC
1457
1460
1461 
1463 
1467 
1466 
1470 
1473
Binds GLUT3 sense 
strand at 3’ UTR.
Binds GLUT3 
antisense strand at 
3’ UTR.
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Table 5.2
This lists the oligonucleotides used as prim ers for autom ated DNA 
sequencing. The sequences are shown reading from the 5’ end to the 3' end. 
Oligonucleotides designated "T" bind to the antisense strand of GLUT3 and 
g en e ra te  sequences co rre sp o n d in g  to the  GLUT3 sense s tra n d . 
Oligonucleotides designated "B" bind to the sense strand of GLUT3 and 
generate sequences corresponding to the GLUT3 antisense strand.
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Table 5.2-
Sequencing Oligonucleotides.
G3 2T 
G3 3T 
G3 3T+
G3 4T 
G3 5T 
G3 1B 
G3 2B+
G3 3B+
G3 4B
ACTGGACCTCCAACT
TCGGCGCGGGTGTGG
ATCTATGCCACCATC
CCAGATTTTTGCTCA
GACTGTGTAAAGTAG
GGGAGAGGTGGCTTT
ACAGTCATGAGCGTG
GT AGCTGG AC ACTCT
TGAGCAAAAATCTGG
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Figure 5.1.a
This show an alignment of the protein sequences of hum an (h), mouse 
(m), rat (r) and rabbit (rb) facilitative glucose transporters in the region of 
pu tative transm em brane helix 8. Residues which are identical in all 
transporter isoforms are shown in bold type. A consensus sequence of GLUTs 
1- 4 is shown below. Residues which vary between isoforms are shown as 
"X", and those which are predicted to lie on the polar face of transmembrane 
helix 8 are marked with an asterisk (*) -see Figure 5.1.b.
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Figure 5.1.a-
Com parison of Amino Acid Sequences in Putative Transm em brane Helix 8 of 
the Facilitative Glucose Transporter Family.
hGLUTl V Y A T I G S G I V N T A F T V V s L F V
mGLUTl V Y A T I G S G I V N T A F T V V s L F V
rGLUTl V Y A T I G s G I V N T A F T V V s L F V
rbGLUTl V Y A T I G s G I V N T A F T V V s L F V
hGLUT2 V Y A T I G V G A V N M V F T A V s V F L
mGLUT2 V Y A T I G V G A I N M I L T A V s V L L
rGLUT2 V Y A T I G V G A I N M I F T A V s V L L
hGLUT3 I Y A T I G A G V V N T I F T V V s L F L
mGLUT3 I Y A T I G A G V V N T I F T V V s L F L
hGLUT4 A Y A T I G A G V V N T V F T L V s V L L
mGLUT4 A Y A T I G A G V V N T V F T L V s V L L
rGLUT4 AY A T I G A G V V N T V F T L V s V L L
hGLUT5 Q Y V T A G T G A V N V V M T F C A V F V
rGLUT7 A Y V T L G S G S V N F L T T V V s L I V
GLUT1- 4 X Y A T I  G X G  X X N  X X X  T X V S  X X X
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Figure 5.1.b
This show s the predicted secondary structure  of GLUT3 putative 
transmembrane helix 8. The a - helix is viewed from above. The amino acid 
sequence begins at lie305 at the "bottom" of the helix (numbered 1), and the 
positions of the following residues rotate upw ard in a clockwise direction 
until the last residue, Leu325 (numbered 21) is reached.
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Figure 5.1.b-
Predicted a -  Helical Structure of GLUT3 Transm embrane Helix 8.
■  M,I,L,V 
H1F,Y,W
■  G,A,P
■  D,E
■  N,Q
■  K,H,R 
H S ,T
m e
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Figure 5.2
This is a diagrammatic representation of the site-directed mutagenesis 
reaction (section 2.6). Note that the purpose of the T5 exonuclease step is the 
removal of rem aining single-stranded cDNA, which has not been represented 
in this diagram  for the sake of clarity.
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Figure 5.2-
Diagram showing Sculptor™ Site-Directed M utagenesis.
Recom binant
oligonucleotide
►
A nnealing
Extension w ith 
dCTP-ocS and 
ligation i
N d  I
T5 Exonuclease 
digestion
Nicking and 
Exonuclease III 
digetion
Repolym erisation
►
i
Transform ation
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Figure 5.3.a
This diagram  shows where the reaction primers bind to pSPGT3 (upper 
plasmid) and shows the sequence of events in both prim ary PCR reactions 
(section 2.7.1 or 2.7.3.a). In reaction 1, G3-Start and the m utagenic prim er, 
corresponding to the antisense cDNA strand in the helix 8-encoding region, 
bind to m elted GLUT3 antisense and sense strands, respectively. New strands 
are then extended from these primers in the 5’ to 3’ direction by Taq or Pfu 
DNA polymerase (dotted lines). Melting, reannealing and extension occur 30 
times producing the -1000 bp fragment "a". This fragment has a Sal I site just 
5' to the coding sequence and the alanine m utation is at the 3' end 
(corresponding to the sense cDNA strand). In reaction 2, the second 
m utagenic prim er (which is com plem entary to that used in reaction 1) and 
G3-End, bind to m elted GLUT3 antisense and sense strands, respectively. 
New. strands are then .extended from .these primers in the 5' to 3' .direction by 
Taq or Pfu DNA polymerase (dotted lines). This time a -600 bp fragment "b" 
is produced. This fragm ent has a Sal I site just 3' to the coding sequence and 
the alanine m utation is at the 5' end (corresponding to the sense cDNA 
strand).
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Figure 5.3.a-
Recombinant PCR used for the Construction of GLUT3 Helix 8 M utants.
Internal prim ers Helix 8
3' Xenopus 
UTRG3End
G3Start
Prim ary  PCR a. A m P Resistance
5' GLUT3 sense strand 3'
5'
V................................................... T ----------
Internal p rim er a.
G3Start
\ -------- L .................................................V>
3' , GLUT3 antisense strand
■ i
Sal  I site. y
^  *
\
Prim ary PCR b. Prim ary product a Helix 8
5' GLUT3 sense strand 3'
      ^
\  ^ \
G3End
Internal p rim erb
*  m m m m m m m m m m m m m k
\  Il-I
3' GLUT3 antisense strand 5'
Helix 8 ±  S a l  I site.
 I  ^
1
Prim ary product b
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Figure 5.3.b
This shows the events occurring during a secondary PCR reaction 
(section 2.7.2 or 2.7.3.b). This time equal quantities of products "a" and "b" are 
used as the templates for a second set of cycles with both G3-Start and G3-End 
primers. For amplification to occur, the two templates m ust melt and anneal 
to form a single template. This is possible since the there is a short overlap of 
18-24 bp between the two templates at the 3' end of the sense cDNA strand of 
prim ary p roduct "a" and the antisense strand of prim ary p roduct "b", 
corresponding to the m utated helix 8 region. In the first few cycles of PCR, 
these strands can anneal and extend in a 5' to 3' direction (dotted lines) to 
form a full length secondary product "ab", which can act as a tem plate for 
amplification w ith G3-Start and G3-End. Note that only the sense strand of 
"a” and antisense strand of "b" can be extended after association, since binding 
of the antisense strand of "a" and sense strand of "b" leads to a complex which 
cannot be extended in a 5' to 3' direction. The form ation of "a"/"b" 
complexes is also a relatively infrequent event w hen com pared to the 
frequency of self-association of "a" and "b" strands. Both these factors make 
secondary PCR yields much lower than those obtained from primary PCR.
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Figure 5.3.b-
Diagram showing Secondary PCR Reactions.
Sal  I site . 
\
X-------
Helix 8 Sa l  I site.
 1 ^ .
Prim ary product a Helix 8 " Prim ary product b
Sense ^
strand a 3'
•
3' ■
■
■
Helix 8 Antisense strand b 3
5'
■■
t 3'
G3Start ^ '  G3End
X
3'
■
■
■
■
5'
Sa l  I site .
■
■■
*
'  \  ; 7~
Helix 8 S a l  I site. 
M utation
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Figure 5.4
This shows a photograph of samples of various PCR products and 
vector cDNAs which have been electrophoresed on a 1% agarose gel and 
stained with ethidium  bromide (section 2.5.3). Lanes 1 and 8 contain 0.625 pg 
of BstE II-digested lambda DNA. Lane 2 contains 1 pi (from a total of 30 pi) of 
prim ary PCR product "b" generated using Pfu DNA polymerase (Figure 5.3.a). 
Lane 3 contains 1 pi (from a total of 30 pi) of prim ary PCR product "a" 
generated using Pfu DNA polymerase (Figure 5.3.a). Lane 4 contains 1 pi 
(from a total of 10 pi) of secondary PCR product "ab" generated using Pfu 
DNA polymerase and 1 pi each of 1/10-diluted products "a" and "b" (Figure 
5.3.b). Lane 5 contains 1 pi (from a total of 5 pi) of EcoR V/BsfX I-digested and 
purified secondary product "ab". Lane 6 contains 1 pi (from a total of 10 pi) of 
EcoR V/BsfX I-digested and purified pSPGT3 vector backbone. Lane 8 
contains 1 pi of 2 m g /m l dsDNA isolated from a subclone transformed with a 
ligation containing 0.5 pi of EcoR V /B s tX  I-digested and purified pSPGT3 
vector backbone and 5 pi of EcoR V/BsfX I-digested and purified secondary 
product "ab". This cDNA subclone was sequenced and found to be pSPGT3 
containing the desired mutation.
Lane Band sizes (in base pairs)
4
6
2
3
5
7
-600
-1000
-1600
871
4825
5696
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Figure 5.4 -
A 1% Agarose gel showing various P.C.R. products and vectors used 
in cloning.
1 2 3 4 5 6 7 8
Figure 5.5
This diagram  shows the EcoR V /B s tX  I digestion of pSPGT3 and 
secondary PCR product, and the ligation of the purified vector backbone and 
the 871 bp PCR insert to produce an intact pSPGT3 vector incorporating a 
m utated GLUT3 codon in the sequence region encoding putative helix 8.
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Figure 5.5-
Digestion of Secondary PCR Products and Subcloning into pSPGT3.
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<xS
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-  r—i
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CL.s
<
M u tation
:coR V 1632
3' X enopus U TR
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Figure 5.6
This diagram  shows the Stu l /P vu  I digestion of both "mutant" and 
w ild-type GLUT3 sequences in pSPGT3, and the ligation of the 3100 bp 
purified vector backbone from the wild-type GLUT3-containing construct and 
the 2596 bp "mutant" insert to produce an intact pSPGT3 vector incorporating 
a m utated GLUT3 codon in the sequence region encoding putative helix 8, but 
w ithout any other altered sequences. This process is designed to excise any 
m isincorporated  bases from the region betw een the Stu I and EcoR V 
restriction sites, introduced by Taq DNA polymerase.
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Figure 5.6-
Excision of Misincorporated Bases using Stu I and Pvu I.
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GLUT3
Helix 8 
M utan tStu 11265
P v u  1 4365
Excision w ith Pvu I &  Stu I
Stu 1 1265
3100 bp 
MUTATED 
VECTOR 
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Misinoarparations
Ligation
Mutant
pSPGT3
N o ' ^  ^  Helix 8
M isincarparations W ild-type
Discard
N o
M isincorporations Helix 8 M utan t
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Figure 5.7
This diagram  shows the Sac I digestion of both "mutant" and wild-type 
GLUT3 sequences in pSPGT3, and the ligation of the 4413 bp purified vector 
backbone from the wild-type GLUT3-containing construct and the 1283 bp 
"mutant" insert to produce an intact pSPGT3 vector incorporating a m utated 
GLUT3 codon in the sequence region encoding putative helix 8, bu t w ithout 
any other altered sequences. This process is designed to excise any misincor- 
porated bases from the region betw een the BstX I and first Sac I restriction 
sites, introduced by Taq DNA polymerase.
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Figure 5.7-
Excision of Misincorporated Bases using Sac I Digestion.
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4413 bp  A*
A m p  Resistance Fragment
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Figure 5.8
This is a diagramm atic representation of the GLUT3 coding sequence 
from the 5' end of the sense cDNA strand to the 3’ end. Position "0" 
corresponds to base "0" in pSPGT3. The GLUT3 open reading frame (ORF) 
begins at position 255 and ends (STOP) at position 1743. The approxim ate 
locations of several restriction sites are shown and the sequence encoding 
putative transm em brane helix 8 bordered by vertical dashed lines. The 
annealing positions of all sequencing primers (Table 5. 2) and G3-Start and G3- 
End are shown. Sequencing primers (dotted lines) pointing from left to right 
and depicted above the GLUT3 cDNA bind the antisense strand and yield 300- 
350 bp sequences of the cDNA to their right. Primers pointing from right to 
left and depicted below the GLUT3 cDNA bind the sense strand and yield 300- 
350 bp sequences of the cDNA to their left. Comparison of sequences using all 
the primers is sufficient to accurately describe the sequence between the EcoR 
V and BstX I restriction sites. All initial screening of possible "m utant” clones 
was achieved using prim er G3 2B+. This was found to yield accurate 
sequences of the helix 8-encoding region. This primer was also chosen since it 
binds the GLUT3 cDNA sense strand, which is the only one present when 
sequencing M13mpl8GT3 ssDNA.
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Figure 5.8-
Diagram show ing the Binding Positions of Various Sequencing and 
M utagenesis Oligonucleotides in the GLUT3 cDNA.
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Figure 5.9
This is a graph showing transport of [3H ]2-deoxy-D -glucose intc 
Xenopus oocytes injected w ith either wild-type, or one of nineteen m utant 
GLUT3 mRNAs. Rates of transport into non-injected oocytes were deductec 
from each injected rate, and the adjusted rate expressed as a percentage of the 
adjusted transport rate into wild-type GLUT3-injected oocytes. Each columi 
represents the adjusted transport rate into 7 oocytes + standard deviations 
from a representative experiment (if n > 1). Typical rates of wild-type GLUT' 
2-deoxy-D-glucose transport were 4.5-5.0 pm oles/m in/oocyte.
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Figure 5. 9-
2-deoxy-D-glucose Transport Rates of Various GLUT3 M utants 
as a Percentage of W ild-type GLUT3 Transport Levels.
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5.5 Discussion.
The im portance of various conserved amino acid residues in GLUT1 
have been extensively investigated by m utagenesis. These studies have 
shown that substitution of some of these residues by other am ino acids has 
led to changes in the behaviour of the transporter protein. These changes 
include reductions of transporter intrinsic activity and reduction of the 
affinity of various sugars and ligands for the transporter (reviewed in section 
5.2.1). How ever the m utagenesis of other transporters has generally been 
limited to construction of chimeric GLUT1/ GLUT4 transporters for the study 
of GLUT4 targeting (reviewed James et al., 1993), with the exceptions being the 
GLUT1/ GLUT2 chimera which was constructed for the study  of kinetic 
differences between the two transporter isoforms (Katagiri et al., 1992), and a 
few site-directed mutagenesis studies described in section 5.2.1.
This study investigates the im portance of the residues of putative 
transmembrane helix 8 in GLUT3. Although work on helix 7 in GLUT1 has 
been extensive, the only other helix 8 residues which have been investigated 
are GLUT1 residue asparagine-317 (Asn317-> lie; Hashiramoto et al., 1992) and 
GLUT4 residue tyrosine-308 (Tyr308->Phe; W andel et al., 1994). Asn3*7-> lie 
exhibited no decrease of 2-deoxy-D-glucose uptake relative to wild-type levels. 
Cytochalasin B and ATB-BMPA labelling levels were also equivalent to wild- 
type GLUT1. Likewise, the Tyr308->Phe m utant showed no differences in 
glucose transport activity and ligand binding from wild-type GLUT4.
Figure 5.1.a show s an alignm ent of protein sequences of hum an, 
mouse, rat and rabbit facilitative glucose transporters in the region of putative 
transm em brane helix 8. As can be seen the sequence is highly conserved 
between transporter isoforms. Residues Tyr306, Thr308, Gly310, Gly312, Asn315, 
and Thr319 (GLUT3 nomenclature) are identical between all isoforms. Note
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that residues Ala307, lie309, Val321, and Ser322 are also identical in GLUTs 1-4, 
which are D-glucose transporters, unlike GLUT5 which transports D-fructose. 
Val314, Thr316, and Phe318 are identical in GLUTs 1, 3 and 4 but are altered in 
GLUT2. Indeed, GLUT2 shows the greatest diversity between isoforms from 
different species, with four non-identical residues in this region alone. All 
other transporte r isoform s have com plete iden tity  of p ro te in  sequence 
between species in this helix.
A possible orientation of GLUT3 helix 8 is shown in Figure 5.1.b. This 
shows a view looking down through the a-helix from above, where residue 
lie305 is at the "bottom" and the helix progresses upw ards in a clockwise 
direction to residue Leu325. The amphipathic nature of the helix can be seen 
as the majority of the polar residues are situated at one side of the helix, and 
the hydrophobic residues are present on the other side. Invariant residues 
Thr308, Asn315, and Thr319 are found on the "polar side", but residue Tyr306 is 
predicted to lie directly opposite these which would infer that it is presumably 
in contact w ith lipid rather than part of a protein pore. The polar residues 
Ser322 and Thr316 are also predicted to lie on the "polar side" of the a-helix.
Preliminary studies revealed that GLUT3 2-deoxy-D-glucose transport 
rates were seemingly unaltered by most substitutions (Figure 5.9). However, 
substitution of Thr308, Thr316, Thr319, and Ser322 by Ala led to a 50% reduction 
in 2-deoxy-D-glucose transport relative to wild-type levels, and residues lie305, 
G ly310, and Gly312 by Ala led to a 150% to 200% increase in transport. Of 
course, the effects of the latter m utations are m ost probably due to an 
increased concentration of transporter protein but an increase in intrinsic 
activity cannot be ruled out. Likewise the observed decreased transport in the 
Thr308, Thr316, Thr319, and Ser322 m utants are quite possibly due to reduced 
expression of these transporter isoforms rather than decreased intrinsic 
activity. These questions can only be answered by m easuring protein levels in
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m utant and wild-type oocyte plasma membranes. Targeting of each m utant 
to the plasma membrane should also be assessed.
In addition, other kinetic param eters need to be m easured. These 
include Km and Vmax values for the zero-trans entry of 2-deoxy-D-glucose and 
D-galactose, the secondary substrate of GLUT3. K* values for the inhibition of 
2-deoxy-D-glucose or D-galactose transport by D-glucose, maltose and 4,6-0- 
ethylidene-D-glucose transport should be m easured as these will give an 
indication of any changes of affinity of the exofacial binding site for these 
sugars. Binding studies with [3H]ATB-BMPA should also be undertaken to 
determine effects m utation on its binding site. ATB-BMPA has been proposed 
to bind to GLUT1 helix 8 (Davies et al., 1991). The site of the covalent bond 
form ed betw een glucose transporters and ATB-BMPA by photolabelling 
might also be discovered by assaying each m utant for binding (if the site of 
interaction is in helix 8).
Cytochalasin B binding studies on oocyte plasm a m em branes which 
express m utant transporters, and m easurem ent of the K* values for this 
com pound's inhibition of 2-deoxy-D-glucose and D-galactose transport by 
m utant GLUT3 isoforms should also be undertaken to assess w hether the 
endofacial sugar binding site has been affected by substitu tion of these 
residues. This is unlikely since the site of cytochalasin B binding has been 
localised to helices 10 and 11, bu t it is possible that other regions also 
contribute to the binding properties of this inhibitor.
It is interesting to note that no reduction of transport activity was 
observed with the Asn3!5- >Ala and Tyr306->Ala m utants relative to wild-type 
GLUT3 levels, since these results were also found w ith substitution of the 
equivalent residues in GLUT1 (Asn317; Hashiram oto et al., 1992) and GLUT4 
(Tyr308; W andel et al., 1994). However the results of this study are by no 
means conclusive.
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A lthough m any transporter residues have been substitu ted  in a 
num ber of studies, the frequency of finding one which affects transport 
activity or ligand binding is low. However, m any residues, which have been 
found not to affect transport, are highly conserved betw een transporter 
isoforms. As speculated by Mueckler (Mueckler et al., 1994a), these residues 
m ust play an im portant role in some aspect of transporter structure, that is 
not measured by the assays performed. Mutations m ight cause an alteration 
of the kinetic properties under physiological conditions that is not measurable 
in Xenopus oocytes, or may affect protein stability or regulation by unknown 
factors.
On the other hand, substitu tion  of non-conserved residues has 
frequently led to a large reduction in transport activity. For example, 
replacement of the non-conserved helix 8 residue, Val402, of SNF3 with lie 
(M arshall-Carlson et al., 1990) and the replacement of Val197 (GLUT2) and 
V al165 (GLUT1) with lie (Mueckler et al., 1994b) completely abolish sugar 
transport. This is su rp rising  given the conservative  n a tu re  of the 
substitutions, but the increased size of the isoleucine side chain relative to the 
wild-type residue may block the transport of glucose.
5.6 Sum m ary
GLUT3 residues 305-325 have individually  been substitu ted  w ith 
alanine by alteration of the sequence of the GLUT3 cDNA. These m utants 
have been expressed heterologously in Xenopus oocytes, by injection with in 
vitro-synthesised mRNA. All m utants have been successfully expressed and 
at least partially successfully targeted to the plasma membrane, as determined 
by the transport of radiolabelled 2-deoxy-D-glucose. Further studies are 
required to quantitate the expression levels and plasma mem brane targeting
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of each m utant transporter. In addition, kinetic parameters for transport of 2- 
deoxy-D-glucose and D-galactose need to be m easured and the inhibitory 
effects of various sugars and ligands determined.
241
CHAPTER 6 
D iscu ssion
Understanding the structural basis of glucose transporter function is a 
key issue when trying to understand glucose transporter dysfunction, which 
may play a causal role in some forms of diabetes. For example, peripheral 
insulin resistance may be caused by GLUT4 depletion or inactivation in 
skeletal m uscle and fat, and lead to non-insulin  dependen t diabetes. 
Moreover, GLUT2 is likely to be an im portant factor in insulin secretion and 
whole-body glucose homeostasis, due to its presence in the p-cells of the 
pancreas and in the liver, respectively.
Many structural studies have been carried out on GLUT1, due to its 
availability and the ability to obtain this isoform in a purified, functional 
form. Investigation of the kinetic profile of this transporter and use of 
physical techniques to directly probe its structure have elucidated a structure 
comprising 12 transmembrane helices which seem to form a pore structure, 
passively transporting D-glucose by virtue of a conformational change which 
re-orientates glucose from an exofacial to an endofacial binding site, where it 
is released inside the cell. Use of specific probes and m utagenic techniques 
have identified certain regions of the prim ary sequence and specific amino 
acid residues which may be im portant in the interaction of the transporter 
and D-glucose and also regions involved in the conformational changes.
Com parison of the prim ary  sequences of o ther m em bers of the 
facilitative glucose transporter family reveals high identity with GLUT1. In 
addition, hydropathy  analysis of these other isoform s yields a pattern  
virtually identical to that of GLUT1. These factors and the similarities of 
substrate specificity, kinetic profile, and ligand binding betw een isoforms 
reveals that all transporters share a similar structure and m ode of action. 
However, the transporters are d istribu ted  in a tissue-specific m anner, 
suggesting that they have subtly evolved to m eet the different glucose 
requirements of these tissues. Indeed expression of glucose transporters in
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oocytes reveals that not only are the kinetic param eters of each transporter 
different, but also the substrate selectivity. For example, GLUT2 has been 
shown to transport both D-fructose and D-glucose, w hilst GLUT5 seems 
primarily to be a D-fructose transporter.
The purpose of this study  is the characterisation of the kinetic 
properties of GLUT2 and GLUT3, whilst expressed in Xenopus oocytes, and, 
using these values as a guideline, to investigate the structural/functional 
properties of amino acid residues in a region which have been implicated as 
the exofacial site of glucose binding in GLUT1, transmembrane helix 8. This 
helix contains several polar residues which are highly conserved between 
glucose transporter isoforms, and also occur in related transporters from 
diverse organisms. These residues have the capacity to form hydrogen bonds 
with the hydroxyl groups of D-glucose, allowing D-glucose to reversibly bind 
to the exofacial binding site. A m utagenic approach was selected, whereby 
each of the nineteen am ino acid residues of helix 8 was indiv idually  
substituted with alanine, rem oving the ability of that residue to form 
hydrogen bonds. A parallel study was carried out investigating the effects of 
effectively removing or substituting the hydroxyl groups of D-glucose on the 
interaction of that sugar with either GLUT2 or GLUT3, whilst expressed in 
Xenopus oocytes.
The kinetic param eters of zero-trans entry of 2-deoxy-D-glucose into 
GLUT2- and GLUT3-expressing oocytes, and the inhibitory effects of other 
sugars on that transport confirm previous findings that GLUT2 and GLUT3 
are low affinity and high affinity transporters, respectively (reviewed in 
Gould & Holman, 1993). In addition, GLUT2 transports p-D-fructose w ith 
low er affinity. Analysis of the effects of D -fructopyranose and  D- 
fructofuranose fixed-ring analogues indicate that whilst D-glucose is known 
to bind in the pyranose ring form, the furanose form of D-fructose seems to
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bind to GLUT2. This is in agreem ent w ith a study of the trypanosom e 
transporter which also transports these configurations of D-glucose and D- 
fructose (Fry et al., 1993).
Following investigations of the molecular basis of the interactions of D- 
glucose with GLUT1 (Barnett et al., 1973; Kahlenberg & Dolansky, 1972) and 
GLUT4 (Rees & Holm an, 1981), sim ilar, if less extensive, studies were 
perform ed with GLUT2 and GLUT3 expressed in Xenopus oocytes. The 
results indicate that hydrogen bonding at the C -l, C-3 and C-4 positions of D- 
glucose occur during binding and transport w ith both isoforms, and that 
hydrophobic interactions between the C-6 position of the sugar and each 
transporter also occur. The nature of the bond betw een the C-3 hydroxyl 
group of D-glucose and GLUT2 is proposed to be different from that formed by 
other transporter isoforms. In addition, the formation of the bond between 
the C-4 hydroxyl group of D-glucose and GLUT3 is less essential for transport 
than required by other transporter isoforms. Differences in the interaction of 
D-glucose with each transporter are predicted by the different substrate 
specificities of each isoform. For example, the relative high affinity of GLUT3 
for D-galactose, the C-4 epimer of D-glucose, is reflected by the different nature 
of that transporter in the region which interacts with the C-4 position of D- 
glucose. The interactions of the transporter/sugar which are m easured above 
probably occur in the exofacial binding site, due to the nature of the assay (see 
chapter 4) but it cannot be ruled out that some of the m easured interactions 
may be influenced by affinities of transporter/sugar during transport itself.
Until it is possible to functionally purify and crystallise all of the 
facilitative glucose transporters, the only means to study their structure, more 
fully than has been done already, is use of molecular biological techniques to 
study which regions and residues are im portant for transporter function.
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One approach utilises the construction of cDNAs w hich encode 
GLUT2/GLUT3 chimeric proteins, with varying proportions of GLUT2 and 
GLUT3 sequence, and expression of these in Xenopus oocytes. For example, 
the ability of each protein to transport D-fructose should indicate which 
part(s) of the GLUT2 sequence is responsible for binding that sugar. Chimeric 
approaches have already been used and have dem onstrated that replacement 
of the C-terminal domain of GLUT1 with that of GLUT2 leads to an increase 
of Km and Vmax values for 2-deoxy-D-glucose transport compared to wild-type 
GLUT1 (Katagiri et al., 1992), suggesting that the C-terminal dom ain might at 
least partially confer some of the kinetic properties specific to each isoform. 
More localised site-directed m utagenesis w ithin the C-terminal dom ains of 
GLUTs 1 and 2 might reveal which amino acid residues of this dom ain are 
responsible for interaction w ith D-glucose or producing  conform ational 
effects such that the intrinsic activity of the transporter is affected.
The use of chim eras is com plem ented  by s tu d ies  involv ing  
mutagenesis of individual amino acids, such as this study. Here, the injection 
of various mRNAs encoding GLUT3, each w ith one helix 8 amino acid 
residue substituted with alanine, into Xenopus oocytes, all resulted in some 
degree of functional expression, as determined the ability to transport 2-deoxy- 
D-glucose. Preliminary comparison of transport levels w ith oocytes injected 
with a similar quantity of wild-type GLUT3, suggest that substitution of any of 
three threonine residues results in a decrease in the ability of GLUT3 to 
transport 2-deoxy-D-glucose. However, increases in the level of transport, 
relative to w ild-type levels, were observed w ith other m utants, which are 
unlikely to be attributable to increased transporter catalytic activity. This issue 
requires to be addressed by m easurem ent of transporter num bers at the cell 
surface and by a more extensive kinetic analysis, including determination of 
the affinities of each m utant for 2-deoxy-D-glucose, D-galactose, D-glucose and
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exofacial ligands such as maltose and 4,6-O-ethylidene-D-glucose. These 
values should indicate whether or not each m utant shows im paired binding 
a n d /o r transport ability. Photoaffinity labelling of m utant transporters with 
ATB-BMPA or cytochalasin B and com parison w ith  relative w ild-type 
labelling should indicate the potential participation of each helix 8 residue in 
either the exofacial or endofacial binding sites, respectively. D isruption of 
ATB-BMPA labelling is much more likely, since this probe has been proposed 
to bind helix 8 of GLUT1 (Davies et al., 1991), whereas cytochalasin B labelling 
occurs in region of helices 10-11 (Holman & Rees, 1987).
The results of this and other m utagenic studies, past and future, could 
be combined with investigations of the specificity of each isoform  for D- 
glucose analogues, as determ ined for w ild-type transporters, to discover 
which transporter residues interact w ith each sugar hydroxyl group, or are 
involved in hydrophobic interactions. This approach could also be used to 
determine which GLUT2 and GLUT5 residues are responsible for interaction 
with each hydroxyl group of D-fructose. Use of m utagenesis and dom ain- 
sw apping in the same protein, after the characterisation of the non-m utant 
construct m ight also prove inform ative. W ith extensive application of 
molecular biological techniques to construct num erous m utant transporters, 
and careful analysis of the properties of each, it should be possible to build a 
picture of the binding sites of each transporter.
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